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Advances	   in	   the	   genetic	   analysis	   of	   humans	   have	   revealed	   a	   surprising	   abundance	   of	   local	  
relatedness	   between	  purportedly	   unrelated	   individuals.	  Where	   common	  mutations	   classically	  
inform	  us	  of	  ancient	  relationships,	  such	  segments	  of	  pairwise	  identical	  by	  descent	  (IBD)	  sharing	  
from	   a	   common	   ancestor	   are	   the	   observable	   traces	   of	   recent	   inter-­‐mating.	   Combining	   these	  
two	  distinct	  sources	  of	  information	  can	  help	  disentangle	  the	  complex	  genetic	  structure	  and	  flux	  
in	  human	  populations.	  When	  considered	  together	  with	  a	  heritable	  trait,	  the	  segments	  can	  also	  
be	  used	  to	  interrogate	  unascertained	  rare	  variation	  and	  help	  in	  locating	  trait-­‐effecting	  loci.	  This	  
work	   presents	   methods	   for	   comprehensive	   analysis	   of	   population-­‐wide	   IBD	   and	   explores	  
applications	  to	  disease	  and	  the	  understanding	  of	  recent	  genetic	  variation.	  
We	  propose	  several	  strategies	  for	  efficient	  detection	  of	   IBD	  segments	   in	  population	  genotype	  
data.	   Our	   novel	   seed-­‐based	   algorithm,	  GERMLINE,	   can	   reduce	   the	   computational	   burden	   of	  
finding	   pairwise	   segments	   from	   quadratic	   to	   nearly	   linear	   time	   in	   a	   general	   population.	  We	  
demonstrate	  that	  this	  approach	  is	  several	  orders	  of	  magnitude	  faster	  than	  the	  available	  all-­‐pairs	  
methods	  while	  maintaining	   higher	   accuracy.	   Next,	   we	   extended	   the	  GERMLINE	   technique	   to	  
process	   cohorts	   of	   unlimited	   size	   by	   adaptively	   adjusting	   the	   search	   mechanism	   to	   meet	  
resource	  restrictions.	  We	  confirm	  its	  effectiveness	  with	  an	  analysis	  of	  50,000	  individuals	  where	  
	  
	  
contemporary	   methods	   can	   only	   process	   a	   few	   thousand.	   One	   draw-­‐back	   of	   these	   two	  
algorithms	  is	  the	  dependence	  on	  phased	  haplotype	  data	  as	  input	  –	  a	  constraint	  that	  becomes	  
more	  difficult	  with	  large	  populations.	  We	  propose	  a	  solution	  to	  this	  problem	  with	  an	  algorithm	  
that	   analyzes	   genotype	   data	   directly	   by	   exploring	   all	   potential	   haplotypes	   and	   scoring	   each	  
putative	   segment	   based	   on	   linkage-­‐disequilibrium.	   This	   solution	   significantly	   outperforms	  
available	  methods	  when	  applied	  to	  full	  sequence	  data	  and	  is	  computationally	  efficient	  enough	  
to	   analyze	   thousands	   of	   sequenced	   genomes	   where	   current	   methods	   can	   only	   determine	  
haplotypes	  for	  several	  hundred.	  
Secondly,	   we	   outline	   two	   algorithms	   for	   analyzing	   available	   IBD	   segments	   to	   increase	   our	  
understanding	  of	  rare	  variation	  and	  complex	  disease.	  Motivated	  by	  whole-­‐genome	  sequencing,	  
we	   present	   the	   INFOSTIP	   algorithm,	   which	   uses	   IBD	   segments	   to	   optimize	   the	   selection	   of	  
individuals	   for	   complete	   population	   ascertainment.	   In	   simulations,	   we	   show	   that	   INFOSTIP	  
selection	  can	  significantly	  increase	  variant	  inference	  accuracy	  over	  random	  sampling	  and	  posit	  
inference	  of	  60%	  of	  an	   isolated	  population	  from	  1%	  optimally	  selected	   individuals.	  Seeking	  to	  
move	  beyond	  pairwise	   IBD	   segment	   analysis,	  we	  describe	   the	  DASH	   algorithm,	  which	   groups	  
shared	  segments	  into	  IBD	  “clusters”	  that	  are	  likely	  to	  be	  commonly	  co-­‐inherited	  and	  uses	  them	  
as	   proxies	   for	   un-­‐typed	   variation.	   In	   simulated	   disease	   studies,	   we	   show	   this	   reference-­‐free	  
approach	  to	  be	  much	  more	  powerful	   for	  detecting	  rare	  causal	  variants	  than	  either	  traditional	  
single-­‐marker	   analysis	   or	   imputation	   from	   a	   general	   reference	   panel.	   Applying	   the	   DASH	  
algorithm	   to	   disease	   traits	   from	   different	   populations,	   we	   identify	   multiple	   novel	   loci	   of	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However beautiful the strategy, you should occasionally look at the results. 
— Winston Churchill 
 






Major	   advances	   in	   mapping	   complex	   traits	   have	   been	   made	   possible	   by	   genome-­‐wide	  
association	   studies	   in	   cohorts	   of	   purported	   unrelated	   individuals.	   The	   investigation	   of	   such	  
large-­‐scale	   genotype	   data	   brings	   renewed	   interest	   and	   potentially	   novel	   insights	   to	   an	   old	  
question:	  Are	  individuals	  really	  unrelated	  and	  to	  what	  extent?	  While	  every	  pair	  of	  individuals	  is	  
descended	  from	  the	  same	  person	  if	  you	  follow	  their	  genealogy	  infinitely	  into	  the	  past,	  we	  are	  
particularly	   interested	   in	   recent	   common	   ancestry,	   occurring	   during	   the	   last	   few	   centuries.	  
More	   specifically,	   we	   focus	   on	   relatives	   in	   the	   genetic	   sense,	   who	   not	   only	   share	   a	   recent	  
progenitor,	  but	  also	  co-­‐inherit	  some	  of	  that	  ancestor's	  genome.	  This	  portion	  of	  the	  genome	  is	  
therefore	  identical	  by	  descent	  (IBD)	  in	  one	  haploid	  copy	  shared	  by	  contemporary	  progeny.	  
Modern	  association	  studies,	  with	  individuals	  by	  the	  thousands	  and	  marker	  counts	  running	  into	  
the	   millions,	   bring	   forth	   fresh	   incentives	   for	   quantifying	   relatedness,	   alongside	   new	  
opportunities	   and	   technical	   challenges.	   In	   terms	   of	   motivation,	   such	   studies	   impel	   kinship	  
analysis	   as	   they	  hinge	  on	   the	  premise	  of	   independent,	   identically	   distributed	  observations	  of	  
unrelated	   individuals	   sampled	   from	   the	   population,	   an	   assumption	   that	   is	   violated	   among	  
related	  individuals	  whose	  alleles	  along	  some	  haploid	  segments	  of	  the	  genome	  are	  IBD.	  Related	  
individuals	   bias	   not	   only	   association	   statistics	   in	   the	   regions	   of	   the	   genome	   shared	   between	  
them,	   but	   may	   also	   taint	   analysis	   of	   population	   structure	   that	   affects	   results	   for	   the	   entire	  
genome.	   On	   the	   other	   hand,	   properly	   understanding	   and	   accounting	   for	   the	   structure	   of	  




homogeneity.	   Moreover,	   where	   traditional	   linkage	   analysis	   is	   practical	   for	   small	   families	   of	  
affected	   individuals,	   shared	   IBD	   segments	   can	   facilitate	   a	   similar	   strategy	   within	   an	   entire	  
population	  by	  treating	  IBD-­‐pairs	  as	  local	  surrogate	  relatives	  -­‐	  extending	  linkage	  techniques	  into	  
the	  GWAS	  era.	  
In	  this	  work,	  we	  present	  computational	  methods	  and	  techniques	  for	  efficiently	  identifying	  IBD	  
segments	  in	  large	  populations	  and	  apply	  our	  understanding	  of	  these	  segments	  to	  study	  recent	  
population	   relatedness	   and	   the	   rare	   variation.	   The	   thesis	   is	   divided	   into	   two	  main	  parts.	   The	  
first	  part,	  “Efficient,	  population-­‐wide	  analysis	  of	  segments	  identical-­‐by-­‐descent”	  motivates	  and	  
outlines	  novel	  algorithms	  for	  analysis	  of	  relatedness	  in	  large-­‐scale	  populations.	  In	  Chapter	  2,	  we	  
describe	   the	   hashing	   and	   extension	   paradigm	   of	   the	   GERMLINE	   algorithm	   that	   allows	  
population-­‐scale	   analysis	   in	   near-­‐linear	   time.	   We	   compare	   this	   algorithm	   to	   contemporary	  
exhaustive-­‐pairs	   strategies	   and	   show	   that	   GERMLINE	   increases	   efficiency	   and	   accuracy.	   In	  
Chapter	   3,	  we	  extend	   this	   algorithm	   to	   analysis	   of	   combined	  populations	  of	   arbitrary	   size	  by	  
optimizing	  detection	  sensitivity	  under	  a	  given	  memory	  threshold.	  We	  demonstrate	  the	  power	  
of	  this	  approach	  by	  analyzing	  a	  large	  combined	  population	  of	  100,000	  chromosomes.	  In	  Chapter	  
4,	  we	  extend	  this	  algorithm	  to	  analyze	  un-­‐phased	  data	  and	  construct	  a	  probabilistic	  model	  for	  
scoring	   putative	   IBD	   segments.	   We	   analyze	   the	   effectiveness	   of	   this	   strategy	   in	   simulated	  
sequence	  data	  and	  compare	  to	  recent	  novel	  methods.	  In	  the	  second	  part,	  “Mining	  population-­‐
wide	   patterns	   of	   IBD	   sharing”	   we	   explore	   the	   utility	   a	   broad	   genetic	   knowledge	   of	   recent	  
relatedness	   can	   offer	   in	   analysis	   of	   populations	   and	   disease.	   In	   Chapter	   5,	   we	   develop	   an	  




relatedness.	   We	   demonstrate	   the	   effectiveness	   of	   this	   algorithm	   in	   simulated	   imputation	  
experiments	  and	  validate	  the	  effectiveness	  of	  IBD	  discovery	  in	  whole-­‐genome	  sequence	  data.	  In	  
Chapter	   6,	  we	   develop	   an	   algorithm	   for	   grouping	   pairwise	   relatedness	   into	   localized	   clusters	  
that	  are	  expected	  to	  be	  entirely	  derived	  from	  a	  common	  ancestor,	  allowing	  us	  to	  move	  beyond	  
simple	  pairs	  in	  studying	  a	  population.	  We	  show	  the	  effectiveness	  of	  these	  clusters	  in	  capturing	  
untyped	   variation	   and	   apply	   it	   specifically	   to	   phenotype	   mapping	   in	   a	   thoroughly	   sampled	  
isolated	  population,	   recovering	  a	  number	  of	   significant	  disease	  associations.	  We	   close	  with	   a	  
discussion	  of	  the	  open	  questions	  and	  challenges	  that	  remain.	  
1 Introduction to human genetics 
1.1 Fundamentals of population genetics 
The	  study	  of	  population	  genetics	  focuses	  on	  understanding	  the	  flux	  of	  genetic	  loci	  in	  groups	  of	  
individuals	  and	  attempts	  to	  elucidate	  the	  guiding	  underlying	  principles.	  From	  a	  computational	  
perspective,	  the	  available	  input	  is	  a	  series	  of	  variable	  markers	  corresponding	  to	  an	  individual	  or	  
group	  of	  individuals	  with	  each	  marker	  consisting	  of	  one	  or	  more	  states	  or	  alleles.	  These	  genetic	  
markers	   can	  be	  as	   simple	  as	   the	  nucleotides	  of	  a	   single	   copy	  of	  a	   chromosome	  of	  DNA,	  with	  
possible	  alleles	  A,	  C,	  G,	  and	  T.	  For	  the	  autosomal	  chromosomes	  of	  a	  human	   individual,	  which	  
inherits	  a	  single	  such	  haploid	  copy	  from	  each	  biological	  parent	  to	  form	  a	  single	  diploid	  genome,	  
the	  alleles	  can	  correspond	  to	  the	  eight	  possible	  diploid	  pairings	  of	  nucleotides	  (or	  six	  possible	  
unique	  pairings).	   These	  markers,	   spanning	   the	   roughly	  3	  billion	  base-­‐pairs	   (bp)	  of	   the	  human	  
genome,	  are	  referred	  to	  as	  genotypes;	  with	  a	  distinction	  commonly	  made	  between	  a	  pairing	  of	  




genetic	   input	  can	  consist	  of	  complex	  markers	  with	  many	  alleles,	   individually	  corresponding	  to	  
spans	   of	   multiple	   nucleotides;	   for	   example,	   representing	   the	   complex	   structural	   variation	  
abundant	  in	  the	  human	  genome.	  However,	  because	  a	  genotype	  is	  one	  of	  the	  most	  basic	  units	  of	  
human	  genetics,	  this	  work	  primarily	  focuses	  on	  the	  analysis	  of	  such	  genotypic	  data	  from	  diverse	  
individuals.	  In	  a	  neutral	  population,	  we	  can	  think	  of	  the	  diversity	  in	  genotypes	  to	  be	  driven	  by	  
two	  primary	  features:	  mutation	  and	  recombination.	  In	  the	  next	  sections,	  we	  will	  quantify	  these	  
phenomena	  and	  discuss	  the	  ways	  they	  have	  shaped	  the	  human	  genetic	  landscape.	  
Mutation	  
A	  mutation	  is	  the	  spontaneous	  change	  in	  the	  allele	  of	  a	  single	  nucleotide,	  and	  accounts	  for	  the	  
single-­‐point	   diversity	   of	   the	   human	   genome.	   These	   mutations	   can	   alter	   the	   function	   of	   cell	  
processes	  in	  a	  myriad	  of	  direct	  and	  in-­‐direct	  ways	  and	  the	  search	  for	  such	  causal	  variants	  and	  
their	   functional	   impact	  motivates	  much	   genetic	   research.	  Within	   a	   single	   human	   generation,	  
the	   mutation	   rate	   is	   approximately	   2.5x10-­‐8	   per	   nucleotide1;	   though	   recent	   study	   of	   whole-­‐
genome	   data	   has	   shown	   this	   figure	   to	   vary	   significantly	   within	   and	   between	   families,	  
documenting	  two	  offspring	  in	  individual	  trios	  (father-­‐mother-­‐child	  family)	  with	  49	  and	  35	  such	  
de	  novo	  mutations	  total2.	  Over	  the	  course	  of	  human	  history,	  these	  mutations	  have	  accumulated	  
such	  that	  a	  single	  individual	  has	  roughly	  3-­‐4	  million	  single	  nucleotide	  polymorphic	  sites	  (SNPs)3.	  
Similarly,	  this	  number	  varies	  significantly	  across	  different	  populations	  and	  is	  a	  first-­‐order	  metric	  
of	   population	   diversity.	   As	   of	   this	   writing,	   the	   database	   of	   all	   known	   Single	   Nucleotide	  





A	  recombination	  is	  the	  cross-­‐over	  event	  that	  occurs	  between	  homologous	  chromosomes	  during	  
meiosis	  and	  results	  in	  different	  tracts	  of	  grand-­‐parental	  genetic	  content	  being	  inherited	  from	  a	  
parent	  by	  the	  offspring.	  Recombination	  accounts	  for	  multi-­‐point	  diversity	  between	  individuals	  
and	   their	   parents	   and	   results	   in	   a	   mosaic	   of	   inherited	   genetic	   segments	   in	   a	   population	   of	  
genomes.	   The	   rate	   of	   recombination	   is	   measured	   in	   units	   called	   centimorgans	   (cM);	   1	   cM	  
corresponding	   to	   the	  distance	  between	   two	  nucleotides	   such	   that	   a	   recombination	  has	   a	   1%	  
chance	  of	  occurring	  in	  a	  single	  meiosis.	  Though	  this	  rate	  is	  on	  average	  1cM/1MBb	  throughout	  
the	  human	  genome,	   fine-­‐scale	  analysis	  has	   revealed	  significant	  variation	  within	   the	  genome4,	  
with	  highly-­‐recombinant	  regions	  referred	  to	  as	  hot-­‐spots5.	  Additionally,	  complex	  differences	  in	  
recombination	   rate	   between	   genders	   have	  been	   long	  documented,	   and	   recent	   study	  of	   fine-­‐






The	  coalescent	  is	  a	  mathematical	  description	  of	  
the	   genealogies	   of	   alleles	   in	   a	   natural	  
population8,9.	   It	   can	   be	   conceptualized	   as	   one	  
or	  more	  trees	  that	  relate	  all	  of	  the	  individuals	  in	  
the	   population	   starting	   from	   the	   current	  
generation	  and	  moving	  backwards	  in	  time.	  The	  
driving	  mathematical	  processes	  of	  a	  coalescent	  
can	   fully	   explain	   the	   observable	   variation	   and	  
much	  work	   has	   gone	   towards	   quantifying	   this	  
process	   in	   a	   realistic	   way.	   The	   classical	  
coalescent	  model	  is	  that	  of	  an	  idealized	  Wright-­‐
Fisher	   population,	   which	   obeys	   specific	  
simplifying	   restrictions:	   the	   number	   of	   male	  
and	   female	   individuals	   is	   balanced,	   any	  
compatible	   individuals	   can	   mate,	   and	   the	  
generations	   are	   non-­‐overlapping	   (Figure	   1.1).	  
This	   model	   is	   very	   useful	   because	   one	   need	  
only	   know	   the	   size	   of	   the	   population,	  
recombination	   rate,	   and	   mutation	   rate	   to	  
	  
Figure	  1.1:	  Wright-­‐Fisher	  coalescent	  process	  
(Top)	   S.G.	   Wright	   and	   R.A.	   Fisher,	   the	   founders	   of	  
theoretical	   population	   genetics.	   (Bottom)	   The	  
coalescent	  process	  is	  shown	  in	  an	  idealized	  population	  
of	   12	   haploid	   individuals,	   with	   genealogies	   changing	  
backwards	   in	   time	   bottom-­‐to-­‐top.	   The	   red	   path	  
represents	   the	   coalescence	   of	   all	   individuals	   to	   a	  








determine	  the	  entire	  distribution	  of	  variants.	  
Effective	  population	  size	  
The	  effective	  population	  size	  (Ne)	  of	  a	  study	  cohort	  is	  the	  size	  of	  a	  corresponding	  Wright-­‐Fisher	  
population	  with	  the	  same	  distribution	  of	  relatedness.	  Ne	  thus	  represents	  a	  simplifying	  summary	  
parameter	   of	   a	   complex	   population	   by	   reducing	   it	   to	   the	   closest	   attainable	   Wright-­‐Fisher	  
model.	  For	  example,	   individuals	   in	  a	   rapidly	  expanding	  population	  would	  have	  a	  continuously	  
lower	   chance	   of	   coalescing	   than	   individuals	   in	   a	   constant	   population,	   and	   so	   the	   effective	  
population	  size	  of	  the	  expanding	  population	  at	  a	  specific	  point	  would	  be	  higher	  than	  that	  of	  a	  
similarly	   sized	   constant	   population.	   In	   this	   way,	   the	  Ne	   for	   humans	   is	   generally	   taken	   to	   be	  
10,000	  though	  this	  is	  a	  gross	  simplification	  of	  the	  complex	  human	  demography10.	  
	  
Figure	  1.2:	  Non-­‐random	  co-­‐occurrence	  of	  markers	  in	  the	  human	  genome	  
Visualization	  of	  the	  disequilibrium	  in	  allele	  co-­‐occurrence	  across	  multiple	  near-­‐by	  markers.	  Each	  SNP	   is	  shown	  
sequentially	  with	  two	  alleles	  color	  coded	  (red/beige);	  groups	  of	  co-­‐occurring	  markers	  are	  shown	  as	  “blocks”	  of	  
contiguous	   sequence,	   separated	   by	  weighted	   paths.	   Gray	   numbers	   below	   each	   block	   indicate	   the	   frequency.	  
(Figure	  from	  Ben	  Fry’s	  isometricblocks	  http://benfry.com/isometricblocks/)	  
	  
Haplotypes	  and	  linkage-­‐disequilibrium	  
As	  previously	  described,	  the	  genome	  of	  a	  single	  individual	  in	  fact	  consists	  of	  two	  copies	  of	  each	  




alleles	  along	  one	  haploid	  chromosome	  copy	  is	  called	  the	  haplotype,	  and	  is	  a	  particularly	  useful	  
feature	  of	  population	  genetics	  as	  it	  corresponds	  to	  an	  inherited	  unit.	  
Due	  to	  the	  fact	  that	  recombination	  acts	  on	  large	  tracts	  of	  the	  genome,	  within	  a	  frequently	  co-­‐
inherited	   haplotype	   we	   also	   expect	   to	   see	   co-­‐occurring	   individual	   marker	   alleles.	   This	   non-­‐
random	  co-­‐occurrence	  of	  alleles	  -­‐	  a	  product	  of	  the	  mosaic	  nature	  of	  recombination	  -­‐	  is	  referred	  
to	  as	  linkage-­‐disequilibrium	  (LD)	  and	  has	  been	  explicitly	  quantified.	  Specifically,	  we	  compare	  the	  
co-­‐occurrence	   of	   two	   markers	   to	   the	   expected	   neutral	   co-­‐occurrence	   based	   on	   their	   allele	  
frequencies	   to	   compute	   D,	   the	   measure	   of	   deviation	   from	   neutrality	   or	   the	   disequilibrium.	  
Because	  this	  simple	  measure	  of	  difference	  depends	  on	  the	  underlying	  allele	  frequencies	  of	  the	  
two	  markers,	   this	  metric	   is	   general	  normalized	   to	  D’,	  which	   is	   the	   ratio	  of	  observed	  D	   to	   the	  
maximum	  possible	  D	   given	   the	   frequencies.	  Alternatively,	   this	  metric	   can	  be	  normalized	   to	   a	  
correlation	   coefficient	   r2,	   which	   has	   other	   convenient	   mathematical	   properties.	   In	   human	  
populations,	   we	   find	   that	   many	   markers	   tend	   to	   co-­‐occur	   together	   in	   high	   LD,	   with	   such	  





Figure	  1.3:	  Distribution	  of	  IBD	  segments	  for	  close	  relatives	  
The	  expected	  distribution	  of	  segment	   lengths	  (left)	  and	  number	  of	  segments	  (right)	   is	  shown	  for	  single-­‐parent	  
relatives	   color-­‐coded	   by	   number	   of	   generations	   to	   their	   common	   ancestor.	   Notably,	   though	   the	   expected	  
number	  of	  segments	  decreases	  rapidly,	  if	  a	  segment	  is	  present	  it	  is	  expected	  to	  be	  substantial	  in	  size.	  
	  
Identity	  by	  descent	  
While	  every	  pair	  of	  individuals	  is	  descended	  from	  the	  same	  person	  if	  you	  follow	  their	  genealogy	  
infinitely	  into	  the	  past,	  it	  is	  possible	  to	  identify	  relatives	  in	  the	  explicitly	  genetic	  sense,	  who	  not	  
only	   share	   a	   recent	   progenitor,	   but	   also	   co-­‐inherit	   some	   of	   that	   ancestor's	   genome.	   Such	   a	  
region	   contiguously	   co-­‐inherited	   from	   a	   single	   common	   ancestor	   between	   two	   individuals	   is	  
called	  identical	  by	  descent	  (IBD)	  and	  these	  segments	  form	  the	  genetic	  fingerprint	  of	  their	  recent	  
relatedness.	   IBD	   between	   two	   individuals	   has	   been	   classically	   quantified13	   following	  Wright's	  
inbreeding	  coefficient14,	   that	  prescribes	  probabilities	  of	   these	   individuals	  sharing	  two,	  one,	  or	  
zero	   alleles	   by	   descent,	   averaged	   across	   the	   genome.	   Yet,	   such	   probabilities	   oversimplify	  




between	   relatives	   is	   low,	   whenever	   an	   allele	   is	   co-­‐inherited,	   a	   very	   long	   genomic	   segment	  
around	   it	   is	   also	   likely	   to	   be	   shared	   (Figure	   1.3).	   Formally,	   a	   pair	   of	   diploid	   kth	   generation	  
descendants	   is	   IBD	   at	   a	   particular	   locus	   if	   the	   ancestral	   haplotype	   is	   copied	   and	   transmitted	  
across	  2k	  meiosis.	  Each	  meiosis	  having	  a	  0.5	  probability	  of	  transmitting	  a	  copy,	  the	  probability	  
of	  such	  a	  copy	  being	  inherited	  down	  both	  lineages	  is	  21-­‐2k	  –	  less	  than	  1%	  for	  any	  k≥4	  (third	  half-­‐
cousins	   or	   less	   related).	   Despite	   being	   a	   low	   probability	   event,	   when	   it	   occurs,	   such	   sharing	  
would	  imply	  a	  very	  long	  segment	  to	  be	  nearly	  identical	  across	  the	  two	  samples.	  Using	  the	  same	  
example,	   segment	   length	   is	   expected	   to	   be	  d/2k	  where	  d	   is	   the	   genetic	   distance,	   defined	   as	  
100cM.	   This	   rate	   of	   change	   in	   IBD	   status	   along	   a	   pair	   of	   genomes	   facilitates	   computing	   the	  
expected	  number	  of	  IBD	  segments	  genome-­‐wide.	  
Table	  1.1:	  IBD	  between	  individuals	  of	  shared	  ancestry	  from	  a	  single	  source	  
Meiosis	  to	  
ancestor	  (k)	  
Likelihood	  	  of	  
sharing	  ( πˆ )	  
Expected	  single	  
segment	  length	  (cM)	  




1	  (half	  sibs)	   50.00%	   50.00	   75	   1,875.00	  
2	  (half	  cousins)	   12.50%	   25.00	   150	   468.75	  
3	   3.13%	   16.67	   225	   117.36	  
4	   0.78%	   12.50	   300	   29.50	  
5	   0.20%	   10.00	   375	   7.40	  
6	   0.05%	   8.33	   450	   1.83	  
7	   0.01%	   7.14	   525	   0.43	  
a	  Human	  genome	  length	  taken	  from	  15	  
	  
Table	  1.1	   illustrates	   these	  statistics	   for	  a	  pair	  of	   individuals	  k	   generations	  apart.	  The	  practical	  
implication	  is	  that	  even	  if	  IBD	  is	  rare,	  when	  it	  is	  present	  at	  a	  segment,	  the	  alleles	  it	  carries	  will	  




(IBS)	  unlikely	  to	  have	  occurred	  by	  chance	  can	  be	  used	  as	  an	  indicator	  of	  underlying	  contiguous	  
IBD.	  
The	  magnitude	  of	  current	  data	  presents	  the	  opportunity	  to	  examine	  shared,	  inherited	  segments	  
with	   more	   information	   and	   finer	   marker	   resolution	   for	   defining	   their	   boundaries15.	   Indeed,	  
renewed	  interest	  in	  IBD16	  has	  led	  to	  the	  development	  of	  novel	  methods	  to	  quantify	  relatedness,	  
by	  either	  genome-­‐wide	  estimates17,	  segment-­‐by-­‐segment	  analysis18,19	  or	  both20.	  Applying	  such	  
methods,	   the	   recently	   published	   Human	   Haplotype	  Map	   (International	   HapMap	   Consortium,	  
2005)	  reported	  the	  surprising	  discovery	  of	  abundant	  long	  haplotype	  segments	  shared	  between	  
individuals	  purported	  to	  be	  unrelated21	  coining	  them	  as	  hidden	  relatives.	  
1.2 Analysis of population genetic data 
Hardware	  platforms	  
The	   genotype	   assays	   primarily	   discussed	   in	   this	   work	   fall	   into	   two	   basic	   categories:	  
oligonucleotide	  SNP	  microarrays	  (often	  simply	  referred	  to	  as	  SNP	  arrays)	  and	  high-­‐throughput	  
DNA	  sequencing.	  
The	   typical	   SNP	   array	   genotyping	   process	   consists	   of	   shearing	   the	   DNA	   with	   restriction	  
enzymes;	   ligating	   an	   adaptor	   to	   the	   resulting	   fragments;	   amplifying	   the	   fragments	   based	   on	  
targeted	  PCR	  primers	  that	  recognize	  the	  desired	  nucleotide	  sequence;	  hybridizing	  the	  amplified	  
DNA	   to	   a	   microarray;	   washing	   off	   excess	   DNA	   and	   optically	   interpreting	   the	   fluorescence	  
intensity	  levels	  at	  each	  probe	  as	  an	  indicator	  of	  the	  observed	  allele	  (with	  redundant	  probes	  for	  




normalization	  techniques	  can	  be	  used	  to	  discretize	  the	  observation	  into	  specific	  allele	  calls	  for	  
each	  site	  and	  individual25,26.	  Typically,	  these	  sites	  are	  only	  interrogated	  for	  two	  common	  alleles	  
and	  so	  are	  treated	  as	  bi-­‐allelic	  markers.	  Over	  the	  past	  decade	  SNP	  arrays	  have	  matured	  to	  be	  a	  
widely-­‐used	   and	   trusted	   technology	   with	   low	   per-­‐marker	   error	   rates	   of	   below	   0.1%25.	   The	  
arrays	  are	   typically	  designed	  to	  capture	  common	  variants	  either	  directly	  or	   indirectly	   through	  
typed	  markers	  that	  are	  in	  LD	  with	  un-­‐typed	  variants	  (so-­‐called	  tags)	  with	  contemporary	  arrays	  
consisting	  of	  several	  millions	  of	  variants.	  As	  such,	  it	  is	  important	  to	  keep	  in	  mind	  that	  SNP	  arrays	  
do	  not	  typically	  represent	  a	  random	  ascertainment	  of	  variants	  in	  the	  population.	  
High-­‐throughput	   sequencing,	   a	   recent	   technological	   platform	   made	   possible	   by	   the	   Human	  
Genome	  Project	  (HGP),	  allows	  for	  full	  examination	  of	  all	  nucleotides	  in	  the	  human	  genome.	  The	  
sequencing	   process	   generally	   consists	   of	   shearing	   the	   amplified	   DNA	   into	   short	   fragments	  
(typically	  50-­‐100bp	   long);	   classifying	   the	   fragments	   (for	  example,	  by	   fluorescence	  or	   ligation);	  
and	   interpreting	   the	   actual	   fragment	   sequence	   content	   to	   generate	   sequence	   reads27,28.	   This	  
process	  is	  massively	  parallelized	  across	  multiple	  cycles	  to	  assay	  the	  entire	  genome	  many	  times	  
over.	   Such	   reads	   are	   then	   computationally	   aligned	   to	   the	   reference	   genome	   with	   allowed	  
mismatches	   to	   account	   for	   potential	   single	   nucleotide	   variants	   (SNVs)	   as	   well	   as	   longer	  
insertions	  and	  deletions29.	  Finally,	  individual	  calls	  are	  made	  for	  each	  site	  based	  on	  the	  number	  
of	  observed	  reads	  for	  each	  allele30.	  Ideally,	  whole-­‐genome	  sequencing	  offers	  an	  opportunity	  to	  
fully	   ascertain	   all	   variants	   in	   the	   genome,	   and	   its	   advances	   have	   significantly	   shifted	   genetic	  
analysis	   towards	   rare	   and	   previously	   unseen	   variants.	   In	   practice,	   variant	   call	   accuracy	   is	  




global	   biases	   (overall	   read	   coverage,	   read-­‐length,	   position	   of	   variant	   in	   read,	   and	  many	   run-­‐
specific	   hardware	  biases)31.	  All	   of	   these	   factors	   lead	   to	   a	   relatively	  high	  per-­‐variant-­‐call	   error	  
rate	   of	   1-­‐3%	  as	  well	   as	   incomplete	   ascertainment3,	   particularly	   as	  much	   interesting	   variation	  
may	   yet	   lie	   specifically	   in	   the	   highly-­‐repetitive	   regions	   that	   are	   difficult	   to	   capture.	   Recent	  
advances	   in	   the	   area	   of	   high-­‐coverage	   sequencing	   show	   great	   promise,	   with	   accurate	   and	  
comprehensive	  sequencing	  from	  as	  low	  as	  50x	  total	  coverage32.	  
Haplotype	  phasing	  
Direct	  ascertainment	  of	  haplotypes	  (with	  techniques	  involving	  cell	  dissection	  or	  sorting)	  tends	  
to	  be	  expensive	  and	  labor-­‐intensive33.	  To	  meet	  this	  challenge,	  algorithms	  have	  been	  developed	  
that	  leverage	  readily	  available	  genotype	  data	  which	  does	  not	  distinguish	  order	  at	  heterozygous	  
positions	  to	  computationally	  infer	  individual	  haplotypes34.	  This	  procedure	  of	  inferring	  the	  phase	  
of	  multiple	   heterozygous	   genotypes	   relies	   on	   the	   availability	   of	   family	   or	   population	   data	   to	  
reduce	   the	   set	   of	   all	   possible	   haplotypes	   that	   can	   describe	   the	   data	   to	   those	   that	   are	  most	  
likely.	  With	  family-­‐data,	  this	  is	  done	  by	  constraining	  potential	  haplotypes	  by	  following	  the	  rules	  
of	  Mendelian	  inheritance;	  for	  example,	  if	  one	  parent	  in	  a	  trio	  is	  homozygous	  at	  two	  SNPs	  for	  the	  
AA	  haplotype	  and	  the	  other	  parent	  is	  alternatively	  homozygous	  for	  the	  CC	  haplotype,	  then	  we	  
can	   phase	   the	   A/C,A/C	   genotypes	   of	   their	   child	   into	   two	   haplotypes	   AA	   and	   CC.	  With	   some	  
approximations,	   this	   procedure	   can	   be	   extended	   to	   more	   complex	   families	   in	   an	   iterative	  
nature35.	  On	  the	  other	  hand,	  one	  can	  take	  advantage	  of	  LD	  in	  population	  genotypic	  data	  to	  infer	  
likely	  haplotypes	   for	  unrelated	   individuals.	   Such	  methods	   tend	   to	   seek	  a	  parsimonious	   set	  of	  




reconstruct	   the	   coalescent	  process	   relating	  observed	   individuals	   and	   identify	   likely	  haplotype	  
paths	  with	  a	  Hidden-­‐Markov	  Model	  (HMM)37,38.	  Phasing	  algorithms	  have	  matured	  significantly	  
and,	  by	  relying	  on	  data	  from	  thousands	  of	  samples,	  can	  now	  reconstruct	  haplotypes	  with	  a	  very	  
high	   degree	   of	   accuracy	   (upwards	   of	   97%	   correct	   phase	   at	   heterozygous	   sites)34.	   However,	  
several	   open	   problems	   still	   exist	   within	   the	   field	   of	   haplotype	   inference;	   particularly	   the	  
accurate	   phasing	   of	   distant	   markers	   where	   LD	   is	   less	   informative39	   (so-­‐called	   long-­‐range	  
phasing)	  and	  efficient	  phasing	  of	  many	  sequenced	  individuals.	  
Linkage	  mapping	  
Linkage	  mapping	   is	   a	  methodology	   for	   identifying	   causal	   variants	   by	   looking	   for	   regions	   that	  
have	  been	  transmitted	  between	  multiple	   related	   individuals.	  The	   transmission	  profile	  of	  each	  
locus	  is	  then	  correlated	  with	  the	  expected	  pattern	  of	  disease	  and	  tested	  for	  significance	  (Figure	  
1.4a).	  Based	  on	  the	  assumption	  that	  transmission	  will	  track	  with	  the	  disease	  over	  causal	  variant	  
and	  occur	  randomly	  elsewhere,	  the	  presence	  of	  an	  unusual	  linkage	  score	  at	  a	  site	  suggests	  that	  
it	  harbors	  (or	  is	  in	  LD	  with)	  such	  a	  variant.	  The	  canonical	  linkage	  algorithms	  seek	  to	  identify	  the	  
most	  likely	  inheritance	  profile	  given	  the	  observed	  genetic	  markers,	  and	  are	  designed	  either	  for	  
small-­‐pedigrees/many-­‐markers40	   or	   large-­‐pedigrees/few-­‐markers41.	   Focusing	   on	   the	   inherited	  
regions	   is	   a	   double-­‐edged	   sword,	   avoiding	   complex	   biases	   due	   population	   sub-­‐structure	   but	  
powered	  primarily	  for	  highly-­‐penetrant,	  recessive	  diseases	  and	  only	  able	  to	  localize	  variants	  to	  
large	   regions	   of	   several	   megabases42.	   Due	   to	   these	   limitations	   and	   the	   difficulty	   in	   assaying	  
many	  related	  individuals	  for	  analysis,	  linkage	  analysis	  has	  primarily	  focused	  on	  the	  study	  of	  rare	  





Genome-­‐wide	   association	   studies	   (GWAS)	  
leverage	   the	   abundance	   of	   LD	   blocks	   to	  
indirectly	   ascertain	   and	   test	   variants	   that	   are	  
putatively	   associated	   with	   disease45,46	   (Figure	  
1.4b).	   GWAS	   take	   advantage	   relatively	  
affordable	  SNP	  arrays	  to	  ascertain	  a	  sampling	  of	  
genome-­‐wide	   markers	   in	   thousands	   of	  
individuals,	   with	   the	   hope	   that	   these	   markers	  
represent	   –	   directly	   or	   through-­‐LD	   –	   a	   large	  
portion	   of	   genome-­‐wide	   variation.	   The	  
individuals	   are	   also	   typed	   for	   the	   phenotypic	  
trait,	   which	   can	   either	   be	   a	   quantitative	  
assessment	   of	   the	   phenotype	   (as	   with	   height,	  
lipid	  levels,	  etc.)	  or	  a	  discrete	  affection	  status	  (as	  
with	   Crohn’s	   disease,	   bipolar	   disorder,	   etc.).	  
Each	   marker	   is	   then	   tested	   for	   association	   by	  
either	   directly	   comparing	   the	   distributions	   of	  
phenotypes	   in	   the	   two	   alleles	   or	   regression	   of	  
the	   phenotype	   and	   genotype	   relationship	   to	  
establish	   strength	   and	   significance	   of	  
	  
Figure	  1.4:	  Mapping	  by	  linkage	  and	  association	  
The	  causal	   variant	   is	   represented	  by	  a	   red	  “m”	  with	  
differing	   ancestral	   haplotypes	   color	   coded	   (blue,	  
green,	  yellow,	  purple).	  In	  linkage	  mapping	  (a),	  the	  co-­‐
inherited,	   recessive	  blue	  haplotype	   is	   observed	  only	  
in	   the	   affected	   individuals,	   suggestive	   of	   an	  
underlying	   causal	   variant	   in	   that	   region	   long.	   In	  
association	   (b),	   only	   the	   short	   contemporary	   sub-­‐
sections	   of	   the	   blue	   haplotype	   are	   correlated	   with	  
the	   disease.	   If	   there	   exists	   a	   SNP	  with	   strong	   LD	   to	  
this	  haplotype,	   it	  too	  will	  be	  strongly	  associated	  and	  





association.	  Assuming	  that	  a	  typed	  and	  variant	  is	  strongly	  correlated	  with	  a	  causal	  mutation	  it	  
should	  exhibit	  a	  strong	  association	  signal.	  Though	  controversial,	  the	  GWAS	  era	  has	  undeniably	  
yielded	  a	  great	  number	  of	  reproducible	  associations	  that	  implicate	  plausible	  genetic	  causes	  to	  
common	  disease	  and	  shed	  light	  on	  non-­‐coding	  variants46.	  In	  fact,	  the	  number	  of	  putative	  causal	  
regions	   has	   increased	   significantly	   with	   the	   rise	   of	   large,	   high-­‐powered	   GWAS	   projects	   as	  
compared	   to	   more	   traditional	   targeted	   and	   linkage	   work	   of	   the	   previous	   decade47.	   Simply	  
quantifying	  these	  regions	  is	  an	  important	  first	  step	  to	  understanding	  the	  biological	  function	  of	  
disease.	   However,	   for	   common	   traits,	   researchers	   have	   largely	   been	   unable	   to	   use	   the	  
associated	  variants	  to	  explain	  the	  full	  spectrum	  of	  inherited	  trait	  variation	  (or	  heritability)	  –	  this	  
drawback	  being	  coined	  the	  problem	  of	  missing	  heritability48.	  In	  light	  of	  this	  missing	  heritability,	  
the	  disease	  genetics	   community	   is	   strongly	   focused	  on	  bridging	   the	  gap	  between	  discovering	  
many	  putative	   causal	   variants	   and	  using	   them	   to	   explain	   a	   substantial	   portion	   of	   phenotypic	  
variation.	  
Population-­‐based	  linkage	  
The	  novel	  disease	  mapping	  strategy	  of	  population-­‐based	  linkage	  seeks	  to	  perform	  relatedness-­‐
based	   tests	   in	  GWAS-­‐sized	   cohorts	   of	   unrelated	   individuals.	  Where	   standard	   linkage	   requires	  
individuals	  related	  through	  a	  known	  pedigree,	  population-­‐based	   linkage	  attempts	  to	  use	   local	  
genetic	   sharing	   as	   an	   surrogate	   indicator	   of	   relatedness.	   The	   intuition	   is	   that	   at	   a	   locus	  
containing	   a	   causal	   variant	   one	   expects	   to	   see	   the	   affected	   individuals	   sharing	  more	   genetic	  
segments	   within	   themselves	   than	   between	   affected-­‐unaffected	   pairs20.	   This	   assumption	   still	  




nearby	   marker	   –	   scenarios	   where	   traditional	   GWAS	   are	   underpowered.	   The	   computational	  
method	  requires	  identifying	  all	  long	  IBD	  segments	  in	  the	  population	  and	  testing	  each	  locus	  for	  
an	  abundance	  of	  case-­‐case	  versus	  case-­‐control	  sharing,	  with	  significance	  generally	  established	  
by	   genome-­‐wide	   permutation20,49.	   Though	   this	   strategy	   has	   found	   limited	   success49,50,	   it	   is	  
expected	  to	  be	  powerful	  in	  densely-­‐related	  populations	  with	  an	  abundance	  of	  IBD	  segments.	  
Variant	  imputation	  
Taking	   advantage	   of	   large	   cohorts	   typed	   for	   millions	   of	   SNPs	   (such	   as	   the	   Human	   HapMap	  
Project),	   a	   class	   of	   algorithms	   has	   been	   developed	   to	   infer	   these	   variants	   into	   individual	  
sparsely-­‐typed	  genome-­‐wide	  studies.	  Such	  imputation	  algorithms	  rely	  on	  identifying	  shared	  LD	  
structure	   between	   an	   individual	   in	   the	   study	   cohort	   and	   individuals	   in	   the	   densely	   typed	  
reference	  panel	  by	  examining	  the	  overlapping	  markers37,51,52.	  Such	  shared	  LD	  can	  be	  indicative	  
of	  a	  shared	  haplotype	  between	  the	  study	  and	  reference	   individual	  and	  facilitate	  assigning	  the	  
reference	  allele	   to	   the	   study	   individual	   at	   that	   site.	  Given	  enough	   statistical	   confidence,	   such	  
imputed	  variants	  can	  then	  be	  tested	  in	  a	  GWAS	  just	  as	  if	  they	  were	  typed	  directly52.	  Imputation	  
accuracy	   depends	   on	   a	   number	   of	   factors;	   mainly,	   the	   diversity	   of	   the	   study	   and	   reference	  
populations,	  as	  well	  as	  the	  density	  and	  size	  of	  both	  typed	  panels.	  Imputation	  experiments	  with	  
the	  HapMap	  panels	  has	  shown	  a	  high	  average	  r2	  correlation	  of	  >0.9	  between	  the	  imputed	  and	  
true	   variants	   in	   many	   tested	   global	   populations53.	   However,	   the	   accuracy	   tends	   to	   drop-­‐off	  





The	  1,000	  Genomes	  Project	  
Recent	  advances	  in	  whole-­‐genome	  sequencing	  have	  culminated	  in	  the	  1,000	  Genomes	  Project;	  
a	  world-­‐wide	  endeavor	  to	  sequence	  the	  entire	  genome	  of	  over	  one	  thousand	  individuals3.	  The	  
project	  consists	  of	  data	  from	  over	  thirty	  world-­‐wide	  populations	  with	  sampling	  emphasis	  on	  the	  
main	  HapMap	  continental	  groups	  of	  Europeans	   (CEU),	   Japanese	  &	  Chinese	  East	  Asians	   (JPT	  +	  
CHB),	   and	   Yoruba	   West	   Africans	   (YRI).	   The	   data	   itself	   consists	   of	   three-­‐types	   of	   sequence	  
strategies:	   low-­‐coverage	   (~4X)	   sequence	   of	   many	   unrelated	   individuals;	   high-­‐coverage	  
sequencing	   of	   a	   small	   number	   of	   trios;	   and	   high-­‐coverage	   exome	   sequencing	   of	   coding	   and	  
flanking	  regions	  in	  a	  small	  number	  of	  sub-­‐populations.	  The	  1,000	  Genomes	  Project	  has	  lead	  in	  
the	   development	   of	   many	   sequence	   analysis	   tools,	   particularly	   for	   joint	   variant	   calling	   in	  
multiple	   low-­‐coverage	   genomes	   and	   subsequent	   internal	   imputation	   to	   significantly	   increase	  
novel	  variant	  sensitivity31,54.	  The	  project	  aims	  to	  be	  a	  diverse	  and	  thoroughly-­‐typed	  reference	  
panel	   for	   rare-­‐variant	   imputation	   in	   future	  GWAS	  with	  preliminary	   results	   showing	   a	  modest	  
boost	  in	  imputation	  accuracy	  for	  low-­‐frequency	  variants55.	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2 Linear-time discovery of pairwise IBD sharing 
2.1 Motivation 
Recently,	   genotyped	   sets	   of	   individuals	   100-­‐fold	   larger	   than	   the	   HapMap	   represent	   more	  
complete	  sampling	  of	  the	  general	  population	  than	  previously	  available,	  facilitating	  many	  more	  
opportunities	  for	  any	  founder	  of	  the	  population	  to	  be	  observed	  as	  a	  co-­‐ancestor	  of	  individuals	  
in	  the	  cohort.	   In	  particular,	  a	  recent	  study	  of	   IBD	  among	  35,000	   Icelanders	  has	  demonstrated	  
the	  relevance	  of	  using	  hidden	  relatedness	  in	  haplotype	  inference	  and	  rare	  variant	  discovery56.	  
Such	   research	   motivates	   extensive	   analysis	   of	   IBD	   in	   large	   cohorts.	   However,	   as	   available	  
sample	  size	  increases,	  previous	  methods	  cannot	  keep	  up	  with	  the	  current	  torrent	  of	  genotype	  
data.	  Specifically,	  methods	  based	  on	  examining	  each	  pair	  of	  individuals	  require	  quadratic	  time20	  
and	  rapidly	  become	  impractical.	  
This	   Chapter	   introduces	   an	   algorithm	   for	   linear-­‐time	   discovery	   of	   segmental	   sharing	   and	   the	  
corresponding	   implementation:	   Genetic	   Error-­‐tolerant	   Regional	   Matching	   with	   LINear-­‐time	  
Extension	   (GERMLINE).	   Inspired	   by	   the	   quintessential	   matching	   algorithms	   for	   noisily-­‐
homologous	   sequences57,58	   GERMLINE	   is	   based	   on	   a	   two-­‐stage	   process:	   first,	   detecting	  
completely	   identical	  match-­‐seeds	  of	  potentially-­‐shared	  segments	  by	  creating	  a	  dictionary59	  of	  
allele	  combination	  words	  across	  the	  population	  observed	  at	  different	  slices	  along	  the	  genome.;	  
second,	   extending	   these	   candidate	   matches	   to	   resolve	   likelihood	   of	   IBD	   by	   a	   dynamic	  
programming	  algorithm	  across	  contiguous	  slices.	  We	  develop	  the	  method	  for	  use	  with	  phased	  




2.2 Haplotype IBD matching – the GERMLINE algorithm 
We	  devise	  a	  search	  for	  IBD	  that	  is	  based	  on	  directly	  matching	  portions	  of	  haplotypes	  between	  
individual	   samples.	   Such	   a	   search	   is	   naturally	   simpler	   in	   the	   hypothetical	   case	   when	   shared	  
segments	   are	   identical	   throughout	   the	   entirety	   of	   the	   haplotype	   considered,	   allele	   calls	   are	  
error-­‐free,	   and	   the	   phase	   of	   input	   sequences	   is	   known.	   This	   simple	   case	   facilitates	   direct	  
matching	  of	  haplotypes	  to	  one	  another,	  and	  we	  first	  present	  GERMLINE,	  our	  methodology	  for	  
efficient	  IBD	  detection,	  in	  such	  a	  demonstrative	  scenario.	  Subsequently,	  we	  introduce	  realistic	  
complexities	  of	  segment-­‐limited	  matching	  and	  data	  errors.	  
Detection	  of	  IBD	  along	  an	  entire	  haplotype	  copy	  
We	  first	  consider	  a	  search	  for	  pairs	  of	  haplotypes	  that	  are	  identical	  throughout	  the	  input	  data,	  a	  
set	  of	  observed	  haplotypes	  for	  n	   individuals	  and	  s	  SNPs	  along	  a	  genomic	  segment	  of	   interest.	  
Formally,	  the	  input	  is	  a	  2n	  ×	  s	  matrix	  H	  with	  rows	  corresponding	  to	  haplotypes	  and	  columns	  to	  
SNPs.	  The	  output	   is	  a	  set	  of	  pairs	  of	   identical	  rows	  of	  H.	  Haplotype	  calls	  are	  represented	  by	  a	  
binary	  alphabet	  corresponding	  to	  the	  alleles.	  A	  matrix	  entry	  H[i,j]	  is	  1	  if	  haplotype	  i	  carries	  the	  
minor	  allele	  of	   SNP	   j,	   and	  0	  otherwise.	   Each	   row	  of	  H	   can	   therefore	  be	   regarded	  as	  a	  binary	  
vector.	  When	  two	  haplotypes	   (i,i′)	  are	   IBD,	   the	  corresponding	  rows	   (i,i′)	  will	  be	   identical	   in	  H.	  
The	  goal	  of	   the	  algorithm	   is	   therefore	   to	  accept	  a	  matrix	  H	   and	  output	  a	   set	  L	  of	   IBD	  shared	  
segments	  (i,i′′).	  Due	  to	  errors	  and	  noise	  that	  are	  likely	  to	  be	  present	  in	  the	  input,	  we	  distinguish	  
between	   the	   observed	  H	   and	   its	   underlying	   counterpart,	   the	  matrix	  Hreal	   of	   true	   haplotypes,	  
without	   errors	   or	   missing	   data.	  We	   defer	   handling	   of	   errors	   to	   the	   next	   section	   and	   in	   this	  




We	  first	  identify	  matches	  across	  the	  s	  SNPs	  in	  matrix	  H	  by	  relying	  on	  a	  dictionary	  of	  haplotypes:	  
the	  set	  D	  of	  size	  no	  larger	  than	  2n	  consisting	  of	  non-­‐redundant	  rows	  from	  H.	  D	  is	  implemented	  
as	   a	   hash-­‐table	   data	   structure	   with	   constant-­‐time	   insertion	   and	   lookup:	   the	   key	   is	   a	   binary	  
vector	  of	  length	  s,	  and	  the	  value	  is	  a	  set	  of	  individual	  haplotypes	  having	  identical	  rows.	  Once	  D	  
is	  constructed,	  each	  pair	  of	  rows	  indexed	  by	  the	  same	  key	  in	  D	   is	  a	  match.	  The	  set	  M(H)	  of	  all	  
such	  matches	   can	  be	  obtained	  by	   traversing	  all	   keys	   in	  D,	   and	  all	   pairs	  of	   rows	  per	   key	  as	   in	  
MATCH	  (Algorithm	  1).	  
Algorithm	  1	  
Identical	  matching	  across	  subsets	  of	  H	  
When	  considering	  a	  large	  fraction	  of	  a	  chromosome,	  true	  IBD	  may	  not	  span	  all	  of	  the	  available	  
SNPs.	   Therefore,	   in	   a	   whole-­‐genome	   or	   whole-­‐chromosome	   context	   we	   are	   interested	   in	  
detecting	   partial	  matches,	   or	   pairs	   of	   individuals	   that	   share	   a	   common	   recent	   ancestor	   only	  
along	  a	  segment	  of	  a	  chromosome.	  As	  such,	  we	  establish	  a	  defined	  threshold	  on	  the	  minimum	  
length	   for	   an	   IBD	   shared	   segment.	   The	   choice	   of	   LIBD	   corresponds	   to	   the	   expected	   segment	  
length	  for	  the	  most	  distantly	  related	  individuals	  we	  aim	  at	  detecting	  (see	  Table	  1.1).	  Formally,	  
we	   define	   the	   length	   L(j,j')	   of	   an	   interval	   between	   columns	   j	   and	   j'	   as	   the	   genetic	   distance	  
MATCH(H):	  
define	  set	  M	  
for	  hi	  in	  H	  do	  D.INSERT(hi→i)	  
for	  h	  in	  D	  do	  
for	  i	  in	  D(h)	  do	  






between	  the	  corresponding	  genes.	  A	  pair	  of	  haplotypes	  (i,i')	  is	  defined	  to	  be	  sharing	  a	  segment	  
in	  a	  SNP	  region	  [j	  ..	  j']	  if	  their	  included	  SNPs	  are	  identical	  and	  L(j,j')	  exceeds	  LIBD.	  The	  problem	  is	  
now	  to	  find,	  given	  H,	  a	  set	  of	  quartets	  (i,i’,j,	   j’)	  such	  that	  (i,i’)	  shares	  the	  segment	  [j	   ..	   j’]	   .	  We	  
now	  propose	  a	  divide	  &	  conquer	   strategy	   for	  using	  MATCH	   to	  discover	   such	   shared	   segments.	  
Our	  goal	  is	  to	  identify	  pairs	  of	  long	  identical	  segments	  that	  are	  shorter	  than	  the	  length	  of	  H.	  We	  
can	  approximate	   this	  by	  dividing	   the	  columns	  of	  H	   into	  equal	   vertical	   intervals,	  or	  slices,	   and	  
finding	  pairs	  of	   individuals	  that	  match	  along	  contiguous	  slices.	  We	  thus	  distinguish	  between	  a	  
haplotype,	  which	  is	  an	  entire	  row	  of	  H	  and	  a	  word	  that	  represents	  the	  part	  of	  a	  haplotype	  that	  
intersects	  a	  slice	  of	  H.	  A	  match	  between	  two	  individuals	  along	  several	  slices	  can	  be	  considered	  
extended	   if	   the	  words	   of	   these	   individuals	   also	  match	   in	   the	   succeeding	   slice,	   otherwise	   the	  
match	  terminates.	  A	  shared	  segment	  can	  thus	  be	  redefined	  as	  belonging	  to	  a	  pair	  of	  individuals	  
that	   extend	   across	   several	   word	   pairs,	   and	   will	   represent	   an	   IBD	   segment	   rounded	   to	   the	  
nearest	  slice	  break.	  
Formally,	  our	  algorithm	  accepts	  as	  input	  H	  and	  iteratively	  uses	  MATCH	  to	  generate	  a	  set	  M′	  of	  all	  
shared	  segments	  in	  H.	  We	  vertically	  slice	  H	  into	  non-­‐overlapping,	  equal	  width	  sub-­‐matrices	  of	  δ	  
columns,	  with	  each	  slice	  denoted	  as	  Hk.	  The	  algorithm	  is	  a	  dynamic	  program	  that	  scans	  slices	  
along	   the	  chromosome	  and	  maintains	   sets	  of	   the	   terminated	  and	  extendable	  matches	  within	  
the	  current	  slice.	  To	  avoid	  redundant	  conversion	  from	  SNPs	  to	  slices,	  we	  will	  henceforth	  refer	  to	  
a	  match	  (i,i′;	  j	  ..	  j′)	  as	  (i,i′;	  m	  ..	  m′)	  such	  that	  j=m·∙δ	  and	  j′=(m′+1)·∙δ-­‐1.	  At	  each	  slice	  k=0→(s/δ)-­‐1,	  
we	  compute	  independent	  Mk=MATCH(Hk),	  the	  set	  of	  identical	  matches	  at	  k.	  As	  detailed	  in	  EXTEND	  




generating	   a	   corresponding	   set	   Mk′	   that	   contains	   all	   extended	   matches;	   naturally,	   each	  
extended	  match	  contains	  m,	  the	  start	  of	  the	  match,	  in	  the	  range	  0	  to	  k-­‐1	  and	  m′,	  the	  end	  of	  the	  
match,	  equal	  to	  k.	  In	  the	  first	  slice,	  define	  M0′=M0;	  subsequently,	  initiate	  Mk′	  =	  Mk,	  and	  search	  
through	  all	  matches	  Mk′	  for	  extendable	  matches	  from	  Mk-­‐1′.	  Where	  they	  exist,	  we	  updated	  the	  
starting	  position	  for	  matches	  in	  slice	  k	  to	  be	  that	  of	  the	  match	  in	  slice	  k-­‐1.	  Similarly,	  terminated	  
matches	  present	  in	  Mk-­‐1′	  but	  not	  Mk	  are	  either	  discarded	  or	  added	  as	  IBD	  to	  M′	  depending	  on	  
their	  length.	  Upon	  completing	  the	  final	  iteration,	  all	  matches	  in	  M(s/δ)-­‐1	  are	  discarded	  or	  added	  




Up	   until	   this	   point,	   we	   have	   ignored	   the	   effect	   genotyping	   errors	   may	   have	   on	   identifying	  
matches.	  While	  modern	   genotyping	   platforms	   achieve	   accuracy	   levels	   >99%	   60,	   across	  many	  
EXTEND(Mk-­‐1′,Mk	  ):	  
let	  Mk′	  :=	  Mk	  
for	  mk	  in	  Mk′	  do	  
i	  	  :=	  mk.INDIVIDUAL[1]	  
i′	  :=	  mk.INDIVIDUAL[2]	  
if	  Mk-­‐1′.CONTAINS(i,i′) 
then	  
mk-­‐1	  :=	  Mk-­‐1′[i,i′]	  






slices	  the	  chance	  of	  an	  error	  becomes	  non-­‐negligible	  even	  in	  a	  single	  sample.	  Across	  thousands	  
of	   samples	   and	   along	   densely-­‐typed,	   complete	   chromosomes	   the	   presence	   of	   errors	  
approaches	  certainty.	  For	  IBD	  matching,	  random	  errors	  are	  unlikely	  to	  produce	  false	  positives.	  
We	  are,	  however	  concerned	  about	  error-­‐induced	  false	  negatives.	  Intuitively,	  a	  true	  IBD	  match	  
would	   be	   present	   in	   several	   consecutive	   slices	   and	  may	   be	   detected	   by	   matching	   in	   any	   of	  
them.	   Assuming	   random,	   uniform,	   and	   independent	   error	   rate	   ε	   per	   SNP,	   the	   number	   of	  
mismatching	  allele	  calls	  between	  a	  pair	  of	   IBD	  haplotype	   intervals	  of	   length	  δ	  SNPs	   is	  Poisson	  
distributed	   with	   parameter	   λ=	   2δε.	   Across	   an	   IBD	   segment	   of	   length	   sIBD	   SNPs	   (where	  









⎢= esNE 	  
and	  typically	  being	  flanked	  by	  nearly	  identical	  slices.	  Specifically,	  the	  chance	  of	  these	  words	  to	  
be	   identical	   is	   (1-­‐ε)2δ,	   with	   the	   length	   of	   a	   complete	   observed	  match	   in	   an	   IBD	   region	   thus	  
geometrically	  distributed.	  
Nearly	  identical	  matching	  
In	  practice,	  with	  δ	   s.t.	  E(NIBD)>1,	   long	   IBD	  segments	  will	   likely	  have	   identical	  matches	  therein.	  	  
The	  entire	  segment	  is	  identified	  by	  merging	  nearly-­‐identical	  flanking	  matches.	  ε	  determines	  the	  
allowed	   mismatches	   in	   otherwise	   identical	   intervals..	   Specifically,	   conservatively	   assuming	  
ε=0.01	   ;	   LIBD=2,000	   SNPs	   ;	   δ=100	   SNPs;	   E(NIBD)=2.7	   ,	   allowing	   1	   mismatching	   bit/slice.	   The	  




(Algorithm	   3),	   we	  modify	   EXTEND	   to	   detect	   nearly	   identical	   matches	   by	   post-­‐processing	   L′	   to	  




for	  mk-­‐1	  in	  Mk-­‐1′do	  
i	  	  :=	  mk-­‐1.INDIVIDUAL[1]	  
i′	  :=	  mk-­‐1.INDIVIDUAL[2]	  
if	  DISTANCE(Hki,Hki′)	  ≤	  d	  then	  





All	  the	  modules	  integrate	  into	  a	  complete	  procedure	  with	  input	  matrix	  H	  and	  output	  set	  L	  of	  all	  
contiguous	  identical	  or	  nearly	  identical	  matches	  in	  H,	  based	  on	  predefined	  length	  and	  mismatch	  
thresholds.	  As	  described	  in	  Algorithm	  4,	  H	  is	  divided	  into	  slices	  that	  are	  analyzed	  sequentially	  by	  
MATCH,	  MERGE	  and	  MERGE-­‐PARTIAL.	  Matches	  that	  could	  not	  be	  extended	  from	  previous	  slices	  are	  
discarded	  or	  output	  as	  L′.	  This	  procedure	  deals	  also	  with	  missing	  data.	  
Algorithm	  4	  
HAPLOTYPE-­‐IBD(H):	  
given	  s,	  sIBD	  ,	  hlen	  
let	  M0	  =	  MATCH(H0)	  
let	  M0′	  =	  M0	  
define	  M′	  
for	  k	  in	  1→(s/hlen)-­‐1	  do	  






Computationally,	  the	  algorithm	  has	  a	  significant	  gap	  between	  worst-­‐case	  and	  typical	  scenarios.	  
Specifically,	  the	  time	  complexity	  is	  highly	  dependent	  on	  expected	  number	  of	  matches,	  which	  is	  
determined	   by	   the	   underlying	   population	   structure.	   In	   general,	   if	   the	   average	   number	   of	  
matches	  per	  word	   is	  m,	   the	  complete	  computation	  requires	  O(sn)	   to	  build	   the	  dictionary	  and	  
O(sm)	   to	   attempt	   extension	   on	   all	   matches.	   In	   the	   worst	   case,	   where	   L	   is	   formed	   by	   the	  
Cartesian	   square	   of	   the	   2n	   haplotypes,	   m=4n2	   and	   GERMLINE	   is	   comparable	   to	   pairwise	  
exhaustive	   search.	   In	   practice,	   if	  we	  make	   a	   naïve	   assumption	   of	   independence	   of	   sites,	   the	  












where	   ps	   and	   qs	   are	   the	   allele	   frequencies.	   A	  more	   realistic	   assumption	  would	   acknowledge	  
local	  LD	  within	  each	  segment.	  If	  we	  denote	  a	  set	  of	  population	  haplotype	  frequencies	  f	  of	  size	  















let	  Mk′	  :=	  EXTEND(Mk-­‐1′,Mk)	  
Mk′	  :=	  EXTEND-­‐PARTIAL(Mk-­‐1′,Mk′)	  
for	  mk-­‐1	  in	  Mk-­‐1′	  do	  






Even	   in	   large	   samples	   sizes	   this	   factor	   is	   low	   enough	   where	   overall	   complexity	   approaches	  
O(sn).	  
2.3 Comparison with other methods 
To	  determine	  the	  effectiveness	  of	  haplotype	  word	  matching	   in	  phase-­‐known	  data,	  GERMLINE	  
was	  used	  to	  identify	  IBD	  in	  the	  HapMap	  Phase	  II	  phased	  release.	  We	  compare	  the	  results	  with	  
those	   of	   the	   PLINK	  whole-­‐genome	   data	   analysis	   toolset	   20,61,	  which	   can	   detect	   extended	   IBD	  
with	   the	   “segmental	   sharing”	   runtime	   option.	   PLINK	   uses	   a	   hidden	   Markov	   Model	   (HMM)	  
approach	  to	  estimate	  multipoint	  probabilities	  of	  IBD	  in	  pairs	  of	  individuals	  based	  on	  IBS	  sharing.	  
We	   used	   both	   real	   and	   simulated	   data	   to	   compare	   accuracy	   and	   efficiency	   of	   the	   two	  
algorithms.	  
We	   simulated	   instances	   of	   pairwise	   segmental	   sharing	   of	   varying	   length,	   planted	   on	   a	  
background	  of	  unrelated	  samples,	  with	  realistic	  genotyping	  error.	   	  The	  average	  accuracy	  rates	  
from	   both	   algorithms	   are	   presented	   in	   Table	   2.1	   as	   evaluated	   by	   three	   figures	   of	   merit:	   (i)	  
Sensitivity	  -­‐	  the	  percentage	  of	  the	  simulated	  IBD	  fragment	  that	  was	  detected	  (in	  SNPs);	  (ii)	  False	  
positive	   extension	   -­‐	   the	   fraction	   of	   non-­‐IBD	   markers	   flanking	   a	   true	   IBD	   segment	   that	   were	  
falsely	  detected	  to	  be	  IBD,	  as	  a	  percentage	  of	  the	  true	  shared	  segment	  length;	  (iii)	  False	  positive	  
(non-­‐flanking)	  –	  the	  remaining	  number	  of	  falsely	  detected	  non-­‐IBD	  markers	  as	  a	  percentage	  of	  
the	  true	  shared	  segment	   length.	   In	  all	   instances,	  GERMLINE	  has	  both	  a	  higher	  sensitivity	  than	  
PLINK	  and	  a	   lower	  overall	   false-­‐positive	   rate.	   Furthermore,	  because	  PLINK	  discovery	  depends	  




number	  of	   the	   simulations	   lead	   to	   false	  discovery	  of	   completely	  non-­‐flanking	   IBD;	  GERMLINE	  
did	  not	  exhibit	  this	  behavior.	  
Table	  2.1:	  Sharing	  concordance	  between	  GERMLINE	  and	  PLINK	  (Kosrae)	  
	   	   Sensitivity	   	   False	  positive	  extension	   	   False	  positive	  non-­‐flanking	   	  
IBD	  length1	  (Mb)	   GERMLINE	   PLINK	  
	  
GERMLINE	   PLINK	   	   GERMLINE	   PLINK	   	  
2.5	   93.7%	   71.2%	   14.7%	   19.1%	   NAb	   NAb	  
5	   99.3%	   72.2%	   4.6%	   8.9%	   0.0%	   11.2%	  
10	   99.4%	   78.9%	   4.2%	   6.3%	   0.0%	   5.1%	  
20	   99.7%	   87.0%	   1.3%	   2.9%	   0.0%	   3.1%	  
40	   99.9%	   85.2%	   0.6%	   1.1%	   0.0%	   0.6%	  
1IBD	   segments	   were	   planted	   onto	   the	   background	   genotype	   data	   of	   Kosrae	   individuals	   that	   are	   otherwise	  
unrelated	   according	   to	  both	  methods,	  with	   the	  entire	  population	   as	   the	   cohort	   analyzed.	   25	  pairs	   of	   parents	  
were	   randomly	   selected	   from	   different	   trios	  without	   any	   4MB-­‐long	   IBD	   segment	   detectable	   by	   either	   of	   the	  
compared	   methods.	   10	   random	   regions	   of	   varying	   lengths	   were	   copied	   in	   turn	   from	   the	   untransmitted	  
chromosome	   15	   haplotype	   of	   one	   parent	   to	   its	   counterpart	  with	   1%	   simulated	   difference	   due	   to	   genotyping	  
error.	   	   For	   PLINK,	   IBD	   detection	   was	   attempted	   within	   an	   analyzed	   cohort	   of	   50	   individuals	   –	   required	   for	  
estimation	  of	  allele	  frequencies.	  For	  GERMLINE	  no	  such	  cohort	  was	  needed.	  




Table	  2.2	  shows	  runtime	  results	  for	  GERMLINE	  as	  well	  as	  the	  two	  comparison	  implementations	  
using	  the	  HapMap	  cohorts.	  We	  calculated	  two	  sets	  of	  results	  for	  the	  segmental	  sharing	  option:	  
a	   default	   under	  which	   every	   available	   SNP	  was	   processed,	   and	   a	   pruned	   set	  which	   excluded	  
highly	   linked	   SNPs	   as	   detailed	   in	   the	   PLINK	   documentation	   61.	   Analyzing	   all	   SNPs,	   GERMLINE	  
runs	  more	   than	   100-­‐fold	   faster	   than	   PLINK.	  When	   PLINK	   is	   executed	   on	   each	   of	   the	   pruned	  
datasets,	   consisting	  of	   2.3%-­‐4.9%	  of	   their	   respective	  originals,	   its	   run	   time	   (pruning	   time	  not	  
included)	  was	  still	  slower	  by	  a	  factor	  of	  3.46	  to	  10.55.	  




Table	  2.2:	  Runtime	  comparison	  between	  GERMLINE	  and	  PLINK	  (HapMap)	  
Population	   All	  SNPs	   GERMLINE	  All	   PLINK	  All	   Pruned	  SNPs	   PLINK	  Pruned	  
CEU	   2,557,252	   00:04:37	   10:23:04	   72,503	   00:22:03	  
YRI	   2,856,346	   00:03:49	   11:17:27	   140,938	   00:40:16	  
JPT	   2,419,983	   00:02:58	   06:49:45	   55,922	   00:10:16	  
CHB	   2,419,983	   00:02:55	   05:	  22:02	   60,350	   00:11:09	  
Time	  reported	  in	  (hours	  :	  minutes	  :	  seconds)	  
Minimum	  length	  of	  segments	  to	  be	  detected	  set	  to	  1Mb.	  
	  
Examining	  discovery	  of	  shared	  segments	  longer	  than	  2.5cM	  in	  these	  HapMap	  cohorts,	  Table	  2.3	  
details	   the	   differences	   in	   segments	   found	   between	   the	   two	   algorithms.	   We	   observe	   high	  
concordance	  between	  the	  methods	  for	  long	  segments,	  where	  in	  populations	  where	  trip	  data	  is	  
available,	   the	   fraction	   of	   PLINK-­‐identified	   segments	   not	   reported	   by	   GERMLINE	   is	   consistent	  
with	   false	   positive	   rate	   of	   HMM-­‐analysis.	   In	   particular,	   the	   three	   pairs	   of	   YRI	   individuals	  
previously	  identified	  as	  closely	  related	  can	  serve	  as	  positive	  controls,	  and	  all	  displayed	  greater	  
than	  90%	  concordance	  between	  methods.	  They	  represent	  only	  a	  small	  part	  of	  the	  detected	  set	  
of	   related	   pairs:	   most	   of	   the	   shared	   segments	   involve	   pairs	   of	   remotely	   related	   individuals.	  
Without	   trio	   data,	   it	   appears	  GERMLINE	  has	   only	   limited	   power	   to	   detect	   IBD.	   For	   segments	  
shorter	  than	  5cM	  we	  observed	  significantly	  more	  segments	  reported	  by	  GERMLINE:	  we	  further	  
compare	   average	   statistics	   of	   detected	   segments	   to	   the	   results	   reported	   by	   the	   HapMap	  
Project21,	  mirroring	  the	  parameters	  of	  their	  analysis	  by	  seeking	  segments	  over	  1	  Mb	  in	   length	  
with	  at	  least	  50	  SNPs.	  
Table	  2.3:	  Sharing	  concordance	  between	  GERMLINE	  and	  PLINK	  (HapMap)	  
Population	   Concordant	  (Length)	   	   Concordant	  (Segments)	  




YRI	   82%	   82%	  
JPT	   14%	   41%	  
CHB	   8%	   31%	  
1Fraction	  of	  total	  PLINK-­‐identified	  sharing	  also	  detected	  by	  GERMLINE.	  
	  
Table	  2.4	  shows	  that	   in	  all	  populations,	  GERMLINE	   identified	  significantly	  more	  segments	  and	  
maintained	   a	   higher	   total	   distance	   spanned	   at	   a	   near	   perfect	   IBS	   rate.	   This	   suggests	   the	  
enrichment	   of	   reported	   segments	   by	   GERMLINE	   reflects	   increased	   sensitivity	   rather	   than	  
additional	  false	  positives.	  Furthermore,	  sensitivity	  to	  shorter	  IBD	  segments	  facilitates	  detection	  
of	  breaks	  in	  IBD	  matches	  -­‐	  breaks	  that	  may	  have	  real	  biological	  meaning,	  as	  we	  explore	  below.	  
These	   effects	   further	   reduce	   the	   mean	   and	   maximum	   length	   of	   detected	   segments	   while	  
increasing	  accuracy.	  
Table	  2.4:	  Shared	  segment	  discovery	  in	  HapMap	  
Population	   CEU	   	   YRI	  	   JPT	   	   CHB	  
	   GERMLINE	   PLINK	   GERMLINE	   PLINK	   GERMLINE	   PLINK	   GERMLINE	   PLINK	  
Total	  number	  of	  segments	   7,120	   427	   7,842	   250	   913	   273	   540	   146	  
Total	  distance	  spanned	   12,744	   2,336	   15,658	   1,416	   1,679	   1,301	   1,108	   704	  
Mean	  segment	  length	   1.8	   5.5	   2.0	   5.7	   1.8	   4.8	   2.1	   4.8	  
Maximum	  segment	  length	   25.9	   56.2	   29.9	   51.7	   22.8	   25.3	   22.8	   15.0	  
Identity	  by	  State	  (IBS)1	   99.8%	   -­‐	   99.9%	   -­‐	   99.8%	   -­‐	   99.8%	   -­‐	  




2.4 Application to whole-genome, whole-population data 
	  
We	  used	  GERMLINE	  to	  detect	  IBD	  in	  SNP	  array	  data	  from	  3000	  individuals,	  essentially	  the	  entire	  
adult	   population	   of	   the	   Island	   of	   Kosrae,	   Micronesia	   (see	   Materials	   &	   Methods	   for	   dataset	  
description).	   We	   first	   phased	   the	   entire	   population	   using	   the	   BEAGLE	   localized	   haplotype	  
clustering	  tool	  38.	  We	  then	  applied	  GERMLINE	  to	  scan	  for	  shared	  segments	  over	  10	  centimorgan	  
(cM)	  in	  length	  according	  to	  a	  consensus	  database	  62	  of	  standard	  genetic	  maps	  63,64.	  
The	  available	  pedigree	  for	  the	  Kosrae	  samples	  brings	  forth	  multiple	  pairs	  of	  related	  individuals	  
as	  positive	  controls.	   	  The	  overall	  fraction	  of	  the	  genome	  detected	  as	  shared	  by	  a	  related	  pair,	  
shown	   in	   Figure	   2.1,	   provides	   additional	   validation	   for	   the	  GERMLINE	  method,	   agreeing	  with	  
theoretical	   expectation	   (Table	   1.1)	   for	   relatives	   up	   to	   4	   meioses	   apart.	   With	   more	   distant	  
 




relationships,	   we	   observe	   more	   sharing	   than	   expected,	   suggesting	   a	   background	   of	   hidden	  
relatedness	  in	  these	  individuals	  consistent	  with	  of	  a	  small,	  isolated	  ancestral	  population.	  
 
Figure	  2.2:	  Moment-­‐based	  and	  segment-­‐based	  metrics	  of	  relatedness	  
Genome-­‐wide	  statistics	  for	  two	  types	  of	  individual	  relationships	  are	  compared,	  averaged	  over	  all	  available	  samples	  
in	   Kosraen	   cohort	   (errors	   bars	   show	   standard	   error).	   πˆ 	   (left)	  measures	   the	   genome-­‐wide	  proportion	  of	   IBD;	   Z1	  
measures	  the	  overall	  probability	  of	  sharing	  one	  allele	  IBD	  (middle);	  and	  cM	  length	  (right)	  is	  the	  average	  length	  of	  
the	  segment	  shared.	  Segment	  length	  clearly	  distinguishes	  between	  the	  two	  relationship	  types.	  
	  
We	  further	  demonstrate	  the	  utility	  of	  segmental	  IBD	  analysis	  beyond	  the	  genome-­‐wide	  statistic	  
by	   comparing	   and	   resolving	   relationships	   that	   appear	   synonymous	   when	   examining	   only	  
genome-­‐wide	   averages.	   Specifically,	   we	   juxtaposed	   pairs	   of	   individuals	   that	   are	   half-­‐siblings	  
(one	  shared	  parent)	  versus	   those	  that	  are	  related	  through	  a	  complete	  avuncular	   relationship.	  
These	  two	  relationships	  are	  expected	  to	  have	  the	  same	  amount	  of	  overall	  sharing	  statistics	   in	  
terms	  of	   both πˆ ,	   the	   genome-­‐wide	  proportion	  of	   IBD;	   as	  well	   as	   Z1,	   the	  overall	   probability	   of	  




distribution	   of	   segment	   lengths.	   In	   accordance	   with	   expectation,	   Figure	   2.2	   demonstrates	   a	  
significant	   difference	   between	   such	   pairs	   of	   Kosraens	   in	   the	   average	   shared	   segment	   length	  
identified	  by	  GERMLINE;	  with	  no	  such	  difference	  observed	  when	  comparing	   πˆ 	  and	  Z1.	  For	  such	  
individuals,	   it	   is	   clear	   that	   the	  multi-­‐point	   segment	   length	   analysis	   provided	   by	  GERMLINE	   is	  
necessary	  to	  distinguish	  between	  relationships.	  
We	   note	   that	   in	   our	   attempt	   to	   confirm	   these	   results	   on	   segmental	   sharing	   with	   the	   PLINK	  
algorithm,	   it	  was	  only	  able	   to	   identify	  whole-­‐chromosome	  sharing.	  With	  PLINK's	   focus	  at	   less	  
related	   cohorts,	   this	   tool	   may	   need	   specific	   tuning	   for	   resolving	   relatedness	   in	   the	   inbred	  
Kosraean	   data	   set.	   Computationally,	   PLINK	   required	   556	   hours	   to	   complete	   analysis	   of	   the	   8	  
shortest	   chromosomes	   while	   GERMLINE	   processed	   the	   same	   data	   in	   40.3	   hours	   (30.8	   for	  
BEAGLE	  phasing	  and	  9.5	  for	  GERMLINE	  analysis).	  
2.5 IBD segment gaps as indicators of data artifacts 
In	  identifying	  IBD	  on	  the	  HapMap	  data,	  we	  discovered	  a	  number	  of	  long	  shared	  segments	  which	  
were	  broken	  up	  by	   short	   regions	   (generally	   less	   than	  100	  SNPs)	   containing	  unusually	   low	   IBS	  
and	   suspected	   these	   gaps	   to	   be	   indicative	   of	   phasing	   errors	   or	   structural	   variation.	   We	  
demonstrate	   that,	   indeed,	   IBD	   gaps	   come	   in	   these	   two	   flavors,	   as	  manifested	  by	   their	   allelic	  
makeup.	  
Each	   individual	   in	   the	   HapMap	   phased	   set	   is	   considered	   to	   have	   one	   Transmitted	   and	   one	  
Untransmitted	  haplotype	  relative	  to	  its	  child,	  referred	  to	  henceforth	  as	  the	  T	  and	  U	  haplotypes	  
respectively.	   In	   regions	   of	   high	   heterozygosity,	   we	   identified	   gaps	   in	   which	   putative	   IBD	  




This	   pattern	  may	   be	   explained	   by	   phasing	   inconsistency	  which	   results	   in	   incorrectly	   oriented	  
haplotypes	   at	   heterozygous	   sites,	   commonly	   referred	   to	   as	   “switch	   error”65,66.	   Table	   2.5	  
provides	   an	   example	   of	   three	   contiguous	   segments	   on	   chromosome	   18	   between	   individuals	  
NA06993	   and	  NA07056	   (CEU	   population)	  with	   IBS	  measurements	   taken	   for	   the	   two	   pairs	   of	  
notable	  haplotypes.	  In	  the	  first	  region,	  the	  two	  individuals	  are	  in	  nearly	  complete	  IBS	  along	  their	  
respective	  Transmitted	  haplotypes.	  In	  the	  subsequent	  42	  SNP	  gap,	  none	  of	  the	  16	  heterozygous	  
positions	   continue	   the	   shared	   segment,	   rather	   they	   match	   the	   Transmitted	   haplotype	   of	  
NA06993	   with	   the	   Untransmitted	   haplotype	   of	   NA07056	   In	   the	   remainder	   of	   the	   shared	  
segment,	  the	  IBS	  switches	  back	  to	  the	  two	  Transmitted	  chromosomes.	  This	  IBS	  switch	  back	  and	  
forth	   is	   consistent	  with	   two	   closely	   spaced	   recombination	   sites	   during	   the	  NA07056	  meiosis.	  
However,	   the	   genotype	   data	   for	   the	   trio	   involving	   NA06993	   reveals	   all	   three	   samples	   to	   be	  
heterozygous	  at	  these	  16	  positions,	  implying	  that	  the	  phasing	  is	  completely	  computational	  and	  
not	  constrained	  by	  Mendelian	  relationships;	  the	  lack	  of	  direct	  information	  makes	  such	  regions	  
particularly	  prone	  to	  short	  phasing	  errors.	  Searching	  the	  two	  HapMap	  cohorts	  with	  known	  trio	  
data	  for	  gaps	  in	  which	  IBD	  mismatches	  were	  contained	  to	  heterozygous	  sites	  and	  phasing	  was	  
not	  based	  on	  familial	  information,	  we	  identified	  58	  such	  regions.	  
Table	  2.5:	  Potential	  phasing	  irregularity	  in	  HapMap	  
Regiona	   Total	  SNPs	   Heterozygous	  SNPs	   IBS	  [T/T]	   IBS	  [T/U]	  
chr18:44042249-­‐48624309	   4912	   2069	   99.5%	   36.6%	  
chr18:48624918-­‐48669808	   42	   16	   0%	  b	   100%	  
chr18:48670200-­‐59773196	   11659	   5211	   99.6%	   38.5%	  
aSamples	  NA06993	  &	  NA07056	  –	  CEU	  Population	  





Another	   interesting	   class	  of	   gaps	   is	   characterized	  by	   regions	  of	  unusually	   low	  heterozygosity,	  
suggestive	  of	   structural	   variation.	  A	   region	  which	  exhibits	   loss	  of	  heterozygosity	  may,	   in	   fact,	  
represent	   incorrectly	   typed	   hemizygosity	   resulting	   from	   a	   segmental	   deletion	   along	   the	  
otherwise	   shared	   haplotype.	   Such	   regions	   would	   also	   feature	   lower	   identity	   rates	   than	  
expected	  by	  IBD	  because	  SNP	  matching	  is	  effectively	  being	  counted	  on	  the	  haplotypes	  alternate	  
to	   those	   that	   are	   actually	   IBD.	  We	   searched	   through	   the	   HapMap	   samples	   for	   gaps	   in	   long	  
segmental	  sharing	  which	  exhibited	  this	  characteristic	  of	  loss	  of	  heterozygosity	  as	  well	  as	  a	  high	  
rate	  of	  IBS	  mismatches.	  Table	  2.6	  documents	  an	  example	  of	  two	  such	  regions	  between	  pairs	  of	  
individuals	   in	   the	   CEU	   population.	   In	   the	   first	   region	   (NA12264	   and	   NA12155),	   two	   shared	  
segments	  over	  6,000	  SNPs	  in	  length	  straddle	  a	  44	  SNP	  gap	  that	  exhibits	  loss	  of	  heterozygosity	  
and	  a	  decrease	  in	  IBS.	  Similarly,	  the	  second	  region	  (NA12717	  &	  NA11840)	  contains	  two	  shared	  
segments	   of	   over	   5,000	   SNPs	   in	   length	   straddling	   a	   14	   SNP	   gap	   that	   exhibits	   loss	   of	  
heterozygosity	   and	   nearly	   complete	   lack	   of	   identity.	   The	   large	   size	   of	   shared	   segments	  
essentially	  guarantees	  these	  regions	  to	  be	  IBD.	  This	  assumption,	  coupled	  with	  significant	  loss	  of	  
heterozygosity	  in	  only	  one	  individual	  of	  the	  pair	  suggests	  that	  such	  gaps	  are	  de	  novo	  segmental	  
deletions.	  
Table	  2.6:	  Potential	  deletion	  regions	  in	  HapMap	  
Region	   Homozygous	  SNPs	   IBS	   SNPs	   Length	  (cM)	  
chr11:63543965-­‐74961563a;b	   53.7%e	   99.9%	   6,950	   10.2	  
chr11:74964989-­‐75019488	   100%a	   40.9%	   44	   -­‐	  
chr11:75020500-­‐80863996	   58.4%e	   99.9%	   6,004	   7.3	  
	   	   	   	   	  
chr1:	  104546035-­‐110007685c;d	   50.2%e	   99.9%	   5,180	   5.9	  
chr1:	  110007814-­‐110015547	   100%d	   57.1%	   14	   -­‐	  




CEU	  samples:	  aNA12264,	  bNA12155,	  cNA12717,	  dNA11840	  
eAverage	  across	  both	  involved	  samples	  
	  
To	   validate	   these	   supposed	   deletions,	   we	   searched	   for	   overlapping	   deletion	   regions	   in	   the	  
Database	   of	   Genomic	   Variants	   67,	   a	   shared	   database	   of	   structural	   variation	   identified	   in	   a	  
number	   of	   studies,	   including	   experimental	   examination	   of	   structural	   variants	   in	   the	  HapMap	  
cell	   lines	   68.	   Because	   identification	   of	   such	   gaps	   by	   GERMLINE	   is	   explicitly	   dependent	   on	  
presence	   of	   IBD,	   we	   targeted	   reported	   gaps	   in	   HapMap	   that	   overlapped	   with	   IBD	   regions	  
identified	   by	   GERMLINE.	   Table	   2.7	   shows	   these	   results,	   split	   up	   by	   the	   validation	   source:	  
experimental	  69	  and	  computational	  70,71.	  The	  “verified	  gaps”	  column	  shows	  the	  number	  of	  gaps	  
identified	  by	  GERMLINE	  which	  overlapped	  with	   those	   in	   the	  dbGV	  reference,	  while	   the	  “false	  
negatives”	  column	  shows	  the	  number	  of	  IBD	  regions	  which	  spanned	  across	  a	  reported	  deletion	  
in	  the	  dbGV.	  We	  note	  that	  IBD	  can	  only	  detect	  deletions	  along	  the	  one	  haplotype	  that	  is	  shared,	  
therefore	   power	   to	   detect	   a	   deletion	   is	   bounded	   by	   50%.	   Overall,	   of	   the	   reported	   deletions	  
present	  in	  an	  IBD	  region,	  42%	  were	  picked	  out	  by	  GERMLINE	  as	  gaps.	  
Table	  2.7:	  Verification	  of	  gaps	  in	  HapMap	  with	  deletions	  in	  the	  Database	  of	  Genomic	  Variants	  
Validation	   Verified	  gaps	  
	  
False	  negatives	  
experimental	   11	   30	  
computational	   19	   11	  






Figure	  2.3:	  Candidate	  deletion	  fluorescence	  intensity	  
	  
We	   further	   explored	   the	   discovery	   of	   segmental	   deletions	   in	   the	   Kosraean	   population	   data	  
where	   IBD	   is	  more	   prevalent	   and	  we	   observe	   a	   larger	   number	   of	   gaps.	  We	   used	   a	   binomial	  
score	   to	   rank	   potential	   deletions	   in	   homozygous	   gaps	   based	   on	   the	   number	   of	  mismatching	  
SNPs	   and	   the	   rate	   of	  mismatch	   in	   the	   flanking	   shared	   segments,	  measured	   across	   all	   shared	  
segments	  with	  the	  suspected	  gap	  (see	  4.2).	  Figure	  2.3	  shows	  an	  example	  of	  such	  a	  gap,	  plotting	  
the	  normalized	   fluorescence	   intensity	  measures	  across	  a	  2	  Mb	  region	  containing	  the	  putative	  
deletion.	  This	  region	  clearly	  coincides	  with	  a	  significant	  decrease	  in	  intensity	  values,	  supporting	  
the	  hypothesis.	  We	  attempted	  to	  validate	  the	  200	  most	  statistically	  significant	  gaps	  with	  three	  
means	   of	   verification:	   (1)	   the	   Affymetrix	   Copy	   Number	   Analysis	   Tool	   72,	   which	   processes	  
fluorescence	   intensity	   in	   an	   HMM-­‐based	   algorithm	   to	   identify	   blocks	   of	   structural	   variation	  
common	   to	   many	   individuals,	   (2)	   examining	   deviations	   from	   the	   average	   in	   normalized	  




for	  CNAT,	  and	  (3)	  overlap	  with	  deletions	  reported	  in	  the	  Database	  of	  Genomic	  Variants.	  Figure	  
2.4	   reports	   validation	   by	   these	   criteria:	   21	   segments	  were	   identified	   by	   the	   Affymetrix	   Copy	  
Number	  Analysis	  Tool	  (CNAT),	  65	  showed	  significant	  deviations	  in	  intensity	  (Intensity),	  and	  124	  
were	  verified	   in	   the	  Database	  of	  Genomic	  Variants	   (dbGV).	  Focusing	  specifically	  on	  CNAT,	  we	  
ran	  a	  similar	  concordance	  analysis	  to	  that	  in	  Table	  2.7	  –	  matching	  deletions	  identified	  by	  CNAT	  
with	   GERMLINE	   IBD	   regions	   and	   gaps	   and	   counting	   unique	   deletions	   rather	   than	   individual	  
segments.	  We	  found	  that	  of	  the	  CNAT	  deletions	  identified	  in	  an	  IBD	  region,	  9%	  were	  picked	  out	  
by	  GERMLINE	   as	   gaps.	  However,	   one	   third	   of	   the	   SNPs	   CNAT	   implicated	   in	   deletions	   did	   not	  
pass	  quality	   control,	   and	  92.7%	  of	   the	   called	  deletions	   contained	  at	   least	   one	  QC-­‐failed	   SNP,	  
making	   these	   deletion	   calls	   suspected	   as	   false	   positives,	   while	   also	   hiding	   these	   SNPs	   from	  






In	  this	  Chapter	  we	  presented	  GERMLINE,	  a	  method	  for	  genome-­‐wide	  discovery	  of	  IBD	  segments	  
shared	   within	   large	   populations.	   We	   introduced	   a	   linear-­‐time	   time	   algorithm	   for	   identifying	  
short	  identical	  genomic	  “slices”	  between	  pairs	  of	  individuals	  and	  then	  extending	  the	  boundaries	  
of	  these	  slices	  to	  discover	  long	  shared	  segments	  representative	  of	  IBD.	  This	  technique	  allows	  us	  
to	  overcome	  the	  typical	  hurdle	  of	  examining	  all	  pairs	  of	  samples	  to	  identify	  pairwise	  segments.	  
In	  simulated	  data,	  GERMLINE	  was	  highly	  accurate	  across	  varying	   lengths	  of	   IBD	  and	   identified	  
few	   spurious	   fragments;	   significantly	   outperforming	   the	   available	   HMM-­‐based	   detection	  
algorithm	   (PLINK).	   Likewise,	   in	  analyzing	   real	  data	   from	  the	   International	  HapMap	  Project	  we	  
find	   that	   GERMLINE	   consistently	   identifies	   more	   segmental	   sharing	   while	   maintaining	   near-­‐
perfect	  identity	  by	  state	  –	  supporting	  the	  validity	  of	  these	  segments.	  Because	  GERMLINE	  is	  able	  
to	  efficiently	  utilize	  all	  of	  the	  available	  data	  and	  not	  require	  pruning	  for	  independent	  markers,	  it	  
is	  particularly	  effective	  in	  discovering	  short	  IBD	  segments	  –	  a	  weak-­‐point	  of	  previous	  methods	  
21.	   The	   accuracy	   and	   efficiency	   of	   GERMLINE	   on	   phased	   data	   from	   HapMap	   motivated	   IBD	  
analysis	  of	  genotype	  data	  from	  the	  significantly	  larger	  and	  more	  densely	  related	  population	  of	  
Kosrae,	   which	   has	   been	   an	   exceptional	   challenge	   due	   to	   extensive	   inbreeding.	   Our	   results	  
mirrored	   expectations	   for	   close	   relatives,	   and	   further	   resolved	   relationships	  with	   statistically	  
indistinguishable	   metrics	   of	   genome-­‐wide	   sharing,	   by	   relying	   on	   the	   divergence	   in	   average	  
length	  of	  GEMLINE-­‐identified	  segments.	  	  




A	  novel	  result	  of	  our	  IBD	  analysis	  in	  various	  populations	  was	  the	  identification	  of	  short	  “gaps”	  in	  
long	   IBD	   segments.	   We	   hypothesized	   that	   these	   gaps	   were	   indicative	   of	   phasing	   error	   or	  
structural	   variation,	   and	   drew	   support	   for	   these	   conclusions	   from	   independent	   data	   sets.	  
Specifically,	  putative	  phasing	  errors	  were	  consistently	  found	  to	  be	  unconstrained	  by	  Mendelian	  
segregation,	   thus	   prone	   to	   errors	   by	   computational	   phasing	   methods.	   This	   highlights	   the	  
potential	  use	  of	  genome-­‐wide,	   fine	   IBD	  structure	   for	  phasing,	  as	   recently	  proposed	   for	  a	  per-­‐
locus	  method	  56.	  Putative	  deletions	  significantly	  overlapped	  catalogued	  deletion	  variants	  as	  well	  
as	  structural	  variants	  discovered	  in	  our	  raw	  data	  using	  analysis	  of	  fluorescence	  intensity.	  Power	  
to	  detect	  deletions	  using	  GERMLINE	  remains	  limited	  to	  sufficiently	  long	  structural	  events	  within	  
IBD	  segments	  whose	  SNPs	  pass	  QC,	  but	  enjoys	  independence	  from	  probe-­‐level	  image	  data.	  This	  
novel	  strategy	  of	  detecting	  polymorphic	  deletions	  using	  a	  GERMLINE-­‐enabled	  fine-­‐scale	  map	  of	  
IBD	   can	   therefore	   complement	   existing	   tools	   for	   the	   hotly	   debated	   association	   analysis	   of	  
microdeletions73,74.	  	  
Looking	   ahead,	   as	   genotyping	   data	   volume	   continues	   to	   increase,	   the	   presence	   of	   hidden	  
relatedness	   will	   become	   ubiquitous.	  With	   GERMLINE,	   we	   have	   overcome	   the	   computational	  
barrier	  of	  pairwise	  sample	  analysis	  and	  can	  now	  scale	  the	  analysis	  linearly	  with	  the	  sample	  size.	  
Understanding	   such	   shared	   genomic	   segments	   has	   previously	   been	   shown	   to	   add	   statistical	  
power	  to	  heritable	  trait	  association	  mapping	  75-­‐77	  as	  well	  as	  gene	  detection	  in	  the	  presence	  of	  
pedigree	   data	   78.	   Recent	   IBD	   research	   in	   a	   large	   population	   has	   also	   demonstrated	   its	  
effectiveness	  for	  haplotype	  inference	  and	  the	  tracking	  of	  known	  structural	  variation	  in	  specific	  




significantly	   restricted	   to	   particular	   regions	   and	   conservative	   rule-­‐based	   thresholds.	   The	  
GERMLINE	   algorithm	   is	   a	   robust	   framework	   for	   identifying	   sharing	   in	   even	   larger	   cohorts	   -­‐	  




3 Memory-optimized IBD discovery for massive cohorts 
3.1 Motivation 
Methods	  for	  IBD	  segment	  mapping	  primarily	  look	  for	  a	  non-­‐random	  increase	  of	  alleles	  identical	  
by	   state	   (IBS)	   that	   is	   indicative	   of	   the	   region	   being	   identical	   by	   descent	   (IBD)	   from	   a	   recent	  
common	   ancestor	   and	   call	   these	   shared	   segments	   using	   a	   Hidden	   Markov	   Model20,49,79	   or	  
haplotype	  sampling80,81.	  While	  the	  HMM	  schemes	  offer	  high	  resolution	  of	  detection	  (segments	  
1cM	   and	   longer),	   the	   implementations	   require	   examining	   all	   pairs	   of	   samples	   and	   are	  
intractable	   for	   GWAS-­‐sized	   cohorts.	   The	   latter	   technique,	   implemented	   in	   the	   GERMLINE	  
algorithm80	   (Chapter	   2)	   and	   recently	   in	   the	   fastIBD	   algorithm81,	   is	   computationally	   efficient	  
enough	  to	  handle	  populations	  in	  the	  tens	  of	  thousands	  with	  trillions	  of	  putative	  IBD	  segments.	  
GERMLINE	   scales	   linearly	   with	   the	   number	   of	   samples	   and	   observed	  matches;	   however,	   the	  
latter	   number	   tends	   to	   grow	   quadratically	   in	   practice.	   With	   data-­‐sets	   upwards	   of	   10,000	  
individuals,	  exploring	  all	  of	  the	  putative	  matches	  becomes	  a	  severe	  computational	  bottleneck	  in	  
itself.	   In	   this	   paper,	  we	   present	   the	   improved	  GERMLINE	   2.0	   algorithm	   that	   adapts	   to	   space	  
limitations	   by	   adjusting	   seed	   lengths	   for	   the	   haplotype	   dictionary	   to	   continue	   identifying	  
segments	  even	  with	  strict	  memory	  thresholds.	  We	  find	  that	  this	  strategy	  is	  succesfully	  able	  to	  
analyze	  large	  data-­‐sets	  with	  limited	  memory,	  allowing	  us,	  for	  the	  first	  time,	  to	  explore	  shared	  




3.2 An “adaptive-seeds” algorithm for IBD detection 
Algorithm	  motivation	  
This	  work	   is	  motivated	  by	   tradeoffs	   between	   accuracy	   and	   complexity	   implicit	   in	   the	   hashed	  
seed	  strategy.	  Overall,	  type	  II	  error	  depends	  on	  either	  poor	  seed	  detection	  or	  match	  extension.	  
A	  seed	  would	  fail	  detection	  in	  the	  case	  of	  input	  data	  errors	  in	  terms	  of	  genotyping	  or	  phasing	  –	  
resulting	   in	  two	  individuals	  that	  should	  be	   identical	  but	  are	  not.	  Thus,	  shorter	  slices	   increases	  
the	   chance	   of	   finding	   an	   exact	   seed	   and,	   subsequently,	   a	   matching	   segment.	   However,	  
computational	   complexity	   of	   both	   time	   and	   space	   increases	   with	   shorter	   slices:	   fewer	   SNPs	  
imply	  less	  haplotype	  heterogeneity	  and	  more	  pairs	  of	  exactly	  matching	  words.	  GERMLINE	  2.0	  is	  
based	   on	   the	   observation	   that	   this	   tradeoff	   can	   be	   managed	   dynamically	   across	   different	  
genomic	   positions	   by	   varying	   the	   slice	   size.	   Specifically,	   loci	   with	   relatively	   high	   haplotype	  
heterozygosity	  can	  decerase	  slice	  size	  and	  loci	  with	  relatively	  low	  haplotype	  heterozygosity	  can	  
increase	   slice	   size	   such	   that	   overall	   complexity	   remains	   nearly	   constant.	   Under	   a	   complexity	  
constraint,	  as	  with	  a	  memory	  boundary,	  this	  policy	  would	  optimize	  overall	  sensitivity.	  
Algorithm	  details	  
We	   first	   re-­‐introduce	   the	   notation	   of	   the	   original	   GERMLINE	   method,	   which	   provides	   the	  
foundation	   for	   the	   current	   contribution.	   GERMLINE’s	   IBD	   search	   assumes	   haplotype	   data	   is	  
available,	   and	   is	   accurate	   locally.	   Each	   𝑖!!	   haploid	   copy	   of	   the	   genome	   is	   represented	   by	   a	  
binary	  vector	  ℎ!,	  with	  entries	   for	  each	  variant	  along	  the	  genome	  of	  size	  𝐺.	  ℎ!"	   is	   the	  allele	  of	  
variant	  𝑣	   along	  haploid	  copy	  ℎ!,	   for	  𝑣 = 1,… ,𝐺.	   For	  𝑁	   individuals,	   the	   input	   to	  GERMLINE	   is	  




copies	   𝑖	   and	   𝑗,	   and	  a	  genomic	   interval	  between	  variants	  𝑢	   and	  𝑣,	  we	   say	   that	   𝑖	   and	   𝑗	  match	  
along	  [𝑢, 𝑣]	   if	  ℎ!" = ℎ!"	  for	  𝑢 ≤ 𝑥 ≤ 𝑣.	   In	  such	  a	  case	  we	  represent	  this	  match	  by	  the	  quartet	  𝑚 = (𝑖, 𝑗,𝑢, 𝑣).	  An	  IBD	  segment	  would	  then	  be	  detected	  as	  a	  long	  exact	  match.	  In	  practice,	  due	  
to	  the	  limitation	  of	  genotype	  data,	  we	  search	  for	  a	  set	  of	  approximate	  matches,	  and	  measure	  
length	  of	  [𝑢, 𝑣]	  as	  genetic	  distance	  between	  the	  markers,	  𝐷(𝑢, 𝑣).	  GERMLINE’s	  final	  output	   is	  
therefore	  a	  set	  𝐴	  of	  such	  approximate,	  long	  matches.	  GERMLINE’s	  key	  idea	  is	  a	  hashing	  step	  to	  
report	  a	  set	  𝑊	  of	  all	  short	  words,	  of	  length	  𝑠,	  that	  recur	  across	  all	  samples	  at	  the	  current	  slice,	  𝑙,	  along	  with	  sample	  ids	  for	  which	  those	  words	  occur;	  this	  step	  is	  denoted	  as	  𝐹𝑖𝑛𝑑𝑆ℎ𝑜𝑟𝑡𝑊𝑜𝑟𝑑𝑠.	  
Each	  of	  these	  words	  𝑤,	  that	  occurs	  in	  𝑛(𝑤) > 1	  copies	  in	  the	  data,	  gives	  rise	  to	  O(n(w)	  choose	  
2)	   seeds,	   along	   a	   slice	   [𝑙, 𝑙 + 𝑠 − 1].	   These	   seed	   matches,	   taken	   as	   the	   output	   𝐸	   from	   the	  
function	  𝐶𝑟𝑒𝑎𝑡𝑒𝐸𝑥𝑎𝑐𝑡𝑀𝑎𝑡𝑐ℎ𝑒𝑠,	  are	  then	  extended	  to	  long	  matches.	  
Given	   𝑁	   haplotypes	   across	   a	   genome	   slice	   𝑠,	   GERMLINE	   requires	   𝑂(𝑁)	   space	   for	   finding	  
matches	  as	  part	  of	  the	  linear-­‐time	  hashing	  step.	  In	  addition,	  for	  every	  n	  ≤	  N	  haplotypes	  sharing	  
a	   common	  word	   at	   slice	  𝑠,	  O(n	   choose	   2)	   space	   in	  memory	   is	   needed	   to	   create	  matches	   for	  
subsequent	  extension	  with	  n	  being	  a	  variable	  factor.	  By	  definition,	  a	  pair	  of	  individuals	  that	  do	  
not	   form	   an	   identical	   match	   at	   interval	   {a,b}	   cannot	   form	   a	   match	   at	   interval	   {a,b+i}.	   Put	  
another	  way,	  increasing	  the	  size	  of	  the	  haplotype	  window	  considered	  cannot	  generate	  any	  new	  
matches,	  and	  must	  therefore	  either	  reduce	  or	  maintain	  the	  number	  of	  active	  matches.	  Hence,	  
by	  using	   larger	  slices	  we	  can	  expect	  the	  size	  of	  the	  hash	  and	  memory	   it	  requires	  to	  decrease.	  
GERMLINE	  2.0	   implements	   this	  by	  precalculating	   the	  expected	   total	  memory	  requirements	  of	  




Extending	   a	   slice	   requires	   the	   hashing	   step	   to	   be	   repeated,	  which	   is	   linear	   in	   the	   number	   of	  
samples	  and	  can	  be	  made	  efficient	  by	  absolute	  measures	  as	  well.	  This	  slice	  extension	  and	  re-­‐
hashing	   are	   performed	   iteratively	   until	   a	   filled	   hash	   would	   fit	   in	   available	   memory	   and	   the	  
algorithm	  can	  proceed	  as	  normal	  to	  output	  an	  approximate	  set	  of	  matches	  (Algorithm	  5).	  
Algorithm	  5	  
Input:	  	  	  	  H:	  2N	  ×	  G	  matrix	  of	  haplotype	  data	  
s:	  user-­‐defined/default	  slice	  size	  
Begin:	  
l	  ←	  1;A	  ←	  ∅	  
repeat-­‐until	  l	  >	  g	  
repeat-­‐until	  FitsInMemory(W)	  
if	  first	  iteration	  r	  ←	  l+a-­‐1	  else	  r	  ←	  r	  +	  Δ	  
W	  ←	  FindShortWords(H,	  [l,	  r])	  
E	  ←	  CreateExactMatch(W,	  [l,	  r])	  
for	  each	  exact	  match	  e	  ∈	  E	  
A	  ←	  A	  ∪	  ExtendMatch(e)	  
l	  ←	  l	  +	  r	  
Return	  A	  
3.3 Data & alternative methods 
Briefly,	  we	  used	  a	  dataset	  consisting	  of	  16,179	   individuals	  and	  455,566	  genotyped	  SNPs	   from	  
the	  Wellcome	  Trust	  Case-­‐Control	  Consortium	  (WTCCC)	  and	  a	  dataset	  of	  46,778	  individuals	  and	  
365,971	  markers	  pooled	  from	  several	  GWAS	  studies	  in	  dbGaP.	  All	  experiments	  were	  conducted	  
on	  a	  Linux	  node	  of	  4×3.0𝐺𝐻𝑧	  Xeon	  CPUs	  with	  8GB	  of	  memory.	  
Data	  from	  the	  Wellcome	  Trust	  Case-­‐Control	  Consortium	  (WTCCC) 
The	   WTCCC	   data	   we	   used	   consists	   of	   genotypes	   ascertained	   in	   2,000	   cases	   for	   each	   seven	  
common	   disease	   and	   3,000	   shared	   controls	   from	   the	   1958	   Birth	   Cohort	   (58C)	   and	   National	  
Blood	  Services	  (NBS).	  Genotyping	  was	  performed	  on	  the	  Affymetrix	  500k	  array	  and	  called	  using	  




WTCCC's	   quality	   thresholds	   our	   final	   dataset	   consisted	   of	   16,179	   individuals	   and	   455,566	  
autosomal	  markers.	  
Table	  3.1:	  dbGAP	  studies	  merged	  for	  single	  large-­‐sample	  cohort	  
	  Study	  Name	   Accession	  Number	  
	  Framingham	  SHARe	  Social	  Network	   phs000153.v3.p3	  
	  Women's	  Health	  Initiative	  SHARe	   phs000200.v3.p1	  
	  Whole	  Genome	  Association	  Study	  of	  Bipolar	  Disorder	   phs000017.v3.p1	  
	  Genome-­‐Wide	  Association	  Study	  of	  Schizophrenia	   phs000021.v3.p2	  
	  POPRES:	  Population	  Reference	  Sample	   phs000145.v2.p2	  
	  IMSGC	  Genome	  Wide	  Association	  Study	  of	  Multiple	  Sclerosis	   phs000139.v1.p1	  
Pooled	  studies	  from	  the	  database	  of	  genotypes	  and	  phenotypes	  (dbGAP) 
The	  studies	  listed	  in	  Table	  3.1,	  were	  collated	  from	  the	  database	  of	  genotypes	  and	  phenotypes	  
ascertained	  on	  the	  Affymetrix	  500k	  or	  Affymetrix	  6	  platforms	  to	   form	  a	  single	  dbGAP	  cohort.	  
Individuals	  and	  markers	  were	  excluded	  based	  on	  the	  specifications	  of	  each	  study.	  Additionally,	  
all	  SNPs	  were	  then	  converted	  to	  a	  unified	  rsID	  where	  available,	  with	  unidentifiable	  markers	  or	  
markers	   with	   greater	   than	   5%	  missingness	   removed	   entirely.	   In	   all	   instances,	   samples	   were	  
phased	   using	   the	   BEAGLE	   software	   with	   default	   parameters,	   in	   batches	   of	   2,000	   randomly	  
selected	  samples.	  
Phasing	  and	  method	  comparison	  
An	   HMM-­‐based	   IBD	   detection	   algorithm	   has	   been	   implemented	   in	   the	   BEAGLE	   fastIBD	  
framework	   and	   shown	   to	   be	   highly	   accurate	   at	   the	   cost	   of	   increased	   run-­‐time	   and	  memory	  
usage.	   However,	   due	   to	   the	   high	   memory	   requirement	   of	   a	   default	   BEAGLE	   run,	   we	   were	  




10	   such	   iterations).	   For	   recovering	  haplotype	  phase,	  we	  were	   able	   to	   split	   the	  data-­‐sets	   into	  
batches	  of	  1,000	  samples	  and	  phase	  separately.	  Although	  we	  do	  not	  recommend	  this	  strategy	  
in	   practice	  without	   thoroughly	   testing	   for	   batch	   artifacts,	  we	   employ	   it	   here	   to	   demonstrate	  
feasibility	   of	   our	   algorithm	   when	   phased	   data	   is	   available.	   For	   IBD	   detection	   with	   fastIBD,	  
however,	   we	   could	   not	   implement	   a	   batch	   strategy	   as	   all	   pairs	   of	   individuals	   need	   to	   be	  
examined	  simultaneously.	  In	  all	  subsequent	  analysis	  we	  consider	  only	  the	  GERMLINE	  algorithm	  
as	  it	  is	  singularly	  capable	  of	  processing	  this	  data	  completely.	  
3.4 Results 
	  We	   evaluated	   GERMLINE	   2.0	   on	   chromosome	   22	   using	   low	   initial	   slice	   sizes	   (64	   SNPs)	   and	  
increasing	  memory	  constraints.	  Performance	  and	  IBD	  segmnet	  concordance	  was	  compared	  to	  
GERMLINE	  1.5,	  which	  uses	  fixed	  slices	  (128	  SNPs),	  unlimited	  memory	  and	  no	  adaptability.	  
Table	  3.2:	  IBD	  segment	  overlap	  with	  constrained	  memory	  	  
	   	   Segment	  overlap	  (v2.0	  constrained)	  
Data	   #	  IBD	  segments	  (v2.0	  constrained)	   8Gb	   4Gb	   2Gb	   1Gb	  
WTCCC	   7.22	  x	  106	   100%	   100%	   80%	   55%	  
dbGaP	   1.58	  x	  108	   100%	   68%	   47%	   30%	  
	  
Table	  3.2	  details	  the	  IBD	  segment	  overlap	  between	  the	  unconstrained	  run	  of	  GERMLINE	  2.0	  and	  
increasing	  memory	  constraints.	  Since	  our	  primary	  focus	  is	  sensitivity	  of	  detection,	  overlap	  was	  
measured	   simply	   as	   the	   length	   of	   segments	   identified	   by	   both	   methods	   over	   the	   length	   of	  
segments	   identified	  by	   the	  unconstrained	  method.	  We	  see	   that	   the	  overlap	   in	  GERMLINE	  2.0	  




dbGaP	  data,	  a	  32%	  drop	  was	  noted	  when	  memory	  was	  reduced	  from	  8Gb	  to	  4Gb,	  with	  similar	  
drops	   for	   other	   memory	   reductions.	   As	   expected,	   average	   slice	   sizes	   increased	   with	   tighter	  
memory	  thresholds,	  e.g.,	  2Gb	  run	  with	  initial	  slice	  size	  of	  64	  SNPs	  showed	  average	  slice	  size	  of	  
68	  SNPs	  (not	  shown).	  
Table	  3.3:	  Algorithm	  runtime	  (minutes)	  with	  constrained	  memory	  
	   Runtime	  (v1.5)	   Runtime	  (v2.0	  constrained)	  
Data	   -­‐	   8Gb	   4Gb	   2Gb	   1Gb	  
WTCCC	   81	   100	   107	   95	   62	  
dbGaP	   160	   213	   192	   130	   80	  
	  
Table	  3.3	  details	  the	  runtime	  necessary	  for	  each	  type	  of	  memory	  constraint,	  as	  well	  as	  for	  the	  
unconstrained	  large-­‐window	  run	  of	  GERMLINE	  1.5.	  	  
	  
Figure	  3.1:	  Comparison	  of	  IBD	  segments	  detected	  with	  GERMLINE	  algorithms	  
Higher	  utilization	  of	  available	  memory	  by	  GERMLINE	  2.0	  (32	  SNPs/40Mb)	  compared	  to	  GERMLINE	  1.5	  (default	  





We	  compared	  overall	  sensitivity	  of	  both	  versions	  of	  GERMLINE	  using	  simulated	  data	  for	  which	  
true	  IBD	  segments	  are	  known.	  This	  enables	  us	  to	  find	  the	  %	  overlap	  in	  IBD	  segments	  reported	  
by	  the	  algorithms	  as	  compared	  true	  IBD	  segments.	  We	  find	  that	  by	  using	  minimal	  initial	  slices	  
(e.g.	   32	   SNPs),	   and	   providing	   adaptability	   to	   memory	   constraints,	   a	   3-­‐fold	   increase	   in	   IBD	  
segments	  was	  seen	  over	  the	  default	  algorithm	  with	  default	  fixed	  slices	  and	  unlimited	  memory	  
without	  adaptability	  (Figure	  3.1	  &	  Figure	  3.2).	   In	  Figure	  3.1	  we	  see	  that	  GERMLINE	  2.0	  always	  
runs	  at	  a	  higher	  complexity	  (#matches/slice)	  when	  compared	  to	  GERMLINE	  1.5.	  The	  additional	  
gap	  between	  the	  maximum	  threshold	  and	  emperical	  GERMLINE	  2.0	  complexity	  exists	  because	  
many	  matches	   are	   actually	   carried	   from	   previous	   slices	   and	   consume	  much	   of	   the	   available	  
memory.	  In	  Figure	  3.2,	  we	  show	  the	  local	  IBD	  overlap	  of	  the	  two	  algorithm	  runs	  with	  ground-­‐
truth	   data.	   This	   finding	   again	   emphasizes	   that	   GERMLINE	   2.0	   is	   consistently	   outperforms	  
GERMLINE	  1.5	  in	  terms	  of	  segment	  sensivitity,	  even	  under	  memory	  constraints,	  due	  to	  the	  fact	  
that	  it	  can	  optimize	  memory	  usage	  at	  each	  slice.	  
	  
Figure	  3.2:	  Comparison	  of	  detection	  accuracy	  across	  consecutive	  windows	  
Accuracy	  of	  GERMLINE	  2.0	   (32	  SNPs/35Mb)	  &	  GERMLINE	  1.5	   (default	  128	  SNPs/unlimited	  memory)	   is	  shown	  for	  






Algorithms	   for	   IBD	   detection	   focus	   on	   long	   shared	   segments	   that	   can	   be	  well-­‐detected	   from	  
SNP	   data;	   as	   the	   expected	   occurrence	   of	   such	   segments	   increases	   quadratically	   with	   the	  
number	   of	   samples,	   it	   is	   particularly	   important	   for	   such	   algorithms	   to	   work	   with	   large	  
populations	   where	   IBD	   becomes	   ubiquitous.	   Here	   we	   have	   presented	   a	   methodological	  
extension	   to	   the	   GERMLINE	   IBD-­‐detection	   algorithm	   that	   can	   adaptively	   adjust	   its	   memory	  
requirements	   to	   analyze	   populations	   of	   any	   size.	   GERMLINE	   2.0	   has	   been	   tested	   on	   two	  
datasets,	  32,000	  haploid	  chromosomes	   from	  the	  WTCCC	  and	  a	  merged	  set	  of	  nearly	  100,000	  
haploid	   chromosomes	   from	   studies	   in	   the	   dbGaP.	   Other	   existing	   algorithms	   have	   reported	  
analysis,	  at	  most,	  on	  a	  single	  sub-­‐panel	  of	  the	  WTCCC	  (roughly	  10,000	  haploid	  chromosomes),	  
and	  were	   not	   able	   to	   process	   either	   of	   the	   data-­‐sets	  we	   examined.	  GERMLINE	   2.0	   therefore	  




4 Probabilistic IBD detection in unphased, genome-wide sequence data 
4.1 Motivation 
The	  IBD	  detection	  algorithms	  described	  in	  Chapter	  2	  and	  Chapter	  3	  have	  relied	  on	  two	  explicit	  
assumptions	   of	   the	   underlying	   data:	   (i)	   that	   haplotypes	   are	   available	   for	   all	   individuals,	  with	  
reasonable	  quality	  for	  the	  initial	  exact	  seeds	  to	  be	  determined;	  (ii)	  that	  the	  input	  markers	  are	  
uniformly	  distributed	  and	  accurate	  IBD	  segment	  detection	  can	  be	  obtained	  by	  using	  a	  number	  
of	   specific	   threshold	   values.	   In	   this	   work	   we	   motivate	   less	   dependence	   on	   these	   two	  
assumptions	  and	  develop	  an	  extension	   to	  GERMLINE	   that	  processes	  unphased	  data	   in	   a	   fully	  
probabilistic	  scheme.	  
Algorithms	   to	   computationally	   recover	   haplotype	   from	   population	   genotype	   data	   –	   so-­‐called	  
“phasing”	  algorithms	  –	  have	  proven	  highly	  successful	  with	  the	  growth	  of	  rich	  population	  data.	  
However,	  as	  these	  algorithms	  tend	  to	  depend	  on	  complex	  phylogenetic	  models	  to	  reconstruct	  
local	   sample	   parsimony,	   they	   are	   intractable	   for	   large	   cohorts	   (>10,000	   samples)	   or	   whole-­‐
genome	  sequence	  data.	  While	  splitting	  large	  cohorts	  into	  subgroups	  and	  phasing	  separately	  (as	  
done	   in	   Chapter	   3)	   is	   a	   viable	   shortcut,	   in	   practice	   it	   tends	   to	   introduce	   a	   number	   of	   batch-­‐
artifacts	   and	   does	   not	   optimally	   utilize	   all	   available	   population	   data.	   This	   poses	   a	   particular	  
problem	   for	   IBD	   detection	   algorithms,	   all	   of	   which	   depend	   to	   some	   degree	   on	   inferring	  
haplotypes,	  and	  resulted	  in	  phasing	  being	  the	  largest	  computational	  bottleneck	  in	  analysis.	  
While	  the	  length-­‐based	  IBD	  detection	  strategy	  of	  GERMLINE	  has	  been	  successful	  with	  uniformly	  




tends	   to	   rely	   on	   arbitrary	   thresholds.	   In	   effect,	   the	   algorithm	   has	   sought	   regions	   of	   shared	  
identity	  by	  state	  that	  are	  so	  long	  as	  to	  be	  impossible	  by	  chance.	  This	  has	  limited	  the	  algorithm	  
sensitivity	  for	  short	  segments;	  which	  are	  precisely	  the	  segments	  we	  would	  expect	  to	  see	  the	  in	  
abundance	   in	   a	   general	   outbred	   population.	   Therefore,	   complex	   genomic	   data	   demands	   a	  
probabilistic	  analysis	  of	  putative	  IBD	  segments	  that	  can	  take	  into	  account	  local	  density,	  marker	  
correlation,	  variable	  error	  rates,	  and	  incomplete	  haplotype	  phase.	  In	  this	  algorithmic	  extension,	  
we	   seek	   to	   incorporate	   such	   features	   in	   conjunction	   with	   estimated	   local	   LD	   to	   calculate	   a	  
posterior	  probability	  on	  any	  observed	  patterns	  of	  IBS.	  This	  score	  allows	  us	  to	  eschew	  the	  hard	  
segment	   length	   threshold	   and	   identify	   any	   putative	   segment	   as	   long	   as	   its	   local	   properties	  
exceed	  a	  desired	  significance.	  
4.2 A robust probabilistic algorithm for IBD detection in unphased populations 
In	  practice,	  we	  find	  that	  concerns	  of	  phase	  and	  accuracy	  are	  closely	   linked:	  permitting	  shared	  
segments	  based	  on	  genotype	   information	   increases	  both	  sensitivity	  and	  Type	   I	  error	  as	  many	  
new	   segments	   are	   considered	   putative	   IBD;	   while	   a	   probabilistic	   score	   that	   incorporates	  
haplotype	  information	  constraints	  the	  allowed	  putative	  segments	  and	  has	  the	  opposite	  effects	  
on	  accuracy.	  With	  this	  in	  mind,	  we	  seek	  to	  optimize	  both	  metrics	  of	  accuracy	  while	  maintaining	  
reasonable	  computational	  complexity.	  
The	   extension	   to	   allow	   genotype	   and	   missing	   data	   can	   be	   accomplished	   trivially	   simply	   by	  
permuting	   all	   of	   the	   possible	   haplotypes	   of	   a	   given	   observed	   genotyped.	   Specifically,	   if	   we	  
consider	   a	   window	   of	   k	   markers	   with	   one	   sample	   containing	   h	   heterozygous/missing	   sites	  




the	   dictionary	   corresponding	   to	   that	   individual.	   If	   these	   haplotypes	   are	   processed	   in	  
lexicographical	   order	   (starting	   with	   the	   major	   allele),	   we	   can	   constrain	   the	   algorithm	   to	  
permute	  over	  a	  limited	  number	  of	  heterozygous	  sites	  by	  h’	  (where	  h’	  is	  less	  than	  or	  equal	  to	  h),	  
which	   would	   threshold	   the	   upper-­‐bound	   memory	   requirement	   of	   the	   window.	   In	   those	  
instances	  where	  h’	  <	  h	  two	  samples	  would	  only	  miss	  a	  match	  in	  this	  window	  as	  long	  as	  there	  is	  a	  
subsequent	  site	  i	  >	  h’	  at	  which	  one	  sample	  is	  homozygous	  for	  the	  minor	  allele	  and	  the	  other	  is	  
heterozygous.	  We	  aim	  to	  set	  the	  constraint	  such	  that	  a	  full-­‐length	  match	  is	  likely	  to	  be	  caught	  in	  
at	  least	  one	  window.	  
We	  note	  that	  such	  a	  model	  is	  flexible	  enough	  to	  allow	  any	  independent	  subset	  of	  the	  data	  to	  be	  
treated	   as	   phased	   or	   unphased,	   enabling	   robust	   IBD	   detection	   in	   the	   presence	   of	   phase	  
ambiguity.	   As	   has	   been	   demonstrated	   with	   the	   pre-­‐phased	   imputation	   approach,	   this	   is	  
particularly	   useful	   in	   large	   data-­‐sets	   where	   the	   costly	   task	   of	   generating	   high-­‐likelihood	  
haplotypes	  –	  oftentimes	  more	  than	  one	  per	  individual	  -­‐	  is	  performed	  once	  in	  advance	  and	  then	  
treated	  as	  gospel	  for	  all	  subsequent	  analysis.	  With	  our	  algorithm,	  it	  would	  be	  straightforward	  to	  
accept	  a	  constrained	  set	  of	  such	  haplotypes	  for	  each	  sample	  and	  detect	  shared	  segments	  across	  
any	  permutation	  thereof.	  
Our	  secondary	  goal	  is	  to	  develop	  a	  confidence	  score	  for	  each	  of	  the	  putative	  segments.	  This	  is	  
particularly	   important	   for	   controlling	   Type	   I	   error,	   which	   can	   increase	   significantly	   when	  
exploring	  the	  entire	  genotype	  space	  as	  we	  allow	  here.	  Such	  a	  confidence	  score	  has	  traditionally	  
been	   calculated	   from	   the	   posterior	   probability	   of	   an	   HMM	  with	   states	   corresponding	   to	   the	  




marker	   LD	   by	   calculating	   the	   joint	   emission	   probability	   of	   pairs	   of	   markers.	   Here,	   we	  
mechanistically	   identify	  emission	  probabilities	  of	  arbitrary	   length	  and	   incorporate	  them	  into	  a	  
linear-­‐time	  likelihood	  maximization	  score	  based	  on	  a	  dynamic	  program.	  
Formally,	  given	  a	  marker	  interval	  {mi,mj},	  two	  observed	  genotype	  vectors	  {ga,	  gb}	  from	  spanning	  
the	  interval	  in	  a	  matrix	  of	  genotypes	  G,	  and	  a	  matrix	  H	  of	  haplotype	  frequencies	  also	  spanning	  
the	   interval;	   we	   seek	   to	   compute	   the	   likelihood	   of	   two	   IBD	   states	   along	   this	   interval	  
P(IBD={0,1,2}|ga,gb,H).	   With	   these	   probabilities,	   we	   can	   maximize	   the	   likelihood	   ratio	  
P(IBD=1|ga,gb,H)/P(IBD=0|ga,gb,H)	   and	   P(IBD=2|ga,gb,H)/P(IBD=0|ga,gb,H)	   to	   determine	   if	   the	  
interval	   is	   likely	   to	   be	   shared	   by	   descent.	   Using	   Bayes’	   theorem,	   we	   re-­‐formulate	   this	  
calculation	  as:	  	  
P(IBD={0,1,2}|ga,gb,H)=	  
P(ga,gb|IBD={0,1,2},H)P(IBD={0,1,2})/P(ga,gb,H)	  
Where	   P(IBD={0,1,2})	   is	   the	   prior	   probability	   of	   observing	   the	   respective	   IBD	   status	   in	   the	  
population,	   while	   P(ga,gb,H)	   is	   the	   prior	   probability	   of	   observing	   these	   genotypes	   and	  
haplotypes.	  Evaluating	  the	  resultant	  likelihood	  ratio	  (LR)	  we	  find:	  






And	  a	  corresponding	  derivation	  for	  IBD=2.	  Note	  that	  since	  the	  same	  genotypes	  and	  haplotypes	  
are	  observed	  in	  both	  parts	  of	  the	  ratio,	  we	  do	  not	  need	  to	  calculate	  their	  prior	  probability.	  We	  
observe	   that	   P(IBD=1)/P(IBD=0)	   and	  P(IBD=2)/P(IBD=0)	   are	  a	  priori	   estimates	  of	   observing	   an	  
IBD	  segment	  between	  this	  pair	  of	   individuals.	   In	  previous	  work,	  this	  prior	  has	  been	  calculated	  
based	   on	   a	  method-­‐of-­‐moments	   estimator	   from	   genome-­‐wide	   IBS	   sharing.	   As	   there	   is	   some	  
debate	   on	   how	   such	   a	   statistic	  must	   be	   calculated,	   and	   it	   remains	   constant	   for	   each	   pair	   of	  
samples,	  we	  assume	   liberally	   that	   the	  ratio	  equals	  1	  and	  allow	  the	  user	   to	  adjust	   it	  based	  on	  
their	  prior	  estimates	  from	  the	  population.	  
In	   computing	   P(ga,gb|IBD=0,H)	  we	  observe	   that	   the	   ga	   and	   gb	   are	   independent,	   and	   the	   joint	  
probability	   is	   therefore	   equal	   to	   the	  product	  of	   the	  probabilities	   P(ga|IBD=0,H)P(gb|IBD=0,H).	  
Given	  a	  genotype	  g,	  we	  iterate	  over	  all	  haplotypes	  h	  in	  H;	  and	  for	  each	  h	  which	  we	  identify	  h’,	  
the	   complementary	   haplotype	   to	   h	   given	   g.	   Formally,	   for	   every	   homozygous	   site	   g[i],	  
h’[i]=h[i]=g[i]	  (iff	  possible)	  and	  for	  every	  heterozygous	  site	  g[i],	  h’[i]	  equals	  the	  complementary	  
allele	  of	  h[i].	  We	  can	  ignore	  any	  pairs	  where	  h	  and	  h’	  are	  not	  consistent	  with	  g,	  and	  calculate	  
P(g|IBD=0,H)	  =	  Σ	  f(h)f(h’)	  where	  f(h)	  is	  a	  function	  that	  returns	  the	  haplotype	  frequency	  of	  h	  in	  H.	  
We	  can	  therefore	  pre-­‐compute	  these	  probabilities	  in	  time	  O(|H||G|),	  where	  |G|	  corresponds	  
to	  the	  number	  of	  unique	  genotypes	  in	  G.	  
In	  computing	  P(ga,gb|IBD=1,H)	  we	  are	  forcing	  one	  haplotype	  to	  be	  shared	  between	  the	  pair	  of	  
genotypes.	   Therefore	   the	   joint	   probability	   is	   no	   longer	   the	   product	   of	   the	   individual	  
probabilities	  and	  must	  be	  calculated	  jointly	  over	  all	  possible	  pairs	  of	  genotypes.	  Given	  a	  pair	  of	  




corresponding	  haplotypes	  for	  h	  given	  ga	  and	  gb	  respectively.	  As	  before,	  we	  ignore	  any	  h	  where	  
ha’	  or	  hb’	  cannot	  be	  computed,	  and	  calculate	  P(ga,gb|IBD=1,H)	  =	  Σ	   f(h)f(ha’)f(hb’)	   to	  obtain	  the	  
overall	   likelihood.	  This	  calculation	  requires	  O(|H||G|2)	  time.	  Simultaneously,	  we	  can	  compute	  
P(ga,gb|IBD=2,H)	   over	   those	   haplotypes	   where	   {h,ha’,	   hb’}	   consist	   fewer	   than	   three	   unique	  
haplotypes	   (i.e.	   h=	   ha’	   and/or	   h=	   hb’	   and/or	   ha’=	   hb’).	   This	   requires	   no	   additional	   search	  
computation	  and	  completes	  the	  full	  set	  of	  necessary	  pre-­‐computed	   IBD	   likelihoods	  for	  the	  LR	  
equations.	  
Having	   pre-­‐computed	   the	   likelihood	   ratios	   for	   each	   interval,	   we	   can	   compute	   the	   overall	  
likelihood	  ratio	  for	  a	  given	  putative	  segment	  as	  the	  product	  of	  the	  ratios	  of	  all	  intervals	  that	  it	  
spans	  (in	  practice,	  the	  sum	  of	  log-­‐likelihoods).	  Moreover,	  if	  we	  assume	  the	  putative	  segment	  to	  
be	  an	  extension	  of	  the	  true	  segment,	  we	  can	  calculate	  the	  max-­‐likelihood	  underlying	  segment	  
efficiently	   with	   the	   algorithm	   for	   the	   classical	   maximum	   subsequence	   sum	   problem.	   This	  
classical	  problem	  seeks	  to	  identify	  the	  longest	  subsequence	  within	  a	  sequence	  of	  real	  numbers	  
such	   that	   the	   sum	  of	   the	   subsequence	   is	   greater	   than	   some	   threshold	   (usually	   zero).	   For	  our	  
purposes,	  we	  are	  looking	  for	  the	  longest	  subsequence	  that	  has	  a	  positive	  sum	  of	  log-­‐likelihood	  
ratios	  (maximized	  over	  LRIBD1	  and	  LRIBD2	  independently).	  This	  computation	  can	  be	  done	  in	  time	  
proportional	   to	   the	   length	  of	   the	   region	  and	   is	   identical	   to	  an	  HMM	  that	  only	  allows	  a	  single	  
segment	  within	  the	  putative	  region.	  
4.3 Estimating detection accuracy in diverse data 
We	  seek	  to	  measure	  the	  accuracy	  and	  efficiency	  of	  this	  algorithm	  on	  three	  canonical	  types	  of	  




whole-­‐genome	   array	   representative	   of	   contemporary	   GWAS	   platforms,	   (iii)	   whole-­‐exome,	  
where	   only	   variants	   in	   the	   coding	   and	   flanking	   regions	   are	   observed	   and	   site	   density	   varies	  
significantly.	   For	   each	   data-­‐type,	   we	   seek	   to	   explore	   detection	   accuracy	   in	   the	   context	   of	  
population	  size	  (i.e.	  the	  degree	  of	  relatedness)	  and	  the	  sample	  size.	  
Simulated	  whole-­‐genome	  data	  
As	  we	  observed	  in	  previous	  IBD	  analysis,	  Type	  I	  error	  is	  particularly	  difficult	  to	  measure	  because	  
it	  requires	  ground-­‐truth	  data	  with	  no	  a	  priori	  IBD	  segments;	  a	  difficult	  task	  in	  dense	  populations	  
or	   for	  very	  short	   segments.	  Previous	   research	  has	  overcome	  this	  problem	  by	   taking	   real	  data	  
and	  permuting	   short	  genomic	   slices	  among	  different	   individuals,	   therefore	   insuring	   that	   for	  a	  
pair	  of	  samples	  to	  share	  a	  long	  segment	  after	  permutation	  is	  extremely	  unlikely.	  However,	  such	  
an	  approach	  can	   result	   in	  disrupted	  LD	  structure	  and	  bias	  against	   false-­‐positive	   IBD	  segment.	  
For	  whole-­‐genome	  data,	  we	  elect	  to	  simulate	  the	  sequence	  of	  a	  population	  of	  individuals	  from	  
a	  neutral	  coalescent	  and	  use	  the	  generated	  output	  directly	  for	  sequence	  or	  sub-­‐sample	  to	  the	  
desired	  marker	  density	  for	  genotype	  arrays.	  With	  this	  approach	  we	  can	  recover	  the	  full	  set	  of	  
ground-­‐truth	  IBD	  segments	  by	  analyzing	  the	  resultant	  coalescent	  tree	  while	  precisely	  tuning	  the	  
population	  and	  sampling	  parameters.	  
Specifically,	   we	   simulate	   two	   populations	   with	   constant	   effective	   population	   size	   9,000	   and	  
3,000;	   corresponding	   to	   an	   outbred	   European	   population	   and	   a	   densely	   related	   isolated	  
population	  respectively.	  For	  each	  population	  we	  generate	  a	  short	  chromosome	  (genetic	  length	  
of	  chromosome	  22)	   for	   two	  cohorts	  of	  50	  and	  250	  samples	  and	   identify	  any	  segments	   longer	  




cohort;	  for	  array	  data,	  we	  randomly	  sub-­‐sample	  to	  the	  density	  of	  an	  Affymetrix	  500k	  SNP	  array	  
such	   that	   the	   output	   allele	   frequency	   spectrum	   matches	   that	   of	   a	   large	   European	   cohort	  
sampled	  on	  this	  platform	  and	  typical	  of	   large-­‐scale	  GWAS.	  These	  four	  cohort	   types	  should	  be	  
representative	   of	   the	   spectrum	   of	   population	   and	   sample	   size	   involved	   in	   modern	   whole-­‐
genome	  studies.	  
Pseudo-­‐real	  whole-­‐genome	  data	  
We	  perform	  a	  secondary	  validation	  of	  the	  simulated	  analysis	  in	  real	  data	  by	  leveraging	  available	  
sequence	  from	  the	  1,000	  Genomes	  Project.	  The	  pilot	  release	  contains	  both	  trio	  and	  population	  
data	   from	   the	   Yoruba	   (YRI)	   and	   European	   (CEU)	   cohorts.	   As	   family-­‐based	   phasing	   is	   highly	  
accurate,	  we	  can	  phase	  the	  trio	  with	  full	  knowledge	  of	  the	  family	  relationship	  and	  reasonably	  
treat	  the	  haplotypes	  of	  the	  parents	  as	  ground	  truth	  –	  with	  any	  observed	  IBD	  segments	  between	  
these	  haplotypes	  assumed	  to	  be	  true	  positive.	  For	  testing,	  we	  generate	  IBD	  segments	  of	  desired	  
length	  by	  planting	  a	  corresponding	  haplotype	  from	  one	  parent	  into	  that	  of	  the	  other	  and	  then	  
process	   the	   genotypes	   of	   these	   individuals,	   hiding	   the	   child,	   along	   with	   the	   rest	   of	   the	  
population	  cohort.	  This	   strategy	  effectively	  allows	  us	   to	  measure	  concordance	  between	  high-­‐
quality	  phasing	  and	  standard	  population	  data.	  
Pseudo-­‐real	  whole-­‐exome	  data	  
Whole-­‐exome	   data,	   which	   consists	   of	   only	   exon	   and	   flanking	   regions,	   has	   a	   unique	   allele	  
frequency	  and	  density	  spectrum	  and	  is	  therefore	  difficult	  to	  simulate	  without	  prior	  assumptions	  
on	   the	   evolutionary	   constraints	   of	   coding	   variants.	   For	   this	   data,	   we	   leverage	   a	   cohort	   of	  




exome	  sequence	  platforms	  as	  part	  of	  the	  NIDDK	  study	  on	  Crohn’s	  disease.	  With	  the	  assumption	  
that	   whole-­‐genome	   analysis	   will	   generally	   be	   more	   accurate,	   we	   determine	   for	   this	   data	   a	  
segment	  threshold	  that	  corresponds	  to	  high	  simulation	  accuracy	  for	  all	  compared	  methods	  and	  
treat	  segments	  longer	  than	  this	  threshold	  as	  ground-­‐truth	  IBD.	  Then,	  as	  with	  the	  whole-­‐genome	  
sequence,	  we	  measure	  overlap	  between	  IBD	  segments	  of	  this	   length	  minimum	  detected	  from	  
exome	  data	  and	  the	  ground-­‐truth	  to	  calculate	  expected	  exome	  detection	  accuracy.	  
Methods	  compared	  
For	  all	  datasets	  we	  compared	  analysis	  with	  the	  traditional	  GERMLINE	  phased	  algorithm	  (labeled	  
“phased	  seed”)	  executed	  the	   input	  data	  after	  phasing	  with	  the	  BEAGLE	  algorithm	  and	  default	  
parameters;	  GERMLINE	  unphased	  probabilistic	  extension	  described	  in	  this	  chapter	  (“unphased	  
seed”)	   with	   no	   phasing	   information;	   and	   the	   BEAGLE	   fastIBD	   algorithm	   with	   default	   IBD	  
segment	   confidence	   (“fastIBD	   hi”)	   and	  minimal	   confidence	   (“fastIBD	   lo”).	   Briefly,	   the	   fastIBD	  
algorithm	   works	   by	   constructing	   a	   variable-­‐order	   Hidden	  Markov	  Model	   from	   the	   genotype	  
data	  where	  states	  represent	  unique	  haplotypes;	  computing	  the	  maximum-­‐likelihood	  paths	  for	  
all	   individuals	   through	   these	   states	   to	   recover	   haplotype	   phase;	   and	   using	   a	   GERMLINE-­‐like	  
hashing	  scheme	  to	  find	  paths	  through	  the	  model	  that	  are	  identical	  between	  pairs	  of	  individuals	  
and	  suggestive	  of	  an	  IBD	  segment	  (with	  confidence	  inversely	  correlated	  to	  the	  path	  frequency	  
in	   the	   population).	   Because	   the	   fastIBD	   algorithm	   is	   stochastic,	   the	   authors	   strongly	  
recommend	  running	  10	  consecutive	  random	  trials	  and	  then	  merging	  all	  identified	  IBD	  segments	  
to	   form	   a	   single	   set	   with	   integrated	   confidence	   and	   we	   followed	   these	   suggestions	   with	   no	  




Error	  and	  accuracy	  measurements	  
Prior	  to	  any	  analysis	  we	  apply	  0.1%	  and	  3%	  random	  error	  to	  all	  of	  the	  genotype	  and	  sequence	  
data	  respectively	  to	  mimic	  realistic	  error	  parameters.	  We	  measure	  accuracy	  as	  sensitivity	  and	  
specificity	  of	  the	  identified	  IBD	  segments	  compared	  to	  ground-­‐truth,	  where	  sensitivity	  is	  the	  %	  
of	   true	   segments	   that	   are	   overlapped	   by	   identified	   segments	   and	   specificity	   is	   the	   %	   of	  
identified	  segments	  that	  are	  overlapped	  by	  true	  segments	  (all	  percentages	  taken	  over	  genetic	  
distance).	  We	  note	  that	  this	  metric	  could	  still	  show	  high	  accuracy	  even	   if	  discovered	  segment	  
length	  was	  poorly	  correlated	  to	  the	  underlying	  segment	  (for	  example,	  if	  a	  long	  true	  segment	  is	  
detected	  as	   several	   short	   segments),	   and	  we	  do	  not	  explore	   length	  accuracy	  explicitly	   in	   this	  
work.	   In	  many	   cases,	  we	   report	   the	   F-­‐score	   accuracy	   rather	   than	   the	   two	   individual	  metrics,	  
where	  F-­‐score	  is	  calculated	  as	  the	  harmonic	  mean	  of	  the	  two	  error	  rates	  as	   is	  appropriate	  for	  
incorporating	  rate	  parameters.	  
4.4 Results 
We	  begin	  by	  examining	  the	  IBD	  detection	  accuracy	  of	  the	  GERMLINE	  unphased	  algorithm	  alone	  
in	  a	  single	  cohort	  and	  then	  perform	  a	  thorough	  methods	  comparison	  over	  the	  simulated	  cohort	  





The	   two	   main	   parameters	   that	  
effect	   unphased	   performance	  
are:	   (a)	   the	   limit	   on	  
heterozygous/missing	   sites	   that	  
are	   permuted	   for	   a	   single	  
sample	   (reported	   here	   as	   the	  
maximum	   number	   of	   permuted	  
haplotypes,	   labeled	   “maximum	  
permutations”),	   which	   effects	  
sensitivity	   of	   detection;	   and	   (b)	  
the	   limit	  on	  the	  number	  of	  unique	  genotypes	  allowed	   in	  the	  window	  for	  calculating	  LD-­‐based	  
IBD	  probabilities	  (labeled	  “Genotype	  density”),	  which	  effects	  the	  precision	  of	  the	  IBD	  score	  and	  
therefore	  overall	  accuracy.	  Working	  in	  the	  largest	  outbred	  cohort	  (Ne=9000,	  N=250)	  we	  expect	  
these	  parameters	  to	  be	  independent	  and	  so	  fix	  one	  while	  examining	  the	  effect	  on	  accuracy	  of	  
the	   other.	   Figure	   4.1	   details	   the	   F-­‐score	   accuracy	   in	   simulated	   array	   data	   as	   a	   function	   of	  
segment	   length	   and	   genotype	   density	   (colored	   series).In	   this	   case	   genotype	   density	   of	   zero	  
corresponds	  to	  calculating	  probability	  of	  each	  marker	  independently	  and	  therefore	  ignoring	  LD	  
information	  completely.	  As	  is	  typical,	  we	  observe	  a	  general	  correlation	  between	  true	  segment	  
length	  and	  detected	  accuracy,	  with	  accuracy	  of	  all	   trials	  at	  or	  above	  90%	  for	  segments	   longer	  
than	  5cM.	  For	  short	  segments,	  there	  is	  an	  accuracy	   increase	  of	  2-­‐5%	  between	  the	  lowest	  and	  
	  
Figure	  4.1:	  Effect	  of	  genotype	  density	  on	  segment	  detection	  
accuracy	  in	  simulated	  array	  data	  
Detection	  accuracy	  of	  simulated	  IBD	  segments	  in	  a	  neutral	  coalescent	  
is	  shown	  as	  a	  function	  of	  true	  segment	  length	  (x-­‐axis	  in	  centimorgans)	  
and	  the	  number	  of	  maximum	  allowed	  unique	  genotypes	  for	  LD-­‐based	  
IBD	   score	   calculation	   (four	   colored	   series).	   Density	   of	   zero	   implies	  




highest	  genotype	  complexity	  which	  becomes	  less	  significant	  with	  longer	  segments.	  Overall,	  we	  
find	  that	  LD-­‐awareness	  has	  a	  measurable	  but	  minor	  impact	  on	  accuracy.	  Represented	  similarly	  
but	  with	  fixed	  genotype	  density,	  Figure	  4.2	  details	  the	  relationship	  of	  accuracy	  to	  the	  maximum	  
allowed	   haplotype	   permutations.	   Here	   we	   see	   a	   significant	   increase	   in	   accuracy	   of	   5-­‐10%	  
between	  the	  lowest	  and	  highest	  permutation	  threshold,	  with	  the	  increase	  consistent	  across	  all	  
window	  sizes.	  As	  before,	  segments	  beyond	  5cM	  are	  detectable	  with	  high	  accuracy	  regardless	  of	  
parameters.	   Based	   on	   this	   analysis,	   we	   select	   genotype	   complexity	   of	   10	   and	   haplotype	  
permutations	   of	   64	   for	   all	   subsequent	   analysis	   as	   the	   thresholds	   where	   more	   exhaustive	  
searching	  would	  lead	  to	  diminishing	  returns.	  
Robustness	  of	  confidence	  score	  
With	   runtime	   parameters	  
established,	   we	   focus	   our	  
analysis	   on	   measuring	  
correctness	  of	  the	  IBD	  likelihood	  
score.	   Figure	   4.3	   details	   the	  
sensitivity	   and	   specificity	   (as	  
described	   previously)	   of	   IBD	  
segment	   detection	   in	   the	   same	  
set	   of	   250	   simulated	   outbred	  
genotypes.	   Accuracy	   is	  
evaluated	   over	   six	   thresholds	   on	   the	   output	   likelihood	   ratio	   with	   no	   assumptions	   on	   the	  
	  
Figure	  4.2:	  Effect	  of	  permutation	  complexity	  on	  segment	  detection	  
accuracy	  
Detection	  accuracy	  of	  simulated	  IBD	  segments	  in	  a	  neutral	  coalescent	  
is	  shown	  as	  a	  function	  of	  true	  segment	  length	  (x-­‐axis	  in	  centimorgans)	  
and	  the	  maximum	  number	  of	  haplotype	  permutations	  allowed	  from	  a	  




population	  IBD	  parameter	  and	  reported	  as	  a	  function	  of	  segment	  length.	  We	  find	  that	  the	  score	  
is	   well	   tuned,	   with	   increased	   confidence	   thresholds	   resulting	   in	   a	   monotonic	   increase	   in	  
specificity,	   with	   high-­‐confidence	   matches	   resulting	   in	   specificity	   of	   at	   least	   85%	   across	   all	  
minimum	  segment	  lengths.	  However,	  we	  also	  see	  that	  for	  reported	  segments	  longer	  than	  3cM	  
the	  confidence	  score	  offers	  little	  specificity	  improvement	  over	  the	  baseline	  confidence.	  In	  most	  
instances,	  sensitivity	  decreases	  in	  proportion	  to	  the	  specificity	  increases,	  such	  that	  the	  overall	  F-­‐
score	  accuracy	  is	  largely	  unaffected.	  As	  such,	  the	  confidence	  score	  is	  primarily	  a	  useful	  measure	  
for	  identifying	  high-­‐quality	  segments	  rather	  than	  enriching	  overall	  accuracy,	  and	  so	  we	  elect	  to	  




Simulated	  data:	  whole-­‐genome	  array	  
Looking	   at	   other	   methods	   for	   IBD	  
detection,	   we	   compare	   the	   effectiveness	  
of	   unphased	   GERMLINE,	   phased	  
GERMLINE,	  and	  two	  variants	  of	  the	  recent	  
fastIBD	   algorithm	   in	   four	   cohorts	   of	  
simulated	   genotype	   array	   data	   (see	  
Chapter	  4.3).	  Figure	  4.4	  shows	  the	  F-­‐score	  
accuracy	  for	  these	  methods	  broken	  down	  
by	  cohort	  and	  segment	  length.	  As	  before,	  
we	   see	   a	   general	   trend	   of	   increased	  
accuracy	   with	   longer	   segment	   length	   for	  
all,	   with	   generally	   high	   accuracy	   at	   and	  
beyond	   5cM.	   Focusing	   on	   the	   shorter	  
segments,	   we	   observe	   that	   the	   fastIBD	  
algorithm	   tends	   to	   outperform	   both	  
implementations	   of	   GERMLINE	   in	   the	  
large	   outbred	   cohort	   (top	   left).	   We	   note	  
that	   there	   is	   a	   slight	   difference	   resulting	  
from	  the	  two	  fastIBD	  parameter	  settings,	  though	  the	  algorithm	  still	  maintains	  a	  5-­‐10%	  increase	  
in	  accuracy	  over	  either	  GERMLINE	  run.	  Because	  the	  large	  sample	  size	  allows	  thorough	  sampling	  
	  
Figure	  4.3:	  Robustness	  of	  IBD	  confidence	  score	  
Specificity	   (top)	   and	   sensitivity	   (bottom)	   of	   IBD	   detection	  
as	  a	  function	  of	  segment	  length	  (x-­‐axis,	  centimorgans)	  and	  
minimum	   segment	   confidence	   score	   (cumulative,	   colored	  
series).	   IBD	   segments	   were	   used	   from	   a	   simulated	  
population	   of	   250	   samples	   with	   Ne=9,000	   and	   all	   other	  




of	  haplotype	  patterns	  and	  the	  outbred	  nature	  increases	  diversity	  and	  minimizes	  false	  segments,	  
this	   dataset	   is	   the	   most	   ideal	   for	   segment	   detection	   and	   yields	   highest	   accuracy	   with	   all	  
methods.	  Simply	  by	  reducing	  the	  number	  of	  available	  samples	  to	  50	  (top-­‐right),	  and	  therefore	  
dampening	   the	   accuracy	   of	   estimated	   haplotypes,	   we	   see	   a	   dramatic	   decrease	   in	   detection	  
accuracy	  for	  fastIBD	  and	  phased	  GERMLINE;	  the	  latter	  identifying	  no	  segments	  at	  all	  of	  length	  
3cM	  or	  higher.	  On	  the	  other	  hand,	  unphased	  GERMLINE	  in	  this	  cohort	  has	  a	  negligible	  reduction	  
in	  accuracy	  across	  all	  segment	  lengths	  and	  consistently	  outperforms	  all	  of	  the	  other	  methods.	  
When	  we	  again	  consider	  the	  large	  250	  sample	  cohort	  but	  with	  a	  densely	  related	  population	  of	  
Ne=3,000	   (bottom-­‐left),	   we	   see	   that	   fastIBD	   performance	   is	   significantly	   affected	   by	   the	   IBD	  
complexity	   parameter,	   with	   defaults	   resulting	   in	   lowest	   overall	   accuracy	   (“fastIBD	   hi”,	   light-­‐
blue),	   with	   phased	   GERMLINE	   resulting	   in	   the	   highest	   accuracy	   and	   unphased	   GERMLINE	  
relatively	  unchanged.	  Lastly,	  when	  we	  consider	  both	  a	  dense	  population	  and	  a	  small	  sample	  size	  
(bottom-­‐right)	  we	  are	  surprised	  to	  find	  that	  fastIBD	  accuracy	  improves,	  now	  close	  to	  or	  slightly	  
higher	   than	   GERMLINE	   unphased.	   We	   suspect	   that	   the	   fastIBD	   confidence	   parameter	   is	  
dependent	   on	   both	   population	   and	   sample	   size	   and	   therefore	   fluctuates	   highly	  when	  one	  of	  
these	  factors	  is	  changed.	  Here	  again	  the	  GERMLINE	  unphased	  accuracy	  is	  largely	  unaffected.	  
From	   this	   analysis,	   it	   is	   clear	   that	  high-­‐quality	  phasing	  of	   array	  data,	  when	  available,	  offers	   a	  
significant	   improvement	   in	  IBD	  detection	  accuracy,	  and	  fastIBD	  or	  phased	  GERMLINE	  tends	  to	  
perform	  better	   than	   unphased	  GERMLINE	   in	   large	   cohorts.	   However,	   unphased	  GERMLINE	   is	  




all	  methods	  in	  smaller	  cohorts	  and	  higher	  accuracy	  than	  default	  fastIBD	  analysis	  of	  non-­‐outbred	  
cohorts.	  
	  
Figure	  4.4:	  IBD	  detection	  accuracy	  in	  simulated	  array	  data	  




Simulated	  data:	  whole-­‐genome	  sequence	  
Next,	   we	   consider	   the	   effectiveness	   of	   the	   same	   set	   of	   algorithms	   when	   whole-­‐genome	  
sequence	  data	   is	  available.	  The	  sequence	  data	   is	  drawn	  from	  the	  same	  coalescent	  tree	  as	  the	  
previous	   analysis	   but	   with	   a	   higher	   error	   rate	   (3%)	   appropriate	   for	   realistic	   low-­‐pass	  
sequencing;	  otherwise,	  all	  algorithms	  are	  executed	  with	  the	  same	  parameters	  as	  previously.	  For	  
the	  unphased	  GERMLINE	   algorithm,	  we	   see	   a	   significant	   overall	   decrease	   in	   error	   by	   roughly	  
50%	   across	   all	   segment	   lengths	   and	   cohort	   types.	  Where	   the	   length	   cut-­‐off	   for	   high-­‐quality	  
segments	  (90%	  accuracy)	  for	  unphased	  GERMLINE	  was	  5cM	  in	  genotype	  data,	  it	  is	  now	  2cM	  in	  
sequence	  data.	  Since	  segment	  length	  decreases	  exponentially	  with	  generations	  to	  the	  common	  
ancestor,	  this	  shifts	  the	  expected	  age	  of	  a	  high-­‐quality	  recovered	  segment	  from	  20	  generations	  
to	   50	   generations	   –	   allowing	   us	   to	   look	   significantly	   further	   into	   the	   past.	   Interestingly,	   the	  
phased	   GERMLINE	   algorithm,	   while	   also	   increasing	   in	   accuracy	   slightly,	   now	   consistently	  
underperforms	   the	   unphased	   approach,	   particularly	   in	   the	   low	   sample	   size	   cohort.	   Likewise,	  
fastIBD	  –	  which	  also	  depends	  on	  haplotype	  phasing	  –	  has	  lower	  accuracy	  than	  the	  runs	  on	  array	  
data.	  Moreover,	   its	  accuracy	  does	  not	  appear	  to	  have	  direct	  correlation	  with	  segment	   length,	  
suggesting	  an	  overwhelming	  amount	  of	  false-­‐positive	  segments.	  The	  haplotype	  inference	  of	  this	  
method	   in	  sequence	  data	  has	  been	   largely	  unexplored,	  and	   these	   initial	   findings	  suggest	   that	  
the	  high-­‐density	  and	  saturation	  of	   rare	  variants	   in	  sequence	  data	  poses	  a	  non-­‐trivial	  problem	  
for	  phasing	  and	  algorithms	  that	  expect	  well-­‐phased	  data.	  The	  unphased	  GERMLINE	  approach,	  
on	   the	   other	   hand,	   appears	   robust	   to	   sequence;	   with	   significantly	   higher	   accuracy	   in	   all	  





Figure	  4.5:	  IBD	  detection	  accuracy	  in	  simulated	  sequence	  data	  
	  




Real	  data:	  Whole-­‐genome	  sequence	  
For	   real	   data,	   taken	   from	   the	   trio-­‐phased	   parents	   of	   CEU	   1,000	   Genomes	   Project	   data	   (see:	  
Pseudo-­‐real	  whole-­‐genome	  data)	  the	  number	  of	  segments	  that	  we	  have	  to	  work	  with	  is	  much	  
more	  limited	  and	  the	  ground-­‐truth	  data	  for	  short	  segments	  less	  precise.	  However,	  we	  can	  use	  
this	   data	   as	   a	   validation	   of	   the	   simulation	   results	   and	   to	   obtain	   a	   rough	   estimate	   of	  
performance	  in	  a	  realistic	  outbred	  population.	  
	  
Figure	  4.6:	  IBD	  detection	  accuracy	  in	  CEU	  whole-­‐genome	  sequence	  
Shared	  haploid	   segments	  were	  planted	  onto	   the	  background	   real	   trio-­‐phased	  parents	   from	   the	   European	  1,000	  
Genomes	  Project	  Data	   (CEU)	  and	  detection	  sensitivity	  measured	   for	  both	  methods	   (left).	  Shared	  segments	  were	  
detected	   with	   liberal	   parameters	   in	   trio-­‐phased	   CEU	   parents	   and	   used	   as	   ground-­‐truth	   for	   population-­‐based	  
specificity	  measures	  of	  two	  methods.	  
	  
Figure	   4.6	   shows	   the	   two	   accuracy	   metrics	   from	   this	   analysis,	   with	   segment	   length	   now	  
cumulative	  rather	  than	  discretized	  due	  to	  the	  small	  overall	  number	  of	  segments.	  Comparing	  the	  




segment	  lengths	  (5-­‐25%	  higher	  for	  segments	  below	  0.5cM)	  and	  higher	  specificity	  for	  segments	  
longer	  than	  0.5cM	  (with	  specificity	  5-­‐7%	  lower	  for	  segments	  below)	  resulting	  in	  overall	  higher	  
accuracy	   at	   all	   lengths.	   As	   before,	   we	   see	   a	   generally	   monotonic	   increase	   in	   accuracy	   with	  
GERMLINE	   and	   a	   sporadic	   decrease	   in	   accuracy	   with	   fastIBD	   (here,	   in	   specificity).	   Such	   a	  
consistent	  distribution	  of	  accuracy	   is	  particularly	   important	   for	  segment-­‐length	  analysis	  which	  
assumes	  that	  the	  distribution	  of	  segment	  lengths	  is	  representative	  of	  population	  structure	  with	  
some	   constant	   degree	   or	   error;	   in	   this	   case	   the	   instability	   of	   the	   fastIBD	   algorithm	   may	  
introduce	  artifacts.	  Though	  these	  relative	  patterns	  are	  consistent	  from	  the	  simulations,	  we	  find	  
that	   absolute	   accuracy	   is	   considerably	   higher	   for	   both	   methods.	   We	   assume	   that	   this	   is	  
somewhat	   due	   to	   the	   ground-­‐truth	   being	   based	   on	   computational	   phase	   and	   partial	  





Real	  data:	  Whole-­‐exome	  sequence	  
	  
Figure	  4.7:	  IBD	  segment	  detection	  overlap	  between	  whole-­‐exome	  and	  genotype	  array	  
	  
Lastly,	  we	  compare	  the	  accuracy	  of	  both	  algorithms	  on	  high-­‐quality	  whole-­‐exome	  data.	  Whole-­‐
exome	   data	   roughly	   consists	   of	   short	   regions	   of	   fully	   ascertained	  markers	   separated	   by	   long	  
gaps	  with	  no	  typed	  variants.	  Our	  hope	  is	  that	  long	  IBD	  segments	  can	  still	  be	  recovered	  from	  this	  
kind	  of	  data	  by	  stringing	  together	  multiple	  high-­‐density	  exon	  regions.	  Though	  no	  ground	  truth	  
IBD	  segments	  are	  available,	  we	  do	  have	  high-­‐density	  genotype	  array	  data	  from	  which	  to	  select	  
high-­‐quality	  IBD	  segments.	  We	  have	  observed	  previously	  that	  all	  algorithms	  are	  highly	  accurate	  
at	  detecting	  segments	  beyond	  5cM	  in	  length	  (Figure	  4.4),	  and	  so	  we	  choose	  this	  threshold	  to	  be	  
the	  minimum	  segment	  length	  in	  genotype	  data	  to	  treat	  as	  ground	  truth	  IBD.	  Figure	  4.7	  shows	  
the	   comparison	   between	   these	   ground-­‐truth	   segments	   and	   segments	   detected	   from	   exome	  




typed	   exome	   data).	   The	  measures	   of	   sensitivity	   –	   how	   well	   exome	   analysis	   can	   detect	   long	  
segments	   -­‐	   clearly	   show	   our	   hypothesis	   to	   be	   incorrect,	   with	   longer	   segments	   being	   more	  
difficult	  to	  detect	  and	  therefore	  less	  accurate.	  On	  the	  other	  hand,	  specificity	  –	  the	  measure	  of	  
accuracy	   the	  exome	   segments	  we	  do	   detect	  –	  does	   increase	  with	   segment	   length,	   it	   does	   so	  
very	   gradually	   and	   is	   generally	   prohibitively	   low.	   Overall,	   both	   methods	   appear	   unable	   to	  
accurately	  detect	  IBD	  segments	  from	  exome	  sequence	  with	  usable	  accuracy.	  Moreover,	  we	  find	  
that	   segment	   length	   is	   no	   longer	   a	   reasonable	   predictor	   of	   relative	   accuracy,	   with	   detected	  
segments	  as	  long	  as	  25MBp	  still	  exhibiting	  low	  accuracy.	  These	  tests	  suggest	  that	  IBD	  detection	  
in	  exome	  sequence	  is	  still	  an	  open	  problem	  for	  the	  either	  of	  the	  algorithms	  compared.	  
Runtime	  performance	  
Lastly,	  we	  examine	  the	  computational	  performance	  of	  the	  three	  algorithms	  as	  well	  as	  haplotype	  
phasing	   and	   how	   it	   scales	   with	   sample	   size.	   For	   brevity,	   we	   assume	   that	   run-­‐time	   is	   not	  
significantly	  affected	  by	  population	  size	  and	  generate	  a	  single	  outbred	  cohort	  (Ne=9000)	  down-­‐
sampled	  to	  seven	  data-­‐sets	  from	  50	  to	  3200	  individuals	  each.	  All	  algorithms	  were	  run	  on	  each	  
data-­‐set	   independently	   five	   times	  and	  average	  CPU	   runtime	  was	   taken.	   Figure	  4.8	   shows	   the	  
results	  from	  this	  analysis	  for	  array	  (A-­‐left)	  and	  sequence	  (B-­‐right)	  data	  in	  log-­‐log	  scale.	  For	  array	  
data,	   we	   see	   that	   phased	   GERMLINE	   is	   several	   orders	   of	   magnitude	   faster	   than	   all	   other	  
methods	  and	  scales	  by	  a	  constant	  factor	  with	  sample	  size.	  Unphased	  GERMLINE	  is	  on	  average	  
3x	   slower	   but	   has	   a	   nearly	   identical	   constant	   factor	   scale.	   If	   we	   also	   consider	   the	   runtime	  
required	   to	   phase	   the	   sample	   (BEAGLE,	   shown	   in	   pink),	   this	   is	   clearly	   the	   computational	  




Since	  fastIBD	  intrinsically	  depends	  on	  first	  performing	  ten	  iterations	  of	  a	  BEAGLE	  phase	  run,	  it	  is	  
another	  order	  of	  magnitude	  slower	  than	  phasing	  alone.	  
	  
Figure	  4.8:	  Runtime	  analysis	  
	  
Though	  we	  do	  not	  consider	  memory	  constraints	  in	  this	  analysis	  and	  the	  8GB	  of	  RAM	  on	  our	  test	  
machine	   was	   enough	   for	   all	   array-­‐based	   runs,	   memory	   usage	   was	   a	   significant	   factor	   for	  
sequence	   analysis.	   As	   shown	   in	   Figure	   4.8B,	   we	   were	   only	   able	   to	   complete	   all	   runs	   of	   the	  
BEAGLE	  phasing	  analysis	  of	  sequence	  data	  for	  fewer	  than	  200	  samples,	  and	  therefore	  could	  not	  
fully	  evaluate	  either	  the	  fastIBD	  or	  phased	  GERMLINE	  algorithms.	  Unphased	  GERMLINE,	  on	  the	  
other	  hand,	  was	  able	  to	  efficiently	  process	  all	  of	  the	  data	  up	  to	  1600	  samples	  (beyond	  which	  we	  
did	   not	   attempt)	   and	   scaled	   at	   the	   same	   rate	   as	   the	   array	   analysis	   but	   about	   an	   order	   of	  




set	  of	   this	  magnitude,	  but	  GERMLINE	  offers	  the	  capability	  to	  efficiently	   identify	   IBD	  segments	  
without	  direct	  phasing	  within	  realistic	  computational	  constraints.	  
4.5 Summary 
In	   this	   Chapter,	   we	   present	   an	   algorithm	   for	   probabilistic	   IBD-­‐detection	   in	   unphased	   data.	  
Working	   off	   of	   the	   hashing	  &	   extension	   paradigm	   of	   the	   GERLMINE	   algorithm,	  we	   allow	   for	  
unphased	   or	   partially	   phased	   data	   by	   permuting	   and	   hashing	   all	   feasible	   haplotypes	  
corresponding	   to	   an	   individual.	   We	   also	   develop	   an	   analytical	   method	   for	   inferring	   IBD	  
probabilities	  and	  likelihood	  ratios	  that	  account	  for	  linkage-­‐disequilibrium	  between	  an	  arbitrary	  
number	   of	   markers.	   This	   method	   allows	   us	   to	   provide	   a	   robust	   score	   for	   each	   generated	  
segment	  and	  accurately	  process	  complex	  data.	  
We	  applied	  our	  algorithm	  to	  a	  variety	  of	  realistic	  simulated	  cohorts	  and	  compare	  to	  GERMLINE	  
implementations	   that	   depend	   on	   phase	   as	   well	   as	   the	   recent	   BEAGLE	   fastIBD	   detection	  
algorithm	   that	   performs	   phasing	   internally.	   In	   genotype	   array	   data,	  we	   found	   that	   unphased	  
GERMLINE	   is	  highly	   robust	   to	  sample	  size	  and	  maintains	  a	  high	  degree	  of	  accuracy	   for	   longer	  
segments	   beyond	   5cM.	   However,	   given	   enough	   samples	   to	   properly	   sample	   the	   haplotype	  
space,	  phase-­‐based	  algorithms	  outperform	  unphased	  GERMLINE	  by	  5-­‐10%.	  Looking	  at	  whole-­‐
genome	   sequence,	   where	   data	   is	   much	   dense	   and	   rare	   variants	   complicate	   the	   coalescent	  
reconstruction	   implicit	   in	   phasing	   algorithms,	   we	   find	   the	   relative	   accuracy	   to	   be	   reversed.	  
Here,	  unphased	  GERMLINE	  increase	  in	  accuracy	  by	  10%	  across	  all	  segment	  lengths	  and	  is	  highly	  
accurate	  at	  segments	  longer	  than	  2cM.	  The	  phased	  GERMLINE	  algorithm	  performs	  better	  than	  




fastIBD	  algorithm	   is	   significantly	   less	   accurate	   than	  all	   implementations,	  dropping	  below	  50%	  
for	  most	  segment	  lengths	  and	  highly	  variable	  in	  small	  cohorts.	  Lastly,	  when	  we	  find	  that	  none	  of	  
the	   tested	   methods	   can	   reliably	   detect	   IBD	   segments	   from	   exome	   data	   due	   to	   the	   high	  
variability	   in	   typed	   variants.	   While	   exome-­‐sequence	   offers	   a	   viable	   stepping-­‐stone	   between	  
genotype	  array	  and	  whole-­‐genome	  sequence	  in	  association	  studies,	   it	  remains	  a	  challenge	  for	  
shared	  haplotype	  detection.	  Looking	  at	  run-­‐time,	  we	  find	  the	  implementations	  of	  GERMLINE	  to	  
be	  at	   least	  an	  order	  of	  magnitude	  faster	  than	  BEAGLE	  and	  fastIBD,	  and	  to	  scale	  by	  a	  constant	  
factor.	   Moreover,	   only	   unphased	   GERMLINE	   was	   able	   to	   analyze	   several	   thousands	   of	  
sequenced	  samples	  with	  realistic	  memory	  constraints.	  
This	   work	   advances	   the	   GERMLINE	   hashing	   strategy	   to	   unphased	   data	   by	   grounding	   it	   in	  
probabilistic	   analysis	   while	   maintaining	   a	   high-­‐degree	   of	   efficiency	   suitable	   for	   all	   data	  
platforms.	  At	   present,	   such	   a	   strategy	   is	   the	  only	   tractable	   approach	   to	  processing	   sequence	  
data	  in	  thousands	  of	  samples.	  With	  the	  significant	  increase	  in	  power	  to	  detect	  short	  segments	  
offered	   by	   sequence	   data,	   the	   GERMLINE	   algorithm	   opens	   the	   door	   to	   studying	   fine-­‐scale	  
relatedness	  of	  large	  cohorts. 
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5 IBD-based sample selection for sequencing: maximizing variant discovery 
5.1 Motivation 
The	  cost	  of	  whole-­‐genome	  sequencing	   is	  not	   trivial	  and	  the	  best	  strategy	   for	   identification	  of	  
rare	   causative	   variants	   must	   balance	   the	   number	   of	   genomes	   sequenced	   with	   the	   insights	  
gained	  that	  are	  applicable	  to	  different	  populations	  and	  multiple	  traits.	  For	  common	  traits,	  one	  
may	  sequence	  a	  reference	  panel	  to	  statistically	  impute	  variants	  in	  populations	  represented	  by	  
such	  a	  panel51.	  However,	  this	  requires	  sequencing	  high	  numbers	  of	  genomes	  and	  is	  still	  severely	  
underpowered	   in	   populations	   or	   variants	   that	   are	   underrepresented	   in	   such	   datasets	   (e.g.	  
isolated	   populations53	   and	   rare	   variants82).	   For	  Mendelian	   diseases	   a	   successful	   strategy	   has	  
been	   whole-­‐exome	   capture	   in	   a	   small	   number	   of	   individuals30,83.	   With	   such	   studies	   being	  
limited	   to	   extremely	   penetrant	   phenotypes	   and	   inherently	   avoiding	   non-­‐coding	   variants.	   An	  
alternative	   strategy	   has	   been	   targeted	   re-­‐sequencing	   of	   candidate	   loci	   detected	   in	   a	   GWAS	  
across	   many	   individuals.	   Pursuing	   such	   a	   strategy	   genome-­‐wide,	   however,	   is	   still	   resource	  
intensive	  despite	  a	  considerable	  drop	  in	  sequencing	  costs,	  and	  scales	  poorly	  for	  multiple	  traits	  
across	  a	  large	  number	  of	  loci	  in	  each.	  
We	   set	   out	   to	   leverage	   the	   opportunities	   and	   address	   the	   challenges	   of	   sequencing-­‐based	  
mapping	   in	   a	   multi-­‐trait	   GWAS	   cohort	   from	   an	   isolated	   population.	   Ongoing	   work	   by	   large	  
sequencing	   consortia,	   such	   as	   the	   1,000	   Genomes	   Project84,85,	   has	   shown	   that	   analyzing	  
multiple	  individuals,	  even	  at	  low	  coverage,	  improves	  quality	  and	  completeness	  of	  detecting	  and	  
calling	  novel	  variants.	  Moreover,	  information	  from	  a	  small	  sub-­‐sample	  of	  sequenced	  individuals	  




much	   of	   the	   missing	   variation	   with	   high	   accuracy51,86.	   We	   use	   this	   insight	   to	   develop	   a	  
combined	   genotyping	   and	   sequencing	   framework	   that	   leverages	   the	   inherent	   potential	   of	   a	  
sizeable	  phenotyped	  cohort	  within	  a	  small	  founder	  population.	  
5.2 INFOSTIP: Optimized sample selection for sequencing 
We	   have	   been	   studying	   genetic	   determinants	   for	   a	   multitude	   of	   traits	   in	   a	   cohort	   of	   2,906	  
individuals	  (the	  majority	  of	  adults)	  from	  the	  Micronesian	  island	  of	  Kosrae.	  This	  cohort	  has	  been	  
previously	   described	   87	   and	   genotyped	   on	   the	   Affymetrix	   500k	   SNP	   array	   platform	   to	   detect	  
positive	  GWAS	  results	  for	  seven	  phenotypes	  88.	  Subsequently,	  we	  reported	  a	  GWAS	  in	  which	  27	  
traits	   were	   analyzed	   under	   family-­‐based	   models	   89	   and	   quantified	   the	   abundance	   of	   IBD	  
segments	  within	  the	  cohort	  80.	  
Here,	   we	   utilized	   the	   autosomal	   SNP	   genotype	   data	   to	   estimate	   pervasiveness	   of	   IBD	   in	  
genomic	   regions	  between	  arbitrary	  pairs	  of	   samples,	  and	  as	  a	  consequence,	   the	  potential	   for	  
imputation	   based	   on	   identity-­‐by-­‐descent	   in	   this	   population.	   Pairwise,	   identical-­‐by-­‐descent	  
regions	   were	   discovered	   using	   GERMLINE,	   a	   tool	   for	   efficient	   whole-­‐genome	   IBD	   segment	  
detection	   from	   partially	   phased	   data	   80.	   For	   the	   purpose	   of	   imputation,	   we	   conservatively	  
examined	   only	   IBD	   segments	   longer	   than	   5cM,	  where	  GERMLINE	   has	   been	   demonstrated	   to	  
have	  100%	  specificity	   in	  simulation80,90.	  We	  found	  that	  for	  an	  average	  individual,	  such	  regions	  
span	  a	  substantial	  10.8%	  of	  all	  genotypes	  in	  the	  remaining	  cohort.	  We	  then	  sought	  to	  estimate	  
the	   utility	   of	   these	   IBD	   segments	   for	   imputing	   genomic	   data	   within	   the	   population	   from	   a	  




representative	  individuals	  to	  sequence	  and	  quantifying	  the	  amount	  of	  data	  that	  can	  be	  inferred	  
from	  their	  genomes.	  We	  will	  next	  introduce	  precise	  notation	  and	  detail	  the	  algorithm.	  
Terminology	  &	  notation	  
IBD	  Haplotypes:	  A	  pair	  of	  descendants	   from	   the	   same	  ancestor	   is	   identical-­‐by-­‐descent	  where	  
they	   share	   loci	   that	   have	   been	   transmitted	   along	   the	   respective	   lineages	   leading	   to	   them.	   A	  
continuous	  run	  of	  such	  loci	  with	  no	  recombination	  along	  the	  lineages	  is	  then	  an	  IBD	  haplotype.	  
The	  shared	  haplotypes	  lie	  on	  homologous	  chromosomes	  of	  different	  individuals	  or	  of	  the	  same	  
individual;	  where	  in	  the	  latter	  case	  the	  individual	  has	  related	  parents.	  Let	  P	  =	  {1,	  2,	  …,	  n}	  be	  the	  
set	  of	  all	  individuals	  belonging	  to	  the	  population	  under	  study.	  We	  denote	  by	  R(i,j)	  the	  collection	  
of	  shared	  regions	  between	   individuals	   i,	   j	   ϵ	  P.	  A	  shared	  region	   in	  R(i,j)	   is	   identified	  by	  a	   tuple	  
(l,r),	  where	  l	  is	  its	  left	  endpoint,	  r	  right	  endpoint.	  
Total	   Information	   Content	   (TIC):	  Our	   aim	   is	   to	   sequence	   only	   a	   subset	   of	   individuals	   to	   infer	  
information	  about	  the	  unsequenced	  population.	  TIC	  of	  a	  subset	  of	  individuals	  Q	  is	  the	  fraction	  
of	  the	  cohort	  members’	  genomes	  that	  we	  directly	  obtain	  or	  indirectly	  can	  infer	  by	  sequencing	  
the	   individuals	   in	   Q.	   Formally,	   if	   we	   define	   an	   indicator	   function	   I(i,k,Q)	   for	   individual	   i	  













Then,	   the	  amount	  that	  can	  be	   inferred	   for	  an	   individual	   i	  not	   in	  Q	   is	  simply	   the	  sum	  of	   these	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Individual	  Utility:	  Given	  a	  set	  of	  already	  sequenced	  individuals	  Q,	  we	  associate	  each	  individual	  i  
ϵ	  ∈P\Q	  with	   it	   a	   quantity	  U(i,Q)	   that	   corresponds	   to	   the	  utility	   of	   sequencing	   i	   at	   this	   stage.	  
U(i,Q)	  is	  the	  total	  fraction	  of	  un-­‐inferred	  regions	  that	  i	  shares	  with	  all	  unsequenced	  individuals	  
across	  all	  chromosomes,	  calculated	  as	  TIC(P,{Q,i})	  -­‐	  TIC(P,Q).	  
Given	   a	   fixed	   sequencing	   budget	   b,	   our	   proposed	   methodology	   optimizes	   the	   selection	   of	  
individuals	  in	  Q	  of	  size	  b	  so	  as	  to	  maximize	  TIC.	  This	  problem	  is	  reducible	  to	  the	  classic	  NP-­‐hard	  
Maximal	  Coverage	  problem.	  At	  each	  locus,	  every	  individual	  has	  a	  set	  which	  contains	  elements	  
corresponding	  to	  any	  other	  individual	  with	  whom	  it	  maintains	  an	  IBD	  segment	  at	  that	  locus.	  The	  
problem	   then	   becomes	   that	   of	   picking	   a	   limited	   number	   of	   individuals	   such	   that	   their	  
corresponding	  sets	  cover	  a	  maximal	  number	  of	  elements	  across	  all	   loci.	  We	  propose	  a	  greedy	  
approach,	   selecting	   individuals	  one	  at	  a	   time	  and	  gradually	  admitting	  samples	   into	   the	  set	  Q.	  
Algorithm	  6	  shows	  the	  pseudo-­‐code	  for	  this	  approach.	  
Algorithm	  6:	  Greedy	  algorithm	  for	  selecting	  sequenced	  samples	  
	   Given:	  P	  population	  set,	  R	  segment	  set,	  b	  budget	  




2	   Find	  individual	  j	  ϵ	  P\Q	  such	  that	  U(j,Q)	  =	  argmaxi	  ϵ	  P\Q	  U(i,Q)	  
3	   Q	  ←	  {	  Q	  ,	  j	  }	  
4	   for	  i	  ϵ	  P\Q:	  
5	   Remove	  any	  r	  ϵ	  R(i,j)	  from	  R	  
6	   for	  k	  ϵ	  P\{	  i	  ,	  Q	  }:	  
7	   Remove	  part	  or	  whole	  of	  any	  r’	  ϵ	  R(i,k)	  that	  overlaps	  with	  any	  r	  ϵ	  R(i,j)	  
8	   return	  Q	  
Formal	  algorithm	  outline	  
A	  naive	   implementation	  of	  this	  greedy	  approach	  would	  be	  computationally	   intractable	  due	  to	  
maintaining	  and	  searching	  lists	  of	  shared	  regions	  for	  each	  pair	  of	  individuals.	  As	  the	  algorithm	  
progresses,	  such	  regions	  keep	  getting	  shattered	  by	  the	  interval	  exclusion	  operation	  in	  step	  7	  of	  
Algorithm	   1.	   Efficient	   implementation	   that	   maintains	   these	   intervals	   requires	   a	   special	   data	  
structure	   for	   quickly	   calculating	   overlapping	   segments.	   We	   use	   a	   structure	   known	   as	   an	  
“interval	   tree”	   for	   this	   purpose.	   Each	   node	   in	   the	   tree	   contains	   an	   interval	   representing	   a	  
shared	  region	  along	  with	  a	  pointer	  to	  the	  node	  in	  the	  tree	  of	  the	  other	   individual	  with	  whom	  
the	  region	  is	  shared.	  The	  first	  step	  is	  to	  calculate	  U(i,Q),	  for	  each	  individual	  i	  ϵ	  P\Q.	  Our	  greedy	  
approach	  now	  selects	  the	  individual	  j	  with	  the	  highest	  value	  of	  U(i,Q).	  Upon	  making	  the	  choice,	  
we	  need	   to	   exclude	   regions	   that	   have	  been	   imputed	  by	  picking	   j	   from	   subsequent	   selection.	  
These	   are	   complete	   regions	   r	   in	   R(i,j),	   i	   ϵ	   P\Q	   which	   we	   will	   impute	   directly	   by	   sequencing	  
individual	   j.	   Additionally,	   we	   will	   indirectly	   impute	   parts	   of	   regions	   r’	   in	   R(i,k),	   k	   ϵ	   P\Q	   that	  
overlap	  with	  r	  in	  R(i,j).	  We	  can	  then	  repeat	  the	  procedure	  for	  selecting	  and	  eliminating	  the	  next	  
individual.	  This	  continues	  until	  we	  have	  picked	   individuals	  up	  to	  our	  sequencing	  budget	  b.	  To	  




(Figure	  5.1).	  Suppose	  individuals	  A	  and	  B	  share	  region	  (5,20	  -­‐	  green);	  B	  and	  C	  share	  (15,25	  -­‐	  red)	  
and	  A	  and	  C	  share	  (30,50	  -­‐	  blue).	  We	  calculate	  that	  U(A,Q)	  =	  35,	  U(B,Q)	  =	  25,	  U(C,Q)	  =	  30.	  The	  
greedy	   algorithm	  will	   first	   pick	  A	   and	   add	   it	   to	  Q.	  Next,	  we	  exclude	  directly	   imputed	   regions	  
(5,20)	   of	   R(A,B)	   and	   (30,50)	   of	   R(A,C).	   Also,	   the	   region	   (15,20)	   in	   R(B,C)	   has	   been	   indirectly	  








Figure	  5.1:	  Illustration	  of	  INFOSTIP	  guided	  sample	  selection	  
5.3 Imputation benchmarks in simulated data 
To	  estimate	  the	  practical	  utility	  of	  guided	  sample	  selection,	  we	  simulated	  the	  process	  of	  variant	  
imputation	   by	   bootstrapping	  
markers	   genotyped	   on	   the	  
array.	   Hiding	   a	   set	   of	  markers	  
and	   imputing	   them	   from	  
reference	   panels	   selected	  
under	   different	   strategies,	  
allows	   us	   to	   assess	   their	  
relative	   effectiveness.	  
Specifically,	   using	  
chromosomes	   18-­‐22	  
(approximately	   10%	   of	   the	  
autosomal	   genome)	   of	   the	  
Kosraen	   genotype,	   we	  
randomly	   selected	   5%	   of	  
polymorphic	   SNPs	   to	   be	   our	  
target	   variants	   for	   imputation.	  
To	  ensure	  that	  they	  were	  amply	  representative	  of	  the	  minor	  allele	  frequency	  spectrum	  in	  the	  
data,	  variants	  were	  selected	  independently	  from	  each	  window	  of	  the	  spectrum	  in	  steps	  of	  1%.	  
We	   then	   constructed	  11	  different	   subsets	   of	   individuals	   to	  be	  used	   as	   reference	   samples	   for	  
	  
Figure	  5.2:	  Bootstrapped	  imputation	  accuracy	  for	  guided	  and	  random	  
sample	  selection	  
Mean	   imputation	   accuracy	   (allelic	   r2	   correlation	   between	   inferred	   and	  
true	  variant)	  is	  shown	  as	  a	  function	  of	  reference	  sample	  size	  for	  samples	  
selected	   randomly	   (“Random”,	   dotted	   line)	   and	   based	   on	   information	  
content	   (“INFOSTIP”,	   solid	   line).	   Error	   bars	   for	   random	   series	   show	  
maximum	   and	  minimum	   accuracy	   from	   10	   trials	   of	   sampled	   individuals	  
(with	   replacement).	   In	   general,	   INFOSTIP	   nearly	   doubles	   the	   effective	  




respective	  imputation	  simulations	  and	  hid	  the	  selected	  markers	  from	  the	  remaining	  individuals	  
in	   each	   simulation.	   	   One	   of	   the	   subsets	   was	   selected	   in	   a	   guided	   fashion	   based	   on	   greedy	  
INFOSTIP	  priority	  from	  the	  five	  chromosomes	  and	  the	  remaining	  10	  subsets	  were	  each	  selected	  
randomly	   and	   independently.	   Imputation	   was	   performed	   using	   the	   BEAGLE	   framework	   with	  
default	   parameters,	   maintaining	   consistency	   with	   the	   data	   phasing.	   Finally,	   accuracy	   was	  
measured	   for	   each	   reference	   set	   as	   the	   average	   allelic	   squared	   correlation	   (r2)	   between	   the	  
inferred	   variant	   call	   and	   the	   true	   variant	   call	   in	   the	   population;	   markers	   that	   could	   not	   be	  
imputed	  (or	  imputed	  as	  monomorphic)	  were	  counted	  as	  having	  r2	  of	  zero.	  
We	   evaluated	   imputation	   accuracy	   across	   a	   range	   of	   reference	   sample	   sizes	   from	   0	   to	   600	  
individuals	   (Figure	   5.2).	   In	   all	   instances	   above	   50	   samples,	   we	   see	   that	   INFOSTIP	   selection	  
produces	  more	   accurate	   imputed	   variants,	  with	   an	   average	   increase	   in	   r2	   of	   1.30-­‐fold	   across	  
reference	  sizes	  above	  100	  samples.	  This	  quotient	  makes	   intuitive	  sense:	   r2	  has	   the	   traditional	  
interpretation	   as	   the	   ratio	   of	   effective	   to	   actual	   sample	   size91,	   and	   the	   increase	   in	   r2	   is	  
consistent	   with	   our	   previous	   theoretical	   observation	   that	   INFOSTIP	   selection	   increases	   the	  
effective	   sample	   size	   by	   1.30-­‐fold	   over	   the	   same	   reference	   sizes	   (Supplementary	   Note).	   This	  
increased	  accuracy	   is	  persistent	  across	  all	  allele	   frequency	  windows	   (Supplementary	  Figure	  1)	  
with	   a	   slightly	   higher	   increase	   in	   accuracy	   for	   low	   frequency	   variants	   (1.60-­‐fold	   for	   variants	  
below	  10%	  minor	  allele	  frequency).	  Though	  this	  relative	  accuracy	  supports	  the	  utility	  of	  guided	  
sample	  selection,	  we	  stress	  that	  the	  increase	  is	  observed	  using	  a	  standard	  imputation	  analysis;	  
we	   expect	   a	   thoroughly	   IBD-­‐sensitive	   imputation	   to	   offer	   absolute	   accuracy	   closer	   to	   the	  




5.4 Validation in a sequenced isolated population 
	  
Figure	  5.3:	  Imputation	  strategy	  and	  information	  capacity	  in	  founder	  population	  
A:	  Schematic	  outline	  of	  the	  strategy.	  IBD	  shared	  haplotypes	  (color-­‐coded)	  are	  identified	  from	  genotype	  data	  (grey	  
spots)	  in	  a	  cohort;	  a	  small	  panel	  of	  individuals	  with	  abundance	  of	  IBD	  is	  sequenced	  (top);	  and	  sequenced	  variants	  
within	  shared	  haplotypes	  are	   inferred	  to	  the	  rest	  of	  the	  cohort	  within	  shared	  regions	  (bottom).	  B:	  Percentage	  of	  
genomic	  content	  of	  the	  cohort	  that	  is	  inferred	  (Total	  Information	  Potential)	  as	  a	  function	  of	  sequenced	  reference	  
panel	   size,	   calculated	   from	  autosomal	  genotype	  data.	  Rapid	  growth	  of	  Total	   Information	  Potential	   in	   the	  highly-­‐
related	  Kosraen	  population	   (2,906	   samples,	   green)	   compared	   to	   slower	   growth	   in	   less	   related	  Ashkenazi	   Jewish	  
population	  (1,200	  Crohn’s	  Disease	  case-­‐control	  samples92,	  brown).	  
	  
We	  estimated	  Total	  Information	  Content	  expected	  by	  sequencing	  a	  small	  reference	  panel	  (see	  
Materials	  &	  Methods)	   as	   a	   function	   of	   the	   sequencing	   budget	   (Figure	   5.3).	  We	   observe	   that	  
sequencing	   50	   randomly	   chosen	   individuals	   (1.7%	   of	   cohort)	   would	   give	   us	   the	   potential	   to	  
impute	  both	  alleles	  of	  variants	   in	  59.5%	  of	  the	  cohort	  genome,	  but	  choosing	   individuals	   in	  an	  
optimized	   fashion	  using	   INFOSTIP	  decreases	   the	   sequenced	  sample	   size	  needed	   for	   the	   same	  
benchmark	  by	  0.76-­‐fold	  to	  38	  individuals	  (1.3%	  of	  cohort).	  Remarkably,	  sequencing	  only	  seven	  
individuals	   (0.24%	  of	  cohort)	   still	  provides	   imputation	  capacity	  of	  24%	  of	   the	  cohort	  genome.	  




92,	   a	   population	   known	   to	   be	   isolated	   but	   less	   densely	   related.	   In	   this	   case	   we	   found	   that	  
utilizing	  our	  optimal	  selection	  method	  and	  sequencing	  38	   individuals	  gave	  us	   the	  potential	   to	  
impute	   variants	   in	   only	   16%	   of	   the	   cohort	   genome,	   whereas	   sequencing	   seven	   individuals	  
allowed	  us	   to	   infer	  only	  4%	  of	   the	  cohort	  genome	  (see	  Figure	  5.3B,	  Supplementary	  Figure	  2).	  
This	   type	   of	   imputation	   is	   agnostic	   of	   allele	   frequency	   as	   long	   as	   a	   relevant	   IBD	   segment	   is	  
available.	  
IBD	  segment	  concordance	  
Assessing	   the	   IBD-­‐based	  motivation	   for	   this	   pilot,	  we	   focused	   on	   the	   1,522	   shared	   segments	  
predicted	  between	   the	   sequenced	   individuals,	   ranging	   in	   length	   from	  330kb	   to	  74Mb.	  Unlike	  
the	   conservative	   INFOSTIP	   analysis,	   which	   examined	   fewer	   but	   higher-­‐quality	   IBD	   segments,	  
these	  segments	  were	  detected	  using	  GERMLINE’s	  default	  parameters	  with	  no	  adjustment	  (3cM	  
segment	  length	  minimum),	  allowing	  us	  to	  estimate	  IBD	  accuracy	  under	  practical	  conditions.	  We	  
evaluated	  the	  accuracy	  and	  utility	  of	  the	  IBD-­‐based	  approach	  by	  examining	  variant	  concordance	  
within	   these	   regions.	   Specifically,	   two	   samples	   that	   are	   IBD	   across	   a	   region	   should	   not	   have	  
sites	  with	  homozygous	  calls	  for	  opposite	  alleles	   in	  that	  region.	  For	  a	  pair	  of	  such	  samples,	  we	  
examine	  all	  sites	  in	  the	  IBD	  region	  that	  are	  mutually	  homozygous	  with	  at	  least	  one	  sample	  being	  
non-­‐reference,	   and	   report	   concordance	   as	   the	   percentage	   of	   these	   sites	   that	   are	   not	  
homozygous	  for	  opposite	  alleles.	  Lack	  of	  such	  concordance	  is	  indicative	  of	  either	  falsely	  called	  
IBD	  or	  poor	  genotype	  calls	  due	  to	  under-­‐sampling	  of	  sequence	  reads	  (true	  heterozygous	  sites	  
miscalled	  as	  homozygous).	  Aside	   from	  some	  effects	  on	  multi-­‐sample	  calling,	   the	  concordance	  




one	   of	   the	   individuals	   had	   not	   been	   sequenced.	   Figure	   5.4	   shows	   concordance	   across	   IBD	  
segments,	   separated	   into	   previously	   known	   (A)	   and	   novel	   (B)	   variants.	   For	   comparison,	   we	  
measured	  the	  background	  distribution	  such	  concordance	  across	  30	  random	  selections	  of	  same-­‐
sized	   regions,	   shown	   in	   black	   points.	  We	   observe	   the	   vast	   majority	   of	   IBD	   segments	   having	  
nearly	  100%	  concordance,	  with	  only	  1.4%	  and	  10.6%	  of	  segments	  below	  90%	  concordance	  for	  
known	  and	  novel	  variants,	  respectively.	  If	  we	  take	  a	  weighted	  average	  across	  all	  segments,	  the	  
aggregate	   concordance	   is	   99.6%	   (known)	   and	   97.3%	   (novel)	   in	   IBD-­‐segments,	   providing	  
encouraging	  estimates	  for	  accuracy	  of	  IBD-­‐based	  imputation.	  This	  is	  compared	  to	  a	  background	  
concordance	  statistic	  averaging	  82.9%	  (known)	  and	  31.0%	  (novel)	   in	  permuted	  segments.	  We	  
attribute	  the	  difference	  between	  known	  and	  novel	  concordance	  in	  IBD	  regions	  to	  be	  an	  artifact	  
of	   lower	   sensitivity	   to	   novel	   variants	   and	   the	   overall	   deviation	   from	   full	   concordance	   to	   be	  





Figure	  5.4:	  Concordance	  of	  known	  and	  novel	  variants	  in	  IBD	  and	  non-­‐IBD	  regions	  
We	   examined	   concordance	   of	   called	   variants	   in	   previously	   predicted	   pairwise	   IBD	   regions.	   For	   all	   sites	   that	   are	  
called	  homozygous	  in	  both	  samples	  with	  at	  least	  one	  being	  non-­‐reference,	  we	  measure	  concordance	  (x-­‐axis)	  as	  the	  
percentage	  where	   both	   are	   non-­‐reference.	  We	   expect	   100%	   concordance	   in	   truly	   co-­‐inherited	   regions	   with	   no	  
sequence	  error.	  Y-­‐axis	  shows	  percentage	  of	  IBD	  segments	  at	  a	  given	  concordance	  level.	  Concordance	  for	  previously	  
known	  variants	  (A,	  white	  bar)	  and	  novel	  variants	  (B,	  yellow	  bar)	  is	  shown	  in	  comparison	  to	  randomly	  placed	  non-­‐
IBD	   regions	   of	   an	   equal	   length	   distribution	   (both,	   black	   points).	   On	   average,	   IBD	   segments	   maintained	   99.6%	  
(known)	  and	  97.3%	  (novel)	  concordance	  compared	  82.9%	  (known)	  and	  31.0%	  (novel)	  in	  a	  background	  distribution	  
of	  non-­‐IBD	  segments.	  
	  
Of	  particular	  interest	  to	  the	  IBD	  community	  is	  the	  minimum	  length	  at	  which	  stretches	  of	  SNPs	  





Figure	  5.5:	  Sequence	  concordance	  as	  a	  function	  of	  IBS	  segment	  length	  
Concordance	  of	  sequenced	  homozygous	  variants	  in	  array-­‐based	  IBS	  regions	  of	  increasing	  length.	  Previously	  known	  
(black	  line)	  and	  novel	  (yellow	  line)	  variants	  shown	  on	  left	  y-­‐axis	  as	  a	  function	  of	  segment	  length	  on	  x-­‐axis.	  Number	  
of	  segments	  at	  each	  IBD	  length	  window	  shown	  in	  grey	  bars	  on	  right	  y-­‐axis.	  
	  
To	  estimate	  this,	  we	  omit	  the	  minimum	  segment	  length	  restriction	  for	  IBD	  detection,	  resulting	  
in	  a	  tally	  of	  all	  runs	  of	  at	  least	  128	  IBS	  SNP-­‐array	  sites	  in	  the	  sequenced	  samples,	  rather	  than	  the	  
set	   of	   putative	   IBD	   regions	   we	   considered	   thus	   far.	   We	   measured	   concordance	   in	   length	  
windows	  of	  1cM	   from	  0-­‐10cM	  and	  above.	   Figure	  5.5	   shows	   this	   concordance	  distribution	   for	  
known	  and	  novel	  variants,	  as	  well	  as	  the	  number	  of	  segments	  measured	  within	  each	  window.	  
As	  previously	  documented80,	  we	  see	  a	  direct	  correlation	  of	  concordance	  with	  segment	  length,	  	  
as	  longer	  IBS	  segments	  are	  more	  likely	  to	  represent	  true	  recent	  IBD.	  However,	  we	  observe	  only	  




either	  a	  small	  number	  of	   false-­‐positive	  segments	  or	  overcalled	   false	   IBD	  primarily	  around	  the	  
boundaries	   of	   true	   IBD	   segments.	   	   Even	   within	   the	   0-­‐1cM	   length	   window	   (median	   physical	  
length	  815kb)	  we	   see	  98.9%	   (known)	   and	  91.6%	   (novel)	   concordance,	   significantly	   above	   the	  
average	  in	  non-­‐IBD	  regions.	  These	  initial	  findings	  suggest	  that	  even	  very	  short	  IBS	  segments	  can	  
be	  useful	  for	  variant	  inference.	  
5.5 Summary 
While	   the	   population	   genetics	   of	   isolated	   groups	   has	   been	   of	   interest	   for	   decades,	   the	  
contribution	   of	   such	   groups	   to	   understanding	   heritable	   traits	   is	   strongly	   dependent	   on	   the	  
research	   methodology	   employed.	   In	   the	   context	   of	   inbred	   populations,	   linkage	   analysis	   of	  
Mendelian	   traits	   using	  microsatellite	   scans	   has	  mapped	  many	  mutations	   that	   are	   rare	   in	   the	  
general	   population.	   In	   contrast,	   association	   analysis	   with	   SNP	   arrays	   relies	   on	   linkage	  
disequilibrium	   in	  populations,	  and	  by	  primarily	   targeting	  common,	  ancient	  variation	  has	  been	  
mainly	  applied	  to	  outbred	  peoples.	  High-­‐throughput	  sequencing	  now	  makes	  possible	  discovery	  
of	  rare	  variants	  in	  the	  general	  population	  but,	  as	  shown	  in	  this	  paper,	  with	  the	  proper	  strategy	  
can	  be	  applied	  to	  the	  study	  of	  isolated	  communities	  efficiently	  and	  to	  great	  effect.	   	  
We	  present	  INFOSTIP,	  a	  novel	  algorithm	  for	  selecting	  individuals	  for	  sequencing	  based	  on	  their	  
inter-­‐relatedness.	   By	   leveraging	   segments	   shared	   identical-­‐by-­‐descent	   between	   pairs	   of	  
individuals,	   INFOSTIP	   attempts	   to	   prioritize	   those	   samples	   that	   have	   the	   highest	   degree	   of	  
unique	   sharing	   to	   the	   entire	   study	   cohort.	   In	   practice,	   this	   amounts	   to	   selecting	   the	   most	  
diverse	   representatives	   from	   the	   population	   and	   saturating	   the	   abundance	   of	   rare,	   unseen	  




able	   to	   double	   the	   effective	   reference	   panel	   size	   when	   compared	   to	   random	   selection.	  
Moreover,	   we	   see	   that	   this	   increased	   power	   is	   consistent	   across	   the	   uncommon	   frequency	  
spectrum	  that	  is	  of	  particular	  interest	  for	  disease	  mapping.	  
Turning	   our	   attention	   to	   IBD	   segments	   within	   low-­‐pass	   sequenced	   genomes	   from	   this	  
population	   we	   find	   97.3%	   concordance	   of	   novel	   homozygous	   variants,	   demonstrating	   the	  
effectiveness	  of	  these	  shared	  segments	  and	  motivating	  the	  inference	  of	  such	  variants	  in	  other	  
un-­‐typed	  but	   IBD	   individuals.	  Given	   this	  high	   rate	  of	  concordance	  even	   in	  very	  short	  putative	  
IBD	  segments,	  we	  expect	  a	   full	  panel	  of	  40	  sequenced	   individuals	  to	   infer	  at	   least	  60%	  of	  the	  
overall	  3,000	  population	  genome.	  
As	  sequencing	  studies	  expand	  geographically	  to	  capture	  the	  bulk	  of	  common	  variation,	  isolated	  
populations	   can	   help	   broaden	   our	   understanding	   of	   rare	   alleles.	  While	   this	   effort	   sequenced	  
only	  a	  handful	  of	  individuals	  and	  the	  sequence	  coverage	  of	  each	  of	  them	  is	  low,	  their	  relation	  to	  
one	   another	   and	  with	  many	   other	   islanders	   facilitates	   both	   reliable	   variant	   calling	   as	  well	   as	  
powered	  association	  analysis	  to	  variants	  detected	  by	  full	  sequencing.	  This	  approach	  avoids	  the	  
ascertainment	   bias	   of	   previous	   SNP-­‐based	   studies,	   and	   suggests	   a	   strategy	   to	   leverage	   SNP	  
array	  data	  in	  large	  samples,	  where	  sequencing	  is	  still	  expensive.	  




6 Clustered IBD segments as proxies for untyped variants 
6.1 Motivation 
Recent	  advances	  in	  whole-­‐genome	  sequence	  analysis	  have	  led	  to	  the	  discovery	  of	  many	  directly	  
causal	   variants	   in	   small	   cohorts	   with	   highly	   penetrant	   diseases,	   stirring	   interest	   in	  
understanding	  the	  links	  between	  rare	  variation	  and	  phenotype.	  In	  complex	  diseases,	  however,	  
independent	   testing	   of	   single	   rare	   variants	   may	   still	   be	   underpowered	   for	   statistically	  
unequivocal	   genetic	   mapping.	   Strategies	   that	   examine	   multiple	   common	   markers	  
simultaneously	  can	   leverage	  combinations	  of	  co-­‐occurring	  proximate	  alleles,	  or	  haplotypes,	   in	  
much	  larger	  and	  readily	  available	  sets	  of	  samples	  to	  precisely	  infer	  rare	  variation.	  A	  haplotype	  
consisting	  of	   common	  alleles	  would	  differ	   in	   frequency	  between	  cases	  and	  controls	  at	   causal	  
loci	  whenever	   it	   co-­‐occurs	  with	  a	   causal	   allele,	   serving	  as	   its	   tag.	  Approaches	   to	  exhaustively	  
test	  such	  haplotypes94,95,	  or	  a	  local	  spectrum	  of	  haplotypes96-­‐98,	  have	  been	  devised	  and	  tend	  to	  
focus	  on	  relatively	  short	  haplotypes	   (below	  20	  SNPs)	  of	  high	   frequency	  that	  can	  be	   identified	  
confidently.	   Methods	   that	   focus	   on	   haplotypes	   known	   to	   tag	   previously	   observed	   variants	  
culminate	   in	   imputation	   of	   the	   untyped	   polymorphism	   based	   on	   a	   densely	   typed	   reference	  
panel51,99,100.	  This	  approach	  has	  been	  widely	  successful,	  particularly	  with	  the	  availability	  of	  the	  
HapMap	   Project	   as	   a	   reference	   panel	   for	   common	   variants.	   However,	   imputation	   inherently	  
depends	  on	  a	  reference	  panel	  that	  has	  haplotypes	  in	  common	  with	  the	  study	  samples	  as	  well	  as	  
deeply	   typed	  markers	   that	  are	  good	   tags	   for	   the	  underlying	  causal	  variant.	  This	  has	  proven	  a	  




Alternatively,	  current	  work	  focusing	  on	  cryptic	  relatedness	  has	  resulted	  in	  accurate	  methods	  for	  
discovery	   of	   long	   genomic	   regions	   recently	   co-­‐inherited	   by	   pairs	   of	   individuals.	   In	   aggregate,	  
these	  IBD	  segments	  can	  represent	  the	  totality	  of	  detectable	  recent	  haplotype	  sharing	  and	  may	  
thus	  serve	  as	  refined	  proxies	  for	  recent	  variants	  that	  are	  generally	  rare	  and	  difficult	  to	  detect	  
otherwise.	  Here,	  we	  propose	  a	  method	  that	  efficiently	  constructs	  pairwise	   IBD	  segments	   into	  
multi-­‐sample	   haplotype	   clusters	   that	   are	   oriented	   towards	   rare	   and	   uncommon	   variants	   and	  
can	  be	  directly	  tested	  for	  association	  to	  phenotype	  without	  dependence	  on	  a	  reference	  panel.	  
6.2 An algorithm for identifying IBD segment clusters 
Let	   us	   define	   haplotypes	   as	   contiguous	   blocks	   of	   genomic	   material	   free	   of	   recent	  
recombination,	   and	   shared	   haplotypes	   as	   those	   haplotypes	  which	   have	   been	   co-­‐inherited	   by	  
multiple	  individuals	  from	  a	  common	  ancestor.	  We	  distinguish	  these	  from	  haploid	  copies	  of	  the	  
genome,	  which	   are	   phased	   genomewide.	  We	   shall	   first	   formulate	   the	   problem	  of	   recovering	  
shared	   haplotypes	   from	   pairwise	   identity	   by	   descent	   at	   a	   single	   locus	   and	   then	   extend	   this	  
methodology	   for	   multiple	   loci.	   Note	   that	   because	   the	   construction	   of	   haplotype	   clusters	   is	  
fundamentally	  dependent	  on	  the	  presence	  of	  IBD	  segments,	  we	  may	  partition	  individuals	   into	  
different	  haplotype	  clusters	  even	   though	   their	   local	  marker	  alleles	  are	   identical	  by	  state	   (IBS)	  
because	   the	   larger	   region	   was	   not	   identified	   as	   being	   shared	   IBD.	   This	   is	   an	   important	  
conceptual	   difference	   of	   our	   method	   and	   the	   resultant	   “haplotype	   clusters”	   compared	   to	  
traditional	  IBS-­‐clustering	  techniques.	  
Formally,	  we	  consider	  N	  haploid	  copies	  of	  the	  genome	  numbered	  1,	  …,	  N,	  along	  a	  genome	  with	  




in	   this	   phased	   dataset,	   where	   each	   sk	   is	   quartet	   (hk,	   h’k,	   lk,rk)	   specifying	   a	   segment	   shared	  
between	   haploid	   copies	   hk	   ,	   h’k	  ∈	   {1,	   …,	  N}	   along	   the	   genomic	   interval	   [lk,rk]	  ⊆	   [1,M].	   We	  
observe	  that	  the	  set	  of	  interval	  boundaries	  B	  =	  {lk}	  U	  101	  includes	  the	  only	  sites	  where	  IBD	  status	  
changes	   in	  this	  cohort.	  We	  therefore	  denote	  the	  unique	  elements	  of	  B	  =	  b1	  ≤	  b2	  ≤	  …	  b|B|	  and	  
partition	  the	  genome	  by	  these	  boundaries	  to	  the	  intervals	  {(bi,bi+1)}	  from	  i=1	  to	  |B|-­‐1	  where	  IBD	  
status	  is	  fixed	  for	  the	  entire	  cohort.	  
Single	  locus	  analysis	  
Within	   a	   given	   fixed-­‐IBD	   region	   (bi,bi+1)	   along	   the	   genome,	  we	   define	   a	  weighted	   undirected	  
graph	  Gi	  =	  (V,	  Ei,	  Wi)	  	  to	  capture	  known	  relatedness.	  The	  presence	  of	  a	  segment	  shared	  between	  
two	   individuals	   IBD	   across	   this	   locus	   is	   represented	   as	   an	   edge	   between	   their	   respective	  
vertices,	  with	   the	  weight	  of	   the	  edge	  corresponding	   to	   the	   total	  genetic	   length	  of	   the	  shared	  
segment.	  Formally,	  V	  =	  {1	  ...	  N},	  Ei	  =	  {	  (hk,	  h’k)	  |	  lk	  ≤	  bi,	  bi+1	  ≤	  rk}	  and	  for	  the	  edge	  eik	  =	  (hk,	  h’k)	  ∈	  Ei,	  
we	  set	  Wi(eik)	  equal	  to	  the	  genetic	  distance,	  in	  centimorgans,	  from	  rk	  to	  lk.	  Assuming	  error-­‐free	  
data,	  a	  complete	  subgraph	  of	  Gi	  would	  be	  indicative	  of	  a	  region	  commonly	  co-­‐inherited	  by	  all	  
vertices	   in	   this	   subgraph	   and	   thereby	   represent	   a	   haplotype	   cluster	   shared	   by	   all	   individuals	  
carrying	   the	   respective	   haploid	   copies.	   Furthermore,	   we	   would	   expect	   all	   connected	  
components	  of	  Gi	  to	  be	  such	  fully	  connected	  graphs	  because	  sharing	  a	  detectable	  IBD	  segment	  
is	   transitive	   with	   regards	   to	   haploid	   copies.	   Under	   these	   assumptions,	   finding	   all	   shared	  
haplotype	   clusters	   involves	   a	   simple	   search	   to	   identify	   the	   set	   of	   all	   connected	   components,	  




In	  the	  presence	  of	  error,	  where	  IBD	  segments	  are	  incorrectly	  detected	  or	  undetected,	  we	  would	  
expect	   to	   see	   false	   or	   missing	   edges	   in	   the	   graph.	   In	   particular,	   when	   the	   errors	   are	   not	  
pervasive	  enough	  to	  generate	  an	  entire	  false	  haplotype	  cluster,	  we	  expect	  to	  observe	  partially-­‐
complete	  subgraphs	  similar	  to	  the	  error-­‐free	  ideal.	  Practically,	  such	  error	  is	  typical	  around	  the	  
boundaries	   of	   a	   true	   segment,	  where	   low	  marker	   density	   or	   insufficient	   detection	   specificity	  
could	   result	   in	   shared	  segments	   that	  are	  called	  as	  extended	   to	   loci	  beyond	   the	   region	   that	   is	  
genuinely	  shared	  or	  fall	  below	  the	  detectable	  segment	  length	  and	  be	  missed.	  Our	  goal	  is	  then	  
to	   systematically	   identify	   a	   set	   of	   subgraphs	   that	   are	   most	   likely	   to	   represent	   shared	  
haplotypes.	   In	   calculating	   this	   likelihood,	   we	   assume	   known	   rates	   of	   false-­‐positive,	   true-­‐
positive,	   false-­‐negative	   segments	   given	   a	   corresponding	   edge	   e	   as	   φFP(e),	   φTP(e),	   φFN(e)	  




















where	   ge∈ and	   ge∈ are	  edges	   in	  g,	  and	  edges	   in	   the	  complement	  of	  g	   (with	   respect	   to	   the	  
complete	  graph	  induced	  by	  g	  only)	  respectively.	  This	  effectively	  calculates	  the	  probability	  that	  
the	  graph	  is	  a	  clique	  with	  erroneous	  edges	  over	  the	  probability	  that	  the	  graph	  is	  entirely	  false,	  
assuming	  edges	  are	   independent.	  We	  note	  that	   this	   formulation	  can	  easily	   incorporate	  error-­‐
rates	   that	   vary	   with	   segment	   length	   by	   parameterizing	   the	   φ	   values	   according	   to	   the	   edge	  
weight	  Wi(eik)	   for	  each	  examined	  edge,	  and	  have	  shown	  in	  previous	  work	  that	  error	   is	   indeed	  




segment-­‐specific,	  and	  Type	  II	  error	  to	  be	  specific	  to	  the	  population	  and	  the	  expected	  number	  of	  
generations	  to	  the	  common	  ancestor.	  
In	   searching	   for	   the	   maximum	   likelihood	   subgraphs,	   we	   observe	   that	   the	   likelihood	   ratio	   is	  
correlated	  to	  the	  density	  of	  that	  subgraph.	  Specifically,	  when	  the	  error	  rates	  are	  constant,	  the	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In	   light	   of	   this,	   we	   borrow	   a	   highly-­‐connected	   subgraphs	   (HCS)	   algorithm	   from	   the	   systems	  
biology	  domain102.	  HCS	  relies	  on	  iteratively	  identifying	  the	  minimum	  cut	  in	  a	  graph;	  that	  is,	  the	  
minimal	  set	  of	  edges	  whose	  removal	  divides	  the	  graph	  into	  two	  subgraphs	  with	  disjoint	  vertices	  
and	   edges.	   The	   algorithm	   performs	   this	   min-­‐cut	   recursively	   until	   it	   identifies	   a	   subgraph	   of	  
desired	   density	   or	   a	   trivial	   subgraph	   that	   contains	   no	   edges	   to	   cut.	   The	   algorithm	   provably	  
identifies	   dense	   subgraphs	  with	  minimum	  diameter	   of	   two	   and,	   in	   practice,	   is	   fast	  when	   the	  
underlying	  subgraphs	  have	  relatively	   few	  sparsely	  connected	  outlier	  vertices.	  This	  gives	  us	  an	  
efficient	   starting	   point	   of	   dense	   subgraphs	   likely	   to	   be	   representing	   haplotypes.	   We	   make	  
amendments	   to	   the	   algorithm	   specifically	   to	   encourage	   the	   largest	   likely	   haplotype	   cluster	  




minimal	  in	  total	  weight	  rather	  than	  size103.	  For	  each	  identified	  subgraph	  we	  also	  perform	  a	  two-­‐
part	  post-­‐processing	  step	  to	  encourage	  homogenously	  connected	  graphs:	  (i)	  during	  clustering,	  
any	   vertex	   whose	   removal	   would	   increase	   the	   likelihood	   of	   the	   graph	   is	   excluded	   from	   it	  
(Appendix:	   Algorithm	   1,	   lines	   7-­‐10);	   (ii)	   after	   clustering,	   any	   vertex	   not	   in	   a	   subgraph	   but	  
incident	  to	  a	  subgraph	  for	  which	  adding	  the	  vertex	  would	  increase	  its	  likelihood	  is	  incorporated	  
into	  it	  (Appendix:	  Algorithm	  2,	  lines	  5-­‐9).	  The	  latter	  step	  is	  performed	  in	  a	  greedy	  fashion	  such	  
that	   vertices	   are	   incorporated	   into	   larger	   subgraphs	   first,	   in	   accordance	   with	   our	   desire	   to	  
identify	   the	   largest	   likely	   subgraphs.	   This	   procedure	   accounts	   for	   instances	   where	   the	   HCS	  
threshold	   is	   not	   aggressive	   enough	   in	   removing	   few	   outliers	   that	   do	   not	  majorly	   impact	   the	  
overall	   density	   of	   a	   very	   dense	   subgraph.	   As	   computed	   in	   Algorithm	   2	   (Appendix),	   our	   final	  
output	  is	  then	  πi,	  a	  set	  of	  subgraphs	  representing	  the	  largest	  likely	  haplotype	  clusters	  within	  the	  





Figure	  6.1:	  DASH	  algorithm	  workflow	  
A	   generalized	   representation	   of	   the	   DASH	   clustering	   algorithm	   across	   three	  windows	   (vertical	   lines)	   of	   a	   single	  
chromosome.	  (A)	  Shows	  pairs	  of	  haploid	  individuals	  (left:	  colored	  circles)	  and	  their	  respective	  identical	  by	  descent	  
(IBD)	   segments,	   if	   any.	   True	   segments	   are	   represented	   by	   a	   thick	   gray	   bar	   spanning	   at	   least	   one	  window,	   false	  
positive	   and	   negative	   regions	   are	   labeled	   and	   unfilled.	   (B)	   Shows	   the	   corresponding	   haplotype	   graph	   for	   each	  
respective	  window,	  with	  haploid	  individuals	  represented	  as	  nodes/circles	  (color	  consistent	  with	  A)	  and	  IBD	  sharing	  
at	   the	   locus	   represented	  as	  edges/lines;	   false	  positive	  and	   false	  negative	   segments	  are	  dashed	  and	  dotted	   lines	  
respectively.	   Gray	   fill	   shows	   the	   most	   likely	   dense	   cluster	   detected	   by	   DASH.	   (C)	   Shows	   the	   final	   haplotypes	  
determined	  by	  the	  algorithm	  for	  each	  window,	  color-­‐consistent	  with	  A	  and	  B.	  
	  
Multi-­‐locus	  analysis	  
We	   implement	  multi-­‐locus	   clustering	  as	  an	  extension	   to	   the	   single-­‐locus	  method	  by	   scanning	  




with	   the	   single-­‐locus	   algorithm	   and	   produces	   an	   initial	   set	   of	   haplotype	   clusters	   π0.	  
Subsequently,	  within	   a	   given	   fixed-­‐IBD	   region	   (bi,bi+1)	  we	   now	  have	   the	   set	   of	   subgraphs	   πi-­‐1	  
from	  the	  previous	  region	  as	  well	  as	  the	  graph	  Gi	  representing	  IBD	  segments	  overlapping	  (bi,bi+1).	  
Because	  the	  subgraphs	  in	  πi-­‐1	  have	  already	  passed	  the	  likelihood	  ratio	  test	  at	  least	  once,	  we	  give	  
them	   precedence	   in	   constructing	   πi;	   this	   strategy	   also	   offers	   the	   benefit	   of	   tracking	   a	   single	  
haplotype	   cluster	   as	   it	   evolves	   across	   multiple	   regions	   to	   minimize	   redundancy.	   For	   each	  
subgraph	   in	   πi-­‐1	   we	   generate	   a	   new	   subgraph	   g΄	   with	   an	   identical	   set	   of	   vertices	   as	   well	   all	  
incident	   edges	   and	   additional	   incident	   vertices	   observed	   in	   Gi	   and	   cluster	   g΄	   (Appendix:	  
Algorithm	  3,	  lines	  3-­‐9).	  Where	  in	  the	  single-­‐locus	  analysis	  this	  procedure	  was	  primarily	  used	  to	  
clean	  established	  subgraphs	  of	  outliers,	  here	  it	  also	  removes/adopts	  any	  vertices	  that	  are	  newly	  
incident	  on	  a	  previously	  established	  subgraph	  or	  have	   lost	  edges	  and	  should	  be	  disconnected	  
from	   a	   previously	   established	   subgraph.	   In	   practice,	   the	   scan	   for	   removal/adoption	   can	   be	  
made	  much	  faster	  by	  examining	  only	  those	  members	  of	  πi-­‐1	  that	  were	  modified	  from	  (bi-­‐1,bi)	  to	  
(bi,bi+1).	   The	   resultant	   set	   of	   haplotype	   clusters	   from	   g΄	   is	   then	   incorporated	   into	   πi	   and	  
removed	  from	  Gi	   (Appendix:	  Algorithm	  3,	  lines	  10-­‐11).	  Subsequently,	  the	  remaining	  graph	  can	  
also	  be	  clustered	  in	  accordance	  with	  the	  single-­‐locus	  approach	  and	  incorporated	  into	  πi.	  In	  this	  
way,	   multi-­‐locus	   subgraphs	   will	   tend	   to	   grow	   and	   shrink	   as	   the	   focus	   moves	   through	  




6.3 Simulated data analysis 
Simulation	  of	  rare	  causal	  variants	  
We	   seek	   to	   measure	   the	   performance	   of	   our	   algorithm	   within	   a	   realistic	   simulation	   of	   rare	  
causal	   variants	   with	   few	   nearby	   low-­‐frequency	   proxy	   SNPs.	   In	   particular,	   we	   design	   our	  
simulation	  to	  require	  as	  few	  assumptions	  as	  possible	  about	  the	  underlying	  haplotype	  space	  to	  
maintain	  an	  unbiased	  analysis.	  Using	  a	  typical	  framework	  for	  testing	  variant	  imputation51,104,	  we	  
randomly	  selected	  rare	  alleles	  to	  be	  our	  simulated	  causal	  mutations.	  For	  each	  such	  causal	  allele	  
we	   simulated	   a	   dichotomous	   trait	   from	   existing	   genotype	   data	   by	   randomly	   assigning	  
case/control	   labels	  to	  respective	  individuals	  such	  that	  the	  causal	  allele	  has	  a	  prescribed	  effect	  
size.	   We	   then	   hid	   all	   rare	   variants	   from	   the	   analysis	   and	   measured	   the	   power	   of	   various	  
methods	  to	  recover	  their	  association	  signal	  at	  a	  fixed	  level	  of	  statistical	  significance.	  
In	  each	  population	  we	  randomly	  selected	  500	  variants	   for	  each	  of	  23	  designated	  minor	  allele	  
frequencies	  from	  0.5%	  to	  4.9%	  (in	  steps	  of	  0.2%).	  To	  obtain	  variants	  that	  are	  likely	  independent,	  
we	  divided	  the	  genome	  into	  1MB	  blocks	  and,	  for	  each	  designated	  frequency,	  selected	  a	  single	  
variant	  closest	  in	  frequency;	  we	  then	  randomly	  selected	  a	  subset	  of	  500	  such	  variants.	  In	  both	  
cohorts,	  the	  chosen	  variants	  were	  within	  0.1%	  of	  the	  designated	  frequency,	  and	  the	  root	  sum	  of	  
squared	   differences	   around	   each	   designated	   frequency	   had	   been	   <0.05%.	   For	   each	   selected	  
variant,	  we	  constructed	  a	  dichotomous	  phenotype	  with	  fixed	  direct	  allelic	  P	  value	  cutoff	  under	  
an	   additive	   disease	  model.	   Specifically,	   the	   cutoff	  was	   set	   to	   2.5x10-­‐20	   =	   0.5	   x	   0.05	   x	   (10-­‐9)2,	  
aiming	   to	   detect	   a	   2-­‐sided,	   genome-­‐wide	   significant	   result	   with	   0.5-­‐fold	   reduction	   of	  




considered	  the	  1-­‐degree-­‐of-­‐freedom	  χ2	  statistic	  Z2=85	  required	  for	  this	  significance	  level,	  while	  
fixing	  the	  frequency	  p	  of	  the	  risk	  allele	  in	  the	  entire	  cohort,	  the	  fraction	  f	  of	  cases	  and	  the	  total	  
sample	  size	  N	  of	  cases	  and	  controls.	  We	  then	  solved	  for	  the	  necessary	  observed	  deviation	  Δ	  of	  
case	   allele	   frequency	   from	   its	   expected	   value,  ∆= 𝒁!!" !!! ! !!! ,	   so	   that	   a	   z-­‐score	   of	   Z	   is	  
attained.	  
In	  Kosrae,	  where	  we	  fixed	  the	  number	  of	  cases	  and	  total	  samples	  at	  500	  and	  2,906	  respectively,	  
the	   resultant	   causal	   variants	   range	   in	   relative	   risk	   from	   4.89	   (at	   0.4%	  MAF)	   to	   2.44	   (at	   4.8%	  
MAF).	   In	   the	  WTCCC	  cohort	  we	  kept	   the	  500:2906	   ratio	  of	   cases	   to	   total	   samples	  with	  2,783	  
assigned	   cases	   and	   13,396	   assigned	   controls	   to	   each	   simulated	   phenotype.	   The	   relative	   risks	  
ranged	  from	  2.62	  to	  1.56.	  We	  then	  removed	  all	  markers	  below	  5%	  MAF,	  including	  those	  marked	  
directly	   causal,	   from	   our	   analysis.	   Removing	   all	   markers	   in	   this	   manner	   forces	   incomplete	  
tagging	  between	  the	  direct	  causal	  variant	  and	  remaining	  SNPs,	  simulating	  our	  desired	  scenario	  
where	   the	   un-­‐typed	   variant	  may	   not	   be	  well	   represented	   in	   the	   study	   set.	   The	   final	   test-­‐set	  
consisted	  of	  11,500	  individually	  simulated	  phenotypes	  for	  each	  population,	  with	  277,243	  SNPs	  
remaining	  in	  the	  Kosrae	  data	  and	  357,594	  SNPs	  in	  the	  entire	  WTCCC	  (Supplementary	  Table	  1).	  
After	   hiding	   low	   frequency	   SNPs,	   both	   datasets	   were	   phased	   using	   the	   BEAGLE	   software	  
package	  with	  default	  parameters.	  
IBD-­‐detection	  and	  haplotype	  clustering	  
We	  used	  the	  GERMLINE	  algorithm	  for	  all	  estimates	  of	   IBD	  segments	   in	  our	  analysis80.	  We	  ran	  
GERMLINE	   with	   parameters	   tuned	   to	   identify	   short	   IBD	   segments	   of	   1cM	   or	   greater,	   with	  




project105.	  We	  also	  set	  a	  window	  size	  of	  32	  sites	  and	  1	  allowed	  mismatching	  site	  (command-­‐line	  
flags:	   `-­‐haploid	   -­‐min_m	   1	   -­‐bits	   32	   -­‐err_hom	   1	   -­‐err_het	   1`).	   These	   parameters	   are	   much	   less	  
restrictive	  than	  is	  typical	  as	  our	  goal	  is	  to	  enrich	  for	  relatively	  short	  haplotypes.	  To	  minimize	  the	  
overall	  number	  of	  	  parameters	  and	  potential	  biases,	  we	  executed	  DASH	  on	  the	  IBD	  segments	  as	  
if	  we	  had	  no	  prior	  information	  on	  IBD	  error	  and	  all	  segments	  were	  assumed	  true	  (φFP=0,	  φTP=1,	  
φFN=1;	   1	   SNP	  minimum	  window	   size),	  which	   effectively	   reports	   all	   connected-­‐components	   of	  
any	   size	   as	   haplotype	   clusters.	   Overall,	   the	   DASH	   analysis	   identified	   330,189	   and	   787,046	  
haplotype	  clusters	  with	  frequency	  greater	  than	  0.1%	  in	  Kosrae	  and	  the	  WTCCC	  respectively.	  
The	  analysis	  was	  run	   in	  parallel	  batches,	  with	  10%	  of	   the	  genome	  requiring	  approximately	  14	  
hours	   to	  phase	  with	  BEAGLE;	  29	  hours	   for	   the	  GERMLINE	   IBD	  discovery	  and	  64	  hours	   for	   the	  
DASH	  haplotype	  clustering	  on	  a	  single	  3GHz	  Intel	  Xeon	  node	  with	  16GB	  of	  RAM.	  
Imputation	  of	  un-­‐typed	  variants	  from	  HapMap	  reference	  
We	  compare	  DASH	  directly	   to	   the	  SNPs	  as	  well	   as	   to	   imputed	  variants	   from	  a	   corresponding	  
HapMap	   reference	   panel.	   For	   consistency	   with	   the	   phasing	   used	   for	   GERMLINE,	   we	   also	  
performed	  the	  imputation	  with	  the	  BEAGLE	  software	  package	  in	  the	  final	  pruned	  test-­‐set.	  Due	  
to	  restrictions	  on	  available	  computation	  power,	  we	  performed	  the	  imputation	  in	  batches	  of	  500	  
randomly	   chosen	   individuals	   with	   default	   parameters	   and	   kept	   all	   imputed	   calls	   that	   had	   a	  
minimum	  estimated	  r2	  of	  0.9.	  As	  a	   reference	  panel,	  we	  used	  1,387,466	  phased	  markers	   from	  
the	   HapMap	   Phase	   3	   panels	   of	   113	   European	   ancestry	   (CEU)	   samples	   and	   170	   East	   Asian	  
ancestry	   (JPTCHB)	   samples	   for	   imputation	   to	   the	   WTCCC	   and	   Kosrae	   respectively.	   In	   both	  




markers	  in	  Kosrae	  and	  706,312	  total	  markers	  in	  the	  WTCCC.	  We	  observe	  that	  over	  80%	  of	  the	  
hidden	  variants	  in	  each	  cohort	  are	  typed	  in	  the	  reference	  panel,	  providing	  the	  opportunity	  for	  
many	  of	   the	   causal	   variants	   to	  be	   imputed	  directly.	   This	  effectively	   implies	  a	   lower	  bound	  of	  
80%	  on	  association	  power	  given	  perfect	  imputation	  and	  reference.	  Though	  the	  optimal	  strategy	  
for	   using	   imputed	  markers	   in	   association	   is	   to	   incorporate	   genotype	  uncertainty	  directly	   into	  
the	   test,	   this	  would	   require	  evaluating	  and	  comparing	  a	  variety	  of	  proposed	   testing	  models52	  
that	  are	  outside	  the	  scope	  of	  our	  analysis.	   In	   light	  of	   this,	  we	  stress	   that	  our	  threshold-­‐based	  
analysis	   strictly	  measures	   the	   power	   of	   high-­‐quality	   imputed	   variants	   rather	   than	   that	   of	   an	  
ideal	  imputation-­‐based	  association	  study.	  
Assessing	  significance	  
To	   establish	   significance	   for	   each	   method	   and	   cohort,	   we	   performed	   1,000	   genome-­‐wide	  
permutations	   of	   an	   allelic	   χ2	   association	   test20	   and	   identified	   an	   empirical	   genome-­‐wide	  
significance	  threshold	  at	  a	  family-­‐wise	  error	  rate	  of	  0.05	  (Supplementary	  Table	  1).	  We	  note	  that	  
although	  there	  are	  many	  fewer	  haplotype	  clusters	  than	  single	  markers	  the	  empirical	  threshold	  
p-­‐value	   for	   genomewide	   haplotype	   clusters	   was	   consistently	   lower	   than	   that	   of	   SNPs	  
(Supplementary	  Table	  1).	   This	   suggests	   the	  SNP	   tests	  as	  a	  whole	  are	  more	   redundant	   to	  one	  
another,	  compared	  to	  the	  set	  of	  haplotype	  cluster	   tests.	  Standard	  Bonferroni	  correction,	   that	  
takes	   into	   account	   only	   the	   sizes	   of	   these	   sets	   can	   thus	   be	   an	   inconsistent	   measure	   of	   the	  
testing	  burden	   they	   incur.	   	   For	  each	  method	  and	   frequency	  window	  of	  500	  markers	  we	   then	  




region	  of	  the	  true	  causal	  variant.	  The	  percentage	  of	  such	  regions	  that	  contained	  an	  association	  




Estimated	  association	  power	  
	  
	  
Figure	  6.2:	  Rare-­‐variant	  association	  power	  in	  one	  isolate	  and	  one	  outbred	  cohort	  
Power	   to	   detect	   a	   single	   rare	   variant	  was	   estimated	   by	   simulating	   causal	   sites	   at	   risk	   allele	   frequency	   range	   of	  
(0%,5%)	  with	   fixed	   direct	   allelic	   significance	   of	   2.5x10-­‐20.	   All	   variants	   below	   5%	  MAF	  were	   subsequently	   hidden	  
from	   analysis	   and	   power	   to	   detect	   association	  with	   remaining	   proxy	  markers	  was	  measured.	   Tested	   separately	  
were	   single	   markers	   (yellow,	   SNP);	   high-­‐quality	   imputed	   markers	   from	   HapMap	   reference	   and	   single	   markers	  
(green,	  IMP);	  DASH	  haplotypes	  and	  single	  markers	  (blue	  DASH	  &	  SNP);	  DASH	  haplotypes	  and	  high-­‐quality	  imputed	  
markers	  (DASH	  &	  IMP).	  For	  each	  method,	  power	  was	  measured	  as	  percentage	  of	  variants	  for	  which	  a	  genome-­‐wide	  
significant	   proxy	  was	   identified	   (see	  Materials	  &	  Methods).	   Panel	   A	   plots	   results	   in	   isolate	   cohort	   from	   Kosrae,	  





We	   performed	   the	   causal	   variant	   simulation	   in	   both	   cohorts	   and	   report	   average	   power	   to	  
recover	   the	   planted	   variant	   using	   four	   association	   techniques	   in	   Figure	   6.2.	   Panel	   A	   shows	  
power	  in	  the	  Kosraen	  cohort	  to	  be	  significantly	  higher	  for	  either	  of	  the	  DASH-­‐based	  techniques	  
at	  all	  risk	  allele	  frequencies,	  particularly	  at	  the	  low	  end	  of	  the	  spectrum	  where	  testing	  DASH	  &	  
SNPs	   together	   has	   a	   40x,	   5x,	   and	   2x	   increase	   in	   power	   over	   SNPs	   alone	   for	   the	   risk	   allele	  
frequencies	   of	   0-­‐1%,	   1-­‐2%,	   and	   2-­‐3%	   respectively.	  We	   caution	   that	  while	   the	   relative	   power	  
increase	  is	  high,	  the	  absolute	  power	  for	  rare	  variants	  below	  1%	  MAF	  is	  still	  in	  the	  low	  range	  of	  
0-­‐11%.	  High-­‐quality	   imputed	  variants	   from	  the	  HapMap	  East	  Asian	  panel	  offer	  greater	  power	  
over	   the	  SNP-­‐based	  association	  but	   still	  underperform	  when	  compared	   to	  DASH	  &	  SNPs	  and,	  
likewise,	  when	  compared	  to	  DASH	  &	  imputed	  variants	  together.	  Looking	  at	  the	  detailed	  power	  
distribution	   (Supplementary	  Figure	  3A)	  we	  see	   that	   the	  power	  of	  DASH	  alone	  converges	  with	  
imputation	   and	   single	  marker	   power	   at	   4.5%	  MAF	   and	   becomes	   less	   powerful	   subsequently.	  
However,	  testing	  DASH	  in	  conjunction	  with	  the	  other	  methods	  always	  offers	   increased	  power	  
then	  the	  methods	  separately,	  with	  DASH	  &	  imputation	  exhibiting	  approximately	  20%	  additional	  
power	  across	  the	  entire	  risk	  allele	  frequency	  spectrum.	  
Figure	   6.2B	   shows	   the	   power	   distribution	   in	   the	   Wellcome	   Trust	   cohort,	   with	   relatively	  
decreased	  power	  across	  all	  methodologies.	  As	  in	  the	  Kosrae	  analysis,	  though,	  we	  again	  see	  that	  
using	  DASH	   in	  conjunction	  with	  the	  other	  methods	   increases	  power	  within	  the	   low-­‐frequency	  
range	   (0-­‐4%	   compared	   to	   single	   markers,	   0-­‐3%	   compared	   to	   imputation)	   However,	   if	   we	  
examine	  the	  detailed	  distribution	  in	  Supplementary	  Figure	  3B,	  we	  see	  a	  conspicuous	  decrease	  




marker	  tests	  at	  3%.	  This	  is	  primarily	  an	  artifact	  of	  the	  minimum	  IBD	  length	  threshold	  we	  place	  
on	   GERMLINE,	   which	   restricts	   the	   potential	   for	   DASH	   to	   capture	   shorter,	   more	   ancient	  
haplotypes.	   As	   higher	   frequency	   variants	   tend	   to	   be	   older106	   and	   therefore	   lie	   on	   the	  
background	   of	  more	   ancient	   haplotypes,	   this	   thresholding	   effect	   will	   decrease	   the	   power	   of	  
DASH	   to	   capture	   such	  alleles	   and	   result	   in	   the	  decreasing	  power	   curve.	  Nevertheless,	   testing	  
the	   DASH	   haplotype	   clusters	   together	   with	   imputed	   variants	   maintains	   power	   gains	   over	  
imputed	  markers	   of	   8x-­‐1.5x	   in	   the	  MAF	   range	   of	   0-­‐1.5%;	  with	   decreased	   power	   in	   the	  MAF	  
range	  of	  3.5-­‐5%,	  at	  an	  average	  decrease	  of	  0.95x.	  
Robustness	  to	  missing	  genotypes	  and	  haplotype	  phasing	  error	  
	  
Figure	  6.3:	  Association	  power	  in	  the	  presence	  of	  missing	  genotypes	  and	  phasing	  error	  
Power	  estimates	  (as	  in	  Figure	  2)	  for	  causal	  variant	  at	  2%	  risk	  allele	  frequency	  are	  plotted	  with	  increasing	  levels	  of	  
missing	  genotypes	  and	  phasing	  error.	   For	  both	   fault	   types,	   three	  methods	  are	  compared:	   single-­‐marker	   (yellow,	  
SNP);	  imputation	  from	  HapMap	  JPTCHB	  (green,	  IMP);	  and	  DASH	  haplotypes	  (blue,	  DASH).	  Panel	  A	  shows	  power	  as	  
function	  of	  %	  of	  variants	  excluded	  at	  random	  (filled	  line)	  and	  in	  increasing	  order	  of	  minor	  allele	  frequency	  (dashed	  
line).	   Panel	   B	   shows	   power	   as	   function	   of	   probability	   that	   a	   heterozygous	   site	  will	   be	   switched	   (filled	   line)	   and	  
probability	   a	   heterozygous	   site	   will	   switch	   the	   subsequent	   haplotype	   (dashed	   line);	   SNP	   and	   IMP	   methods	  





We	   sought	   to	   examine	   the	   effect	   that	  missing	   genotypes	   and	  phasing	   error	   can	  have	  on	   the	  
power	  of	  the	  association	  methodologies.	  We	  focused	  on	  the	  2%	  risk	  allele	  frequency	  in	  Kosrae,	  
where	  all	  methods	  had	  appreciable	  power	  to	  detect	  the	  planted	  variants	  and	  redo	  the	  power	  
experiment	  (including	  phasing,	  IBD	  detection,	  haplotype	  clustering;	  as	  well	  as	  imputation)	  while	  
introducing	   increasing	   missing	   genotype	   rates.	   Figure	   6.3A	   shows	   the	   effects	   on	   power	   of	  
simulated	   missing	   genotypes	   by	   randomly	   marking	   increasing	   subsets	   of	   SNPs	   as	   missing	  
without	   changing	   the	   multiple-­‐testing	   burden.	   When	   SNPs	   were	   labeled	   missing	   at	   random	  
(solid	  line),	  we	  see	  little	  effect	  on	  power	  in	  any	  of	  the	  methods	  even	  when	  20%	  of	  the	  SNPs	  are	  
excluded:	   as	   compared	   to	  no	  missing	  markers,	  power	  dropped	  by	  a	   factor	  of	  0.85,	   0.91,	   and	  
0.97	  for	  SNPs,	  imputed	  markers,	  and	  DASH	  respectively.	  This	  demonstrates	  the	  high	  degree	  of	  
correlation	  between	  the	  ascertained	  SNPs	  which	  allows	  for	  such	  robustness	  to	  missingness.	  On	  
the	   other	   hand,	   when	   we	   labeled	   the	   SNPs	   missing	   in	   increasing	   order	   of	   allele	   frequency	  
(dashed	   line),	   simulating	   incomplete	   ascertainment	   of	   low-­‐frequency	   variants,	   we	   see	   a	  
significant	  decrease	   in	   the	  power	  of	  association	   from	  SNPs	  and	   imputed	  markers	  but	  not	   the	  
DASH	  analysis.	  Comparing	  no	  missing	  markers	  to	  20%	  excluded,	  the	  most	  extreme	  scenario,	  we	  
see	   power	   drop	   by	   a	   factor	   of	   22.3,	   1.4,	   and	   1.1	   for	   SNPs,	   imputed	   markers,	   and	   DASH	  
respectively.	  This	   is	  consistent	  with	  the	  general	  trend	  of	   increased	  association	  power	  of	  DASH	  
haplotype	  clusters	  in	  tagging	  low-­‐frequency	  variants.	  
Because	   the	   GERMLINE	   algorithm	   works	   explicitly	   on	   phased	   data,	   the	   presence	   of	   phasing	  
errors	   could	   significantly	   impact	   the	   sensitivity	   of	   IBD	   detection	   and	   subsequently	   introduce	  




phasing	  error	  into	  the	  input	  haplotypes	  for	  GERMLINE,	  examining	  the	  effect	  on	  power	  at	  a	  2%	  
risk	  allele	  frequency	  in	  Kosrae	  as	   in	  the	  previous	  analysis.	  Figure	  6.3B	  shows	  power	  measured	  
across	  increasing	  rates	  of	  two	  types	  of	  error:	  the	  solid	  line	  represents	  data	  where	  heterozygous	  
sites	   were	   flipped	   without	   effecting	   adjacent	   haplotypes;	   the	   dashed	   line	   represents	   the	  
traditional	   scenario	   of	   a	   flip	   also	   inducing	   a	   phase	   switch	   in	   all	   subsequent	  markers.	   As	   the	  
other	   two	   methods	   are	   not	   affected	   by	   phasing	   error,	   they	   are	   plotted	   unchanged	   for	  
reference.	  We	  see	  that	  both	  types	  of	  phasing	  error	  have	  an	  effect	  on	  the	  power	  of	  DASH,	  with	  a	  
2%	   chance	   of	   the	   full	   haplotype	   switch	   decreasing	   power	   by	   a	   factor	   of	   0.69	   though	   no	  
reduction	   in	   power	   from	   the	   single-­‐point	   flip	   until	   4%.	  We	   stress	   that	   this	   demonstrates	   the	  
decrease	  in	  power	  as	  an	  effect	  of	  phasing	  error	  in	  excess	  of	  what	  is	  already	  inherent	  in	  the	  data.	  
6.4 Association protocol for real phenotypes 
Data:	  Isolated	  population	  from	  the	  island	  of	  Kosrae,	  Micronesia	  
A	   full	   description	   of	   the	   screening	   and	   genotyping	   of	   the	   Kosraen	   cohort	   was	   provided	  
elsewhere88.	  Briefly,	   3,148	  highly	   related	   individuals	  were	   surveyed	   from	   the	  Pacific	   Island	  of	  
Kosrae	  in	  three	  separate	  screenings	  carried	  out	  in	  1994,	  2001,	  and	  2003,	  which	  represent	  >75%	  
of	  the	  adult	  population	  on	  the	  Island.	  2,906	  study	  participants	  were	  successfully	  genotyped	  on	  
the	  Affymetrix	  500k	  array;	  data	  were	  generated	  at	  Affymetrix.	  Genotypes	  were	  called	  with	  the	  
BRLMM	  algorithm	  and	  a	  minimum	  call	   rate	  of	  95%	  was	  achieved,	  with	  a	   final	   set	  of	  398,876	  
polymorphic	   autosomal	   markers.	   26	   traits	   relating	   to	   metabolic	   syndrome	   were	   ascertained	  
and	   are	   detailed	   in	   Supplementary	   Table	   6.	   Phenotypes	   were	   adjusted	   for	   age	   and	   gender,	  




of	  these	  traits	  have	  been	  tested	  with	  the	  PLINK/QFAM-­‐total	  framework88,107	  and	  all	  have	  been	  
tested	  with	   the	   EMMAX	   variance	   components	  model108,109.	  We	   compare	   to	   the	   latter	   results	  
when	  referencing	  single	  marker	  analysis	  in	  Kosrae.	  
Data:	  The	  Wellcome	  Trust	  Case-­‐Control	  Consortium	  
Data	   ascertainment	   and	   cleaning	   for	   the	   WTCCC	   cohort	   has	   been	   described	   in	   detail	  
previously110.	   The	  WTCCC	   data	  we	   used	   consists	   of	   genotypes	   ascertained	   in	   2,000	   cases	   for	  
each	  seven	  common	  disease	  and	  3,000	  shared	  controls	  from	  the	  1958	  Birth	  Cohort	  (58C)	  and	  
National	   Blood	   Services	   (NBS).	   Genotyping	  was	   performed	   on	   the	   Affymetrix	   500k	   array	   and	  
called	  using	  the	  Chiamo	  algorithm.	  After	  excluded	  the	  30,956	  SNPs	  and	  815	  individuals	  that	  did	  
not	  pass	   the	  WTCCC’s	  quality	   thresholds	  our	   final	  dataset	  consisted	  of	  16,179	   individuals	  and	  
455,566	  autosomal	  markers.	  The	   traits	   studied	  and	   their	   respective	   sample	   sizes	  are	   listed	   in	  
Supplementary	  Table	  7.	  We	  tested	  this	   final	  set	  of	  markers	   for	  association	  by	  splitting	  up	  the	  
cohort	  in	  two	  ways:	  using	  only	  the	  58C	  &	  NBS	  samples	  as	  controls	  (“controls	  only”);	  and	  using	  
all	   other	   samples	   -­‐	   58C	   &	   NBS	   and	   cases	   for	   traits	   other	   than	   the	   one	   tested	   -­‐	   as	   controls	  
(“pooled	  controls”).	  
Variance	  components-­‐based	  association	  in	  Kosrae	  
Due	   to	   the	   significant	   degree	   of	   relatedness	   between	   individuals	   on	   Kosrae	   we	   used	   the	  
EMMAX	   program108	   to	   perform	   the	   association	   testing	   in	   real	   data.	   EMMAX	   uses	   a	   pairwise	  
relatedness	  matrix	   to	   incorporate	  random	  effects	   into	  the	  association	  test.	  This	  approach	  has	  




a	  relatedness	  matrix	  constructed	  from	  pairwise	  genome-­‐wide	  IBS	  scores	  and	  ran	  EMMAX	  with	  
default	  parameters	  for	  all	  analysis.	  
Conditional	  analysis	  of	  haplotype	  clusters	  
In	   instances	   where	   multiple	   significant	   haplotype	   clusters	   overlapped	   a	   single	   locus	   we	  
performed	  a	  step-­‐wise	  conditional	  analysis	  to	  identify	  independent	  haplotype	  clusters.	  Iterating	  
in	  order	  of	  decreasing	  significance,	  we	  introduced	  each	  cluster	  as	  a	  covariate	  for	  all	  remaining	  
clusters	  within	  a	  logistic	  regression	  test	  in	  PLINK	  or	  directly	  as	  a	  fixed	  effect	  in	  EMMAX,	  for	  the	  
WTCCC	   and	   Kosrae	   data	   respectively.	   Any	   haplotype	   clusters	   that	   remained	   genome-­‐wide	  
significant	  after	  conditioning	  were	  reported	  as	  independent.	  
To	  identify	  whether	  a	  cluster	  association	  was	  more	  significant	  than	  typed	  markers,	  particularly	  
in	   regions	   with	   multiple	   independent	   association	   signals,	   we	   performed	   two	   types	   of	  
conditional	  analysis.	  First,	  we	  iteratively	  conditioned	  the	  cluster	  of	  interest	  on	  each	  SNP	  within	  
1MB	   of	   either	   physical	   cluster	   boundary	   (or	   from	   chr6:20-­‐40MBp	   for	   any	   cluster	   within	   the	  
MHC)	   and	   reported	   the	   association	   that	   minimizes	   conditional	   significance.	   This	   measure	  
represents	  the	  residual	  haplotype	  cluster	  signal	  given	  any	  single	  nearby	  marker,	  and	  we	  refer	  to	  
it	  as	  the	  “conditioned”	  p-­‐value.	  Separately,	  we	  performed	  a	  step-­‐wise	  logistic	  regression	  where	  
all	  genome-­‐wide	  significant	  SNPs	  were	  iteratively	  added	  as	  additional	  covariates	  until	  no	  such	  
SNPs	  were	  present,	  and	  reported	  the	  final	  residual	  haplotype	  cluster	  association.	  This	  measure	  
represents	   the	   residual	   haplotype	   cluster	   signal	   given	   all	   independently	   genome-­‐wide	  




Fine-­‐mapping	  of	  nominal	  haplotype	  clusters	  
We	   assess	   the	   utility	   of	   very	   short	   haplotype	   clusters	   that	   cannot	   be	   efficiently	   detected	   on	  
genome-­‐scale	  by	  performing	  a	  second-­‐stage	  short	  haplotype	  association	  analysis	   in	  regions	  of	  
nominal	   significance.	   We	   identified	   any	   haplotype	   associations	   at	   most	   two	   orders	   of	  
magnitude	   less	   significant	   than	   the	   genome-­‐wide	   threshold	   and	   established	   non-­‐overlapping	  
regions	  of	   interest	  within	  500kb	  of	  the	  haplotype	  boundaries.	  We	  then	  re-­‐ran	  GERMLINE	  IBD-­‐
detection	  with	  no	  minimum	  length	  threshold	  and	  a	  window	  size	  of	  10	  markers	  with	  no	  allowed	  
mismatches	  (command-­‐line	  flags:	  `-­‐min_m	  0	  -­‐bits	  10	  -­‐err_hom	  0	  -­‐err_het	  0`),	  effectively	  looking	  
for	   10	   SNP	   haplotypes	   with	   complete	   IBS.	   We	   then	   ran	   the	   DASH	   haplotype	   clustering	   and	  
association	  in	  the	  same	  way	  as	  described	  above	  (including	  testing	  for	  independence),	  retaining	  
only	   those	  clusters	   that	  had	  surpassed	  the	  significance	  threshold	  established	   in	  genome-­‐wide	  
analysis	  and	  were	  conditionally	  independent	  of	  any	  previously	  identified	  clusters	  in	  the	  region.	  
Follow-­‐up	  in	  low-­‐pass	  sequencing	  pilot	  
Seven	  Kosraen	  individuals	  were	  lightly	  sequenced	  using	  the	  SOLiD	  System	  with	  50bp	  and	  35bp	  
mate-­‐paired	   reads	   for	   an	   average	   of	   3-­‐6X	   sequence	   coverage	   of	   non-­‐redundant,	   uniquely	  
placed	  pairs	  for	  each	  individual112.	  Calling	  and	  variant	  quality	  filtering	  was	  done	  in	  all	  samples	  
together	   using	   the	   Genome	   Analysis	   Toolkit113	   following	   the	   best-­‐practices	   of	   the	   1,000	  
Genomes	  Project	  (see	  online	  resources).	  
6.5 Results 
We	  identified	  a	  number	  of	  loci	  with	  haplotype-­‐based	  associations	  to	  real	  phenotypes	  in	  the	  two	  




associations	   identified	   in	   either	   dataset	   that	   were	   genome-­‐wide	   significant	   and	   had	   strong	  
residual	   signal	   when	   conditioned	   on	   single	   markers	   overlapping	   the	   region.	   Specifically,	   we	  
compared	   p-­‐values	   of	   the	   DASH	   clusters	   at	   each	   such	   locus	   to	   the	   localized	   DASH	   analysis,	  
listing	  the	  cluster	  which	   is	  most	  significantly	  associated	  from	  either	  analysis	  of	  that	   locus.	  We	  
further	   list	   the	  most	   significant	  association	   to	  a	   single	  marker	   from	  the	  original	  GWAS	  within	  
1MB	  of	  the	  physical	  haplotype	  boundaries	  (or	  chr6:20-­‐40Mbp	  for	  clusters	  in	  the	  MHC),	  as	  well	  
as	   the	   “conditional”	   p-­‐value,	   representing	   the	   residual	   association	   signal	   of	   the	   cluster	   given	  
any	  individual	  markers	  in	  the	  region	  (see	  Chapter	  6.4).	  
Table	  6.1:	  Significant	  and	  independent	  haplotype	  associations	  






WTCCC	   CD	   16q12	   7.2%	   1.80	   1.7E-­‐24	   7.5E-­‐19	   3.0E-­‐10	   NKD1	  
	   T1D	   6p21	   0.6%	   3.94	   4.2E-­‐24	   4.9E-­‐175	   2.7E-­‐13	   MHC	  
	   RA	   6p21	   2.4%	   2.35	   1.0E-­‐23	   9.4E-­‐64	   1.8E-­‐16	   MHC	  
	   CAD	   6q26	   1.7%	   2.17	   4.1E-­‐14	   5.9E-­‐05	   2.6E-­‐09	   SLC22A3,	  LPAL2,	  LPA	  
	   T2D	   11p14	   0.3%	   3.79	   1.9E-­‐10	   3.1E-­‐03	   4.3E-­‐08	   	  
Kosrae	   Uric	  Acid	   11q13	   1.8%	   0.13	   6.6E-­‐49	   9.6E-­‐35	   2.9E-­‐17	   SLC22A11,	  SLC22A12	  
	   HBA1C	   16q24	   9.9%	   0.47	   2.5E-­‐24	   6.3E-­‐08	   2.1E-­‐17	   	  
	   Triglycerides	   11q23	   27.4%	   1.31	   2.2E-­‐15	   3.0E-­‐12	   6.8E-­‐05	   APOA1,	  APOA5	  
	   Total	  Cholesterol	   6q26	   13.4%	   1.33	   6.9E-­‐11	   2.5E-­‐06	   4.9E-­‐06	   LPA	  
	   Total	  Cholesterol	   12q23	   2.7%	   0.54	   9.1E-­‐11	   5.9E-­‐04	   1.6E-­‐08	   	  
	   LDL	   12q23	   2.8%	   0.59	   1.0E-­‐08	   1.0E-­‐04	   2.5E-­‐06	   	  
	   LDL	   19q13	   1.0%	   0.45	   2.1E-­‐08	   1.7E-­‐06	   1.0E-­‐03	   	  
	   Folate	   19p13	   3.2%	   1.68	   6.4E-­‐08	   6.7E-­‐05	   5.1E-­‐05	   LDLR;	  TYK2	  
	   Total	  Cholesterol	   11q23	   23.5%	   1.21	   8.5E-­‐08	   2.0E-­‐05	   9.1E-­‐04	   APOA1,	  APOA5	  




1Most	  significant	  association	  in	  locus,	  conditionally	  independent	  of	  all	  genome-­‐wide	  significant	  and	  local	  haplotypes	  on	  
chromosome.	  
2Most	  significant	  nearby	  single	  marker	  association	  (see	  	  
Supplementary	  Table	  2	  for	  break-­‐down	  by	  type	  of	  controls).	  
3Least	  significant	  haplotype	  association	  after	  conditioning	  on	  all	  nearby	  single	  markers.	  
	  
For	  the	  WTCCC	  data	  (Table	  6.1	  -­‐	  top),	  all	  p-­‐values	  shown	  are	  from	  the	  “pooled	  controls”	  analysis	  
which	   used	   cases	   for	   alternative	   traits	   as	   controls.	   We	   detail	   the	   DASH	   clusters	   that	   are	  
significant	   but	   partially	   explained	   by	   single-­‐marker	   association	   in	   Supplementary	   Table	   2-­‐5.	  
Overall,	   association	   results	   across	   the	   entire	   genome	   demonstrate	   a	   distribution	   with	   low	  
genomic	  inflation	  (not	  shown).	  
In	  Kosrae,	  DASH	  identified	  eight	  association	  loci,	  with	  the	  localized	  test	  strengthening	  three	  of	  
these	  and	  uncovering	  two	  additional	  genome-­‐wide	  significant	  regions	  for	  a	  total	  of	  ten	  unique	  
regions.	  The	  strongest	  association	  we	   identified	  was	  a	  cluster	  at	  11q13	   for	  Uric	  Acid	   (p-­‐value	  
5.5x10-­‐48)	  which	  we	  have	  refined	  in	  a	  separate	  work	  and	  found	  to	  be	  four-­‐fold	  more	  significant	  
than	   any	   previously	   associated	   SNP	   at	   that	   locus109.	   We	   also	   identified	   regions	   with	   no	  
significant	  single-­‐marker	  associations	  and	  describe	  these	  in	  detail.	  A	  region	  at	  12q23	  containing	  
a	  single	  cluster	  was	  strongly	  associated	  with	  both	  Total	  Cholesterol	  (p-­‐value	  9.1x10-­‐11)	  and	  LDL	  
cholesterol	   (1.0x10-­‐8).	   This	   cluster	   overlaps	   the	   Farnesoid	   X-­‐activated	   receptor	  NR1H4	   [MIM	  
603826],	  which	  regulates	   the	  catabolism	  of	  cholesterol	   into	  bile	  acid	  and	   is	  a	   likely	  candidate	  
gene.	  Two	  clusters	  at	  16q24	  associated	  with	  Hemoglobin	   levels	   (HBA1c)	  were	   localized	   into	  a	  
single	   core	   cluster	   that	  was	   strongly	   significant	  with	   a	   p-­‐value	   of	   2.5	   x	   10-­‐24.	   This	   cluster	   lies	  
nearby	  the	   Interleukin-­‐17	  receptor	   IL17C	   [MIM	  604628]	  which	   is	   involved	   in	  the	  TnF	  pathway	  




In	  the	  WTCCC,	  we	  identified	  twelve	  unique	  associations	  of	  which	  five	  were	  conditionally	  more	  
significant	   than	   any	   nearby	   single	   markers.	   Two	   such	   associations,	   for	   Rheumatoid	   Arthritis	  
[MIM	   180300]	   and	   T1D	   [MIM	   222100],	   were	   identified	   in	   the	   MHC	   region	   significantly	  
independent	  of	  any	  individual	  SNP	  (“conditional	  P	  DASH”	  column)	  or	  combination	  of	  genome-­‐
wide	  significant	  SNPs	  (Supplementary	  Table	  2-­‐3).	  The	  presence	  of	  multiple	  causal	  signals	  is	  not	  
unexpected	  in	  this	  region,	  as	  it	  exhibits	  complexity	  in	  LD-­‐structure	  and	  enrichment	  for	  disease	  
associations.	   Three	   other	   haplotype	   clusters	   were	   identified	   outside	   this	   region,	   one	   which	  
refined	  a	  well-­‐known	  association	  of	  Crohn’s	  Disease	  [MIM	  266600]	  to	  NKD1	  [MIM	  607851],	  and	  
another	   intergenic	  at	  11p14	  with	  no	  significant	  nearby	  single-­‐marker	   tags.	   Lastly,	  we	   found	  a	  
genome-­‐wide	  significant	  cluster	  associated	  with	  Coronary	  Artery	  Disease	  [MIM	  607339]	  at	  6q26	  
with	   a	   p-­‐value	   of	   8.2x10-­‐15,	   much	   stronger	   than	   the	   most	   significant	   single-­‐marker	   variant	  
(associated	  at	  5.9x10-­‐5).	   Indeed,	  this	  region	  has	  recently	  been	  mapped	  to	  the	  SLC22A3-­‐LPAL2-­‐
LPA	   gene-­‐cluster	   [MIM	   604842,	   611682,	   152200	   respectively]	   in	   a	   genome-­‐wide	   haplotype	  
association	   study	   which	   focused	   on	   short	   10	   SNP	   haplotypes114,	   though	   with	   much	   lower	  
significance	  (4.34x10-­‐8	  with	  6	  df	  test)	  than	  we	  find	  here.	  
Supplementary	  Figure	  4	  and	  Supplementary	  Figure	  5	   show	  the	   region	  of	  association	  signal	  at	  
each	  of	   the	  detected	   loci	   in	  detail.	   In	  most	   instances,	   the	  haplotype	  clusters	  are	  bounded	  by	  
recombination	   hot-­‐spots	   as	   would	   be	   expected;	   however,	   some	   can	   span	   multiple	   such	  
hotspots,	  particularly	  in	  the	  Kosraen	  population	  where	  haplotypes	  tend	  to	  be	  longer	  and	  decay	  
more	  slowly	   (e.g.	  T2D	  [MIM	  125853]	  at	  11p14,	  Uric	  Acid	  at	  11q13,	  Folate	  at	  19p13).	  We	  also	  




particular,	  two	  of	  the	  five	  significant	  clusters	  identified	  in	  the	  WTCCC	  do	  not	  overlap	  nominally	  
significant	   markers	   (CAD	   at	   6q26,	   and	   T2D	   at	   11p14),	   as	   well	   as	   four	   of	   the	   ten	   significant	  
clusters	  identified	  in	  Kosrae	  (Total	  Cholesterol	  at	  12q23,	  LDL	  at	  12q23,	  Folate	  at	  19p13,	  and	  Uric	  
Acid	  at	  19q13).	  These	   regions	  generally	  have	  several	  nominal	   clusters	   surrounding	   those	   that	  
are	   significant	   at	   a	   genome-­‐wide	   level,	   but	   do	   not	   appear	   to	   have	   any	   overlapping	   single-­‐
marker	  tags.	  
Potential	  effects	  of	  genotyping	  error	  
Previous	  analysis	  of	  the	  WTCCC	  data	  identified	  a	  number	  of	  spurious	  associations	  that	  were	  a	  
result	   of	   genotyping	   error26,115;	   with	   such	   sites	   even	   introducing	   false	   short-­‐haplotype	  
associations	  in	  some	  instances.	  Identifying	  such	  sites	  conclusively	  has	  necessitated	  re-­‐analyzing	  
the	   genotype	   call	   intensity	   plots	   by	   hand	   or	   re-­‐calling	   the	   genotypes	   with	   diverse	  methods.	  
Qualitatively,	  the	  fact	  that	  significant	  associations	   identified	  by	  DASH	  are	  almost	  all	   in	  regions	  
implicated	   by	   independent	   studies	   suggests	   that	   the	   method	   is	   robust	   to	   false-­‐positive	  
associations.	  However,	  because	  we	  only	  filtered	  out	  those	  markers	  that	  failed	  standard	  metrics,	  
this	   possibility	   of	   confounding	   genotyping	   error	   is	   still	   a	   serious	   concern.	   To	   estimate	   the	  
potential	   effects	   of	   such	   error,	   we	   re-­‐tested	   all	   regions	   harboring	   genome-­‐wide	   significant	  
haplotype	   clusters	   on	   subsets	   of	   markers	   with	   much	   more	   stringent	   filtering	   criteria.	   If	   the	  
original	  signal	  is	  robust	  and	  not	  the	  result	  of	  calling	  error,	  we	  expect	  strong	  correlation	  between	  
the	  cluster	  identified	  in	  the	  original	  and	  filtered	  data.	  Specifically,	  we	  established	  two	  minimum	  
call-­‐confidence	  thresholds	  (0.95	  and	  0.98)	  and	  designated	  any	  markers	  with	  fewer	  than	  98%	  of	  




17.0%	   of	   markers	   respectively).	   For	   each	   region,	   we	   then	   re-­‐ran	   the	   GERMLINE	   and	   DASH	  
analysis	  on	   this	   filtered	  data	  and	  reported	   the	  strongest	   r2	   correlation	  between	  any	   resultant	  
clusters	   and	   the	   original	   associated	   clusters.	   For	   the	   genome-­‐wide	   analysis	   (Supplementary	  
Table	  2),	  we	  find	  that	  3	  out	  of	  11	  haplotype	  clusters	  are	  significantly	  disrupted	  (r2	  <	  0.8)	  by	  the	  
0.95	  call	  confidence	  threshold,	  and	  an	  additional	  cluster	  is	  disrupted	  by	  the	  0.98	  threshold.	  This	  
lack	  of	  correlation	  implies	  that	  low-­‐confidence	  calls	  that	  may	  have	  been	  poorly	  genotyped	  are	  
contributing	   to	   some	  of	   the	  original	  haplotype	  cluster	  associations.	  However,	   in	   the	   localized	  
analysis	  (Supplementary	  Table	  3),	  where	  the	  underlying	  IBD	  segments	  are	  very	  short	  and	  exact,	  
none	  of	  the	  identified	  clusters	  were	  significantly	  affected	  by	  strict	  filtering.	  Overall,	  none	  of	  the	  
conditionally	  significant	  associations	  we	  report	  in	  Table	  6.1	  fall	  below	  an	  r2	  of	  0.98	  under	  either	  
filtering	  scenario,	  suggesting	  that	  the	  underlying	  haplotypes	  are	  not	  the	  spurious	  result	  of	  low-­‐
confidence	  genotype	  calls.	  
Replication	  of	  associated	  Kosraen	  locus	  in	  a	  European	  cohort	  
We	  have	  sought	  replication	  of	  the	  independent	  haplotype	  cluster	  associations	  from	  the	  Kosraen	  
dataset	  in	  an	  independent	  European	  cohort	  from	  the	  Diabetes	  Genetics	  Initiative	  (DGI)116.	  The	  
cohort	  consists	  of	  3,142	  Scandinavian	  samples	  genotyped	  on	  the	  Affymetrix	  500k	  platform	  and	  
phenotyped	   for	   18	   clinical	   traits.	   In	   particular,	   480	   of	   the	  DGI	   samples	  were	   phenotyped	   for	  
HBa1c,	   for	   which	   we	   identified	   a	   highly	   significant	   cluster	   in	   Kosrae	   at	   16q24	   (Table	  
6.1,Supplementary	   Table	   8).	   We	   performed	   a	   standard	   DASH	   analysis	   on	   the	   DGI	   samples	  
following	  the	  previously	  described	  phasing	  and	  haplotype	  construction	  protocol.	  Looking	  within	  




overlapping	  cluster	  spanning	  16	  SNPs	  from	  87,404,625	  to	  87,560,132.	  Though	  it	  is	  significantly	  
less	  frequent	  at	  0.64%,	  the	  cluster	  is	  associated	  with	  an	  allelic	  p-­‐value	  of	  0.015	  (after	  Bonferroni	  
correction)	  and	  stronger	  effect	  size	  in	  the	  same	  direction	  (Supplementary	  Table	  8).	  Additionally,	  
a	  Kolmogorov-­‐Smirnov117	  like	  analysis	  across	  the	  entire	  chromosome,	  testing	  sets	  of	  replication	  
clusters	   that	   lie	   increasingly	   further	   away	   from	   the	   initial	   association	   for	   enrichment	   of	  
significant	  associations,	  showed	  that	  haplotype	  clusters	  at	  this	  locus	  in	  the	  DGI	  were	  generally	  
of	   elevated	   significance	   compared	   to	   the	   null.	   We	   did	   not	   observe	   any	   single	   marker	  
associations	  that	  surpassed	  their	  respective	  multiple-­‐testing	  burden	  in	  the	  region.	  	  
Putative	  causal	  mutation	  and	  structural	  variation	  
To	   assess	   the	   utility	   of	   these	   haplotype	   cluster	   associations	   in	   the	   context	   of	  whole-­‐genome	  
sequence	  data,	  we	  analyzed	  seven	  Kosraen	  genomes	  that	  had	  been	  lightly	  sequenced118,	  three	  
of	  which	  were	  carriers	  for	  the	  HBA1c	  associated	  cluster.	  We	  identified	  seven	  non-­‐synonymous	  
SNVs	   present	   only	   in	   carriers	   of	   the	   haplotype	   cluster,	   four	   of	   which	   were	   not	   in	   dbSNP	  
(Supplementary	  Table	  8),	  and	  classified	  these	  according	  to	  their	  effect	  using	  the	  SiFT	  tool119.	  We	  
used	  the	  Sequenom	  iPLEX	  genotyping	  platform	  to	  assay	  these	  sites	  in	  90	  islanders,	  selected	  to	  
be	   a	   mix	   of	   haplotype	   cluster	   carriers	   at	   the	   extreme	   end	   of	   the	   respective	   phenotype	  
distribution	  and	  non-­‐carriers	  near	  the	  phenotype	  mean.	  Of	  the	  four	  sites	  which	  were	  typed	  as	  
polymorphic,	   none	   showed	   strong	   correlation	   to	   cluster	   status	   or	   significant	   residual	  
association	   (Supplementary	   Table	   9).	   Due	   to	   the	   low	   sensitivity	   of	   variant	   detection	   in	   the	  




Focusing	   on	   CNV	   analysis	   in	   the	   associated	   region,	   we	   find	   a	   number	   of	   long	   heterozygous	  
deletions	  contained	  within	  the	  HBA1c	  associated	  haplotype	  that	  are	  not	  present	  at	  such	  length	  
in	  the	  non-­‐carriers.	  Supplementary	  Figure	  6	  shows	  the	  CNV	  calls	  within	  500kbp	  of	  the	  haplotype	  
region,	  with	   normalized	   coverage	   as	  well	   as	   the	   algorithmic	   segmentation	   of	   the	   region	   into	  
discrete	   heterozygous	   deletion	   calls	   (P<0.05).	   Overall,	   we	   see	   that	   the	   cluster	   carriers	   have	  
three	  times	  more	  deleted	  content	  per	  sample	  overlapping	  the	  associated	  region	  and	  that	  there	  
are	  a	  number	  of	  regions	  present	   in	  two	  or	  more	  carriers	  explicitly	  (Supplementary	  Figure	  7B).	  
For	  comparison,	  only	  3.3%	  of	  the	  mapped	  autosomal	  genome	  contains	  a	  CNV	  overlapping	  in	  at	  
least	  two	  of	  samples,	  and	  0.2%	  contains	  a	  CNV	  explicitly	  in	  two	  or	  more	  of	  these	  carriers.	  The	  
presence	  of	   these	   carrier-­‐specific	   sub-­‐regions	   is	   highly	   unusual	   and	   they	  harbor	   a	   number	  of	  
candidate	  gene	  targets	  for	  this	  trait	  (Supplementary	  Figure	  7G).	  
6.6 Summary 
Haplotypes	  can	  provide	  insights	  into	  underlying	  LD	  structure	  at	  a	  locus	  of	  interest,	  and	  help	  us	  
map	   rare	   causal	   loci	   that	   are	  not	  well	   tagged	  by	  a	   single	   common	  marker.	  With	  high-­‐density	  
array	  data,	  using	  IBD	  segments	  as	  building	  blocks	  allows	  us	  to	  base	  haplotype	  identification	  in	  
recent	  sharing	  that	  is	  likely	  to	  be	  accurately	  detected.	  We	  have	  presented	  here	  a	  method	  that	  
uses	   graph	   techniques	   to	   rapidly	   construct	   haplotype	   clusters	   out	   of	   segments	   shared	   IBD	  
between	  pairs	  of	  individuals.	  
We	  have	  explored	   the	  power	  of	   this	  method	   through	   simulations	   in	   two	  very	  different	  data-­‐
sets;	  one	  isolate	  (Kosrae)	  with	  an	  abundance	  of	  long	  IBD	  segments	  and	  one	  large	  and	  outbred	  




association	  to	  be	  much	  more	  powerful	  than	  direct	  or	  imputed	  association	  for	  all	  variants	  below	  
5%	  risk	  allele	  frequency.	  In	  European	  samples,	  where	  IBD	  segments	  are	  likely	  to	  be	  much	  less	  
recent	  and	   therefore	  harder	   to	  detect,	  we	  see	   that	  haplotype	  association	   is	   still	  powerful	   for	  
tagging	   rare	   variants.	   Additionally,	   it	   provides	   orthogonal	   information	   to	   directly	   typed	   or	  
imputed	  markers,	  with	  testing	  both	  being	  the	  most	  powerful	  strategy	  for	  risk	  alleles	  up	  to	  4%	  in	  
frequency.	  
Lastly,	  we	  have	  shown	  this	  approach	  to	  be	  effective	  at	  uncovering	  regions	  of	  association	  in	  real	  
data.	  In	  Kosrae,	  we	  identified	  10	  independent	  loci	  with	  haplotype	  cluster	  associations	  that	  were	  
more	   significant	   than	   any	   surrounding	   individual	  markers.	   Half	   of	   these	   loci	   were	   in	   regions	  
harboring	  no	   significantly	  associated	  SNPs,	  and	  one	  of	  which	  we	  were	  able	   to	   replicate	   in	  an	  
independent	   European	   cohort.	   In	   the	   WTCCC,	   we	   identify	   5	   conditionally	   independent	  
haplotype	   clusters,	   two	  of	  which	  are	   in	   regions	  not	   implicated	   in	   the	  original	   study	  with	  one	  
being	   recently	   identified	   in	   a	   separate	  multi-­‐marker	   analysis	   with	   additional	   samples114.	   The	  
identified	   clusters	   provide	   us	   with	   the	   boundaries	   of	   the	   associated	   region	   as	   well	   as	   the	  
expected	  carrier	  individuals.	  Such	  information	  can	  be	  used	  in	  conjunction	  with	  LD-­‐structure	  and	  
tagging	   SNPs	   to	   select	   samples	   and	   define	   region	   boundaries	   when	   following	   up	   with	   fine-­‐
mapping	  techniques120.	  Indeed,	  whole	  genome-­‐sequencing	  of	  carriers	  of	  one	  cluster	  revealed	  a	  
significant	  enrichment	  in	  deleted	  regions	  that	  isolate	  candidate	  genes	  for	  additional	  follow-­‐up.	  	  
Overall,	   the	   haplotype-­‐based	   approach	   provides	   a	   bridge	   between	   the	   availability	   of	   tens	   of	  
thousands	  of	  samples	  with	  densely-­‐typed	  genotypes	  and	  the	  emerging	  sequence-­‐based	  studies	  




increases	  power	  to	  discover	  putative	  associations	  with	  rare	  underlying	  variants.	  For	  the	  latter,	  
haplotypes	  emphasize	  features	  of	  the	  data	  that	  are	  practically	  useful	  in	  study	  design. 





In	   this	   last	   section,	   we	   discuss	   the	   conclusions	   of	   the	   previous	   research;	   briefly	   review	  
contemporary	  methods	  and	  techniques	  that	  have	  been	  developed	  in	  parallel	  to	  our	  work;	  this	  
lends	   context	   to	   a	   general	   discussion	   of	   open	   problems	   in	   the	   field	   which	   serves	   as	   the	  
conclusion.	  
7 Contributions of this work 
This	   thesis	   work	   presents	   a	   comprehensive	   analysis	   of	   population-­‐wide	   recent	   genetic	  
relatedness	   and	   its	   applications	   to	   disease	  mapping	   and	   study	   design.	   IBD	   segment	   analysis	  
offers	   the	   opportunity	   to	   precisely	   identify	   tracts	   of	   sharing	   between	   putatively	   unrelated	  
individuals	   in	   a	   population.	   Following	   in	   the	   tradition	   of	   haplotype	   inference,	   our	   underlying	  
assumption	   is	   that	   understanding	   local	   LD-­‐structure	   and	   examining	   multiple	   markers	  
simultaneously	   offers	   deep	   insights	   into	   the	   mosaic	   of	   genetic	   relationships	   between	  
individuals.	   Grounding	   these	   methods	   in	   algorithms	   to	   quantify	   and	   exploit	   linkage	  
disequilibrium	  offers	  a	  counterpoint	  to	  single-­‐marker	  studies	  or	  genome-­‐wide	  moments.	  With	  
the	  abundance	  of	  high-­‐density	   genome-­‐wide	  data	   further	  breaking	   the	  assumption	   that	  each	  
typed	   marker	   is	   an	   identical	   and	   independent	   statistical	   draw,	   this	   kind	   of	   multi-­‐marker	  
approach	   continues	   to	   increases	   in	   power	   and	   usefulness.	   However,	   unlike	   traditional	  
haplotype	  analysis	  which	  generally	  begins	  with	  a	  single	  point	  and	  grows	  outwards	  to	  construct	  
putative	  haplotypes,	  IBD	  analysis	  seeks	  to	  identify	  very	  long	  tracts	  of	  alleles	  that	  are	  unlikely	  to	  




approach	   eschews	   the	   computational	   burden	   associated	   with	   constructing	   short	   haplotypes	  
and	   focuses	   on	   local	   co-­‐inheritance	   of	   very	   high-­‐confidence.	   The	   main	   draw-­‐back	   of	   this	  
strategy	  is	  that	  it	  is	  well-­‐powered	  only	  for	  recent	  variation	  that	  is	  individually	  unlikely	  to	  occur,	  
and	  may	   simply	   be	   too	   scarce	   to	   offer	   enough	   evidence	   for	   statistical	   significance	   in	   down-­‐
stream	   analysis.	   As	   such,	   our	   motivation	   has	   been	   to	   develop	   methods	   that	   can	   efficiently	  
analyze	   very	   large	   general	   cohorts	  where	   IBD	   is	   expected	   to	   be	   abundant	   and	   to	   emphasize	  
analysis	   of	   IBD	   in	   isolated	  populations	  which	   generally	   have	   increased	   levels	   of	   homogeneity	  
and	  relatedness.	  
In	   the	   first	   part,	   we	   detailed	   three	   algorithms	   for	   efficient	   detection	   of	   IBD	   segments	   in	  
population	  genotype	  data.	  We	  presented	  GERMLINE,	  a	  novel	  seed-­‐based	  approach	  to	  segment	  
detection	   that	   reduces	   the	   computational	   burden	   from	   quadratic	   to	   nearly-­‐linear	   time	   in	   a	  
general	  population.	  We	  showed	  that	  this	  method	  is	  several	  orders	  of	  magnitude	  faster	  than	  the	  
available	   all-­‐pairs	   algorithms	   while	   maintaining	   higher	   accuracy	   by	   utilizing	   all	   available	  
markers.	  Applying	   this	   algorithm	   to	   an	   isolated	  population	  on	   the	   island	  of	   Kosrae	  we	   found	  
that	   IBD	   segment	   length	   is	   a	   superior	   indicator	   of	   relatedness	   when	   compared	   to	   standard	  
genome-­‐wide	   metrics.	   We	   also	   described	   several	   instances	   where	   unusual	   gaps	   in	   IBD	  
segments,	  even	  from	  gold-­‐standard	  data,	  can	  be	  used	  as	   indicators	  of	  phasing	   inaccuracy	  and	  
structural	  variation.	  
Next,	  we	   extended	   the	  GERMLINE	   algorithm	   to	  process	   cohorts	   of	   unlimited	   size	   through	   an	  
adaptive-­‐seeds	   strategy.	   By	   dynamically	   pre-­‐computing	   the	   maximum	   amount	   of	   space	  




given	   the	  memory	   constraints,	   the	   algorithm	   can	   continue	   to	   discover	   IBD	   segments	   even	   in	  
regions	  where	  the	  data	  is	  highly	  complex.	  We	  demonstrated	  the	  effectiveness	  of	  this	  strategy	  
by	  performing	   IBD	   segment	   analysis	   on	   a	  population	  of	   50,000	   individuals;	   under	   constraints	  
where	  contemporary	  methods	  can	  only	  process	  a	   few	  thousand.	  We	  also	  showed	  that,	  when	  
used	  without	  memory	  constraints,	  this	  adaptive	  seeds	  strategy	  offered	  increased	  accuracy	  over	  
the	  traditional	  GERMLINE	  algorithm	  by	  maximizing	  detection	  sensitivity.	  
These	  two	  algorithms	  depend	  on	  the	  availability	  of	  accurately	  phased	  data	  as	  input	  –	  a	  task	  that	  
becomes	  more	   difficult	   with	   large	   populations	   (where	   computation	   is	   intractable)	   or	   whole-­‐
genome	  sequence	  (where	  rare	  variants	  confound	  current	  methods).	  We	  concluded	  this	  part	  of	  
the	   thesis	   with	   an	   algorithm	   that	   analyzes	   genotype	   or	   partial-­‐haplotype	   data	   directly	   by	  
permuting	   potential	   haplotypes	   and	   scoring	   each	   putative	   segment	   with	   a	   robust	   LD-­‐based	  
metric.	   We	   showed	   that	   accuracy	   of	   this	   algorithm	   is	   largely	   independent	   of	   population	  
parameters,	   unlike	   comparable	   haplotype-­‐based	   detection	  methods.	  We	   also	   showed	   that	   it	  
significantly	   outperforms	   available	   methods	   when	   applied	   to	   full	   sequence	   data	   and	   is	  
computationally	  efficient	  enough	  to	  analyze	   thousands	  of	  sequenced	  genomes	  where	  current	  
methods	  can	  only	  phase	  a	  few	  hundred.	  
In	   the	   second	   part	   of	   this	   thesis,	   we	   proposed	   two	   algorithms	   for	   analyzing	   available	   IBD	  
segments	   to	  maximize	  our	  understanding	  of	   rare	   variation	  and	  disease.	  Motivated	  by	  whole-­‐
genome	   sequencing	   for	   full-­‐population	   ascertainment,	  we	   presented	   the	   INFOSTIP	   algorithm	  
which	   utilizes	   IBD	   segments	   to	   optimize	   the	   selection	   of	   individuals	   for	   sequencing.	   By	  




single	   individual	   that	  has	   the	  most	  genetic	   surrogates	   in	   the	  population	  and	  would	   therefore	  
most	   likely	   contain	   previously	   unseen	   variants.	   In	   simulations,	   we	   showed	   this	   approach	   to	  
significantly	  increase	  imputation	  accuracy	  over	  random	  sampling,	  sometimes	  as	  far	  as	  doubling	  
the	  effective	  reference	  panel	  size.	  Looking	  at	  the	  Kosraen	  population	  ascertained	  for	  GWAS,	  we	  
find	   that	   as	   few	   as	   40	   out	   of	   3,000	   individuals	   are	   expected	   to	   infer	   60%	   of	   the	   population	  
genetic	   content.	   Performing	   a	   low-­‐coverage	   sequence	   pilot	   of	   seven	   Kosraen	   individuals,	  we	  
demonstrate	  the	  accuracy	  of	  IBD	  segments	  detected	  in	  these	  individuals	  as	  indicators	  of	  shared	  
rare	   variation	   and	   motivate	   a	   full	   IBD-­‐based	   imputation	   strategy	   given	   a	   larger	   sequenced	  
reference.	  
Seeking	   to	  move	   beyond	   pairwise	   IBD	   segment	   analysis,	   we	   developed	   the	   DASH	   algorithm,	  
which	  groups	  the	  shared	  segments	  into	  IBD	  clusters	  that	  are	  likely	  to	  be	  commonly	  shared	  and	  
can	   be	   proxies	   for	   untyped	   variation	   that	   is	   likely	   to	   lie	   on	   the	   back	   of	   such	   segments.	   The	  
algorithm	   constructs	   IBD-­‐graphs	   based	   on	   the	   shared	   segments	   overlapping	   a	   locus	   and	  
attempts	   to	   identify	   densely-­‐shared	   clusters;	   the	   carriers	   of	   each	   cluster	   are	   then	   coded	   as	  
carriers	  of	  a	  standard	  genetic	  marker	  and	  used	  for	  direct	  association	  to	  phenotype.	  In	  simulated	  
disease	  studies,	  we	  showed	  this	  approach	  to	  be	  much	  more	  powerful	  for	  detecting	  rare	  causal	  
variants	   than	   traditional	   single-­‐SNP	   analysis	   and	   imputation	   from	   a	   general	   reference	   panel.	  
Moreover,	  as	  DASH	  does	  not	  require	  a	  reference	  panel	  at	  all,	  it	  is	  particularly	  useful	  in	  isolated	  
or	  complex	  populations	  where	   imputation	  techniques	  tend	  to	   lose	  power.	  Applying	  the	  DASH	  




cohort,	  we	   identified	  multiple	  novel	   loci	  of	  association	  and	  supported	   these	  putative	  variants	  
with	  replication	  or	  sequence	  analysis.	  
8 Review: other recent work in the field 
At	   the	   time	   of	   this	   writing,	   the	   detection	   of	   IBD	   segments	   has	  matured	   significantly,	   with	   a	  
number	   of	   available	   algorithms	   ranging	   from	   direct	   pair-­‐wise	   analysis	   in	   an	   HMM	   over	  
genotypes20,49	   to	   a	   recent	   exact-­‐seeds-­‐based	  method81.	  With	   densely-­‐typed	   data	   and	   proper	  
parameter	  tuning,	  these	  methods	  can	  achieve	  reasonably	  accurate	  detection	  of	   IBD	  segments	  
as	   low	   as	   1cM,	   and	   have	   effectively	   solved	   the	   problem	   of	   detection	   at	   >3cM81	   in	   most	  
populations.	  In	  the	  area	  of	  disease	  mapping,	  a	  tool	  motivated	  by	  similar	  principles	  as	  DASH	  has	  
been	  developed	   to	   identify	   segments	  shared	  simultaneously	  by	  multiple	   individuals	  within	  an	  
MCMC	   framework121	   though	   it	   is	   intended	   for	   very	   small	   sample	   sizes	   or	   targeted	   analysis.	  
Recently,	  an	  algorithm	  based	  on	  Bayesian	  graphical	  models	  has	  been	  developed	  to	  detect	  IBD	  
segments	  and	  perform	  imputation	  from	  sequence122,	  showing	  compelling	  results	  in	  the	  field	  of	  
IBD-­‐based	   variant	   inference.	   Similarly,	   an	   IBD	   clustering	   approach	   not	   unlike	   DASH	   has	   been	  
demonstrated	   to	  accurately	   impute	  HLA-­‐locus	   types	   in	  untyped	   individual123.	   In	  one	   instance,	  
an	   IBD	  haplotype	   in	   the	  Kosraen	  cohort	  was	  successfully	  shown	  to	  be	  a	  highly	  significant	  and	  
novel	  association	  to	  plasma	  plant-­‐sterol	  levels120.	  
Though	   mentioned	   only	   briefly	   here,	   IBD	   analysis	   has	   offered	   much	   to	   the	   field	   of	   recent	  
population	  genetics.	  In	  other	  work,	  we	  have	  shown	  IBD	  segments	  to	  act	  as	  accurate	  classifiers	  




reveal	  regions	  of	  extensive	  sharing	  likely	  to	  be	  indicators	  of	  recent	  selection124;	  the	  presence	  of	  
such	  regions	  was	  also	  found	  in	  an	   independent	   IBD-­‐based	  analysis125.	  Analyzing	   IBD	  segments	  
as	  indicators	  of	  population	  structure	  has	  proven	  fruitful,	  as	  demonstrated	  by	  a	  comprehensive	  
analysis	  of	  the	  Jewish	  population126.	  Focusing	  on	  a	  much	  more	  recent	  time-­‐frame,	  IBD-­‐segment	  
analysis	   has	   been	   highly	   accurate	   in	   inferring	   recent	   relationships	   between	   unknown	  
individuals127	  and	  reconstructing	  full	  pedigrees128.	  
9 Open problems 
Probabilistic	  detection	  of	  short	  IBD	  segments	  
In	  this	  work	  we	  have	  demonstrated	  highly	  accurate	  detection	  of	  IBD	  segments	  down	  to	  1cM	  in	  
length,	  with	  a	  rapid	  increase	  in	  error	  below	  that	  threshold.	  It	  is	  yet	  an	  open	  question	  whether	  
accurate	   detection	   below	   this	   threshold	   can	   be	   possible.	   Such	   an	   improvement	   would	   be	  
particularly	  useful	  because	  segment	  length	  is	  inversely	  proportional	  to	  the	  coalescence	  time,	  so	  
reducing	   the	  detectable	  segment	   length	   threshold	   from	  1cM	  to	  0.5cM	  would	  double	  how	  far	  
we	  can	  track	  segments	  “into	  the	  past”.	  At	  some	  point,	  such	  segments	  would	  become	  so	  short	  as	  
to	   converge	   with	   the	   IBS-­‐clusters/LD-­‐blocks	   techniques	   commonly	   used	   in	   tag-­‐SNP	   and	  
haplotype	   association	   algorithms.	   These	   algorithms	   construct	   increasingly	   larger	   haplotypes	  
and	   generally	   exhibit	   a	   high	   degree	   of	   noise	   compounded	   by	   long	   run-­‐times.	   Ideally,	   there	  
exists	  a	  sweet-­‐spot	  where	  pairwise	  shared	  segments	  can	  still	  be	  efficiently	  detected	  in	  the	  seed-­‐




High-­‐quality	   whole-­‐genome	   sequence	   may	   offer	   the	   potential	   for	   this	   kind	   of	   detection	  
accuracy.	   As	   we	   have	   already	   seen	   in	   Chapter	   4,	   the	   low-­‐frequency	   sequenced	   variants	  
significantly	  increase	  accuracy	  of	  segment	  detection	  with	  an	  LD-­‐based	  detection	  model.	  On	  the	  
other	  hand,	  where	  genotype	  data	  is	  available,	  high-­‐quality	  haplotype	  phase	  increases	  accuracy	  
over	   the	  more	  naïve	  LD-­‐based	  model.	   If	  phasing	  algorithms	   improve	   to	  process	   large,	  whole-­‐
genome	  cohorts	   then	   the	  additional	   value	  gained	   from	  rare-­‐variants	   could	  be	  combined	  with	  
the	  coalescent	  information	  implicit	  in	  phased	  haplotypes	  to	  achieve	  the	  accuracy	  gains	  of	  both	  
strategies.	  
We	   have	   observed	   that	   population-­‐feature	   priors	   have	   a	   significant	   impact	   on	   detection	  
accuracy,	  specifically	  the	  expected	  chance	  of	  having	  an	  IBD	  segment	  in	  the	  population:	  P(IBD).	  
Though	   in	   this	  work	  we	   simply	   allow	   the	   user	   to	   furnish	   their	   own	   prior,	   the	   prior	   could	   be	  
calculated	  directly	  from	  the	  observable	  data,	  resulting	   in	  higher	  accuracy	  and	  flexibility.	   If	  the	  
IBD	  segments	  were	  known	  in	  advance	  then	  this	  population	  prior	  is	  trivial	  to	  calculate;	  likewise,	  
the	  IBD	  segments	  can	  be	  accurately	  detected	  if	  this	  population	  prior	   is	  available.	  Such	  mutual	  
dependence	   problems	   have	   been	   successfully	   optimized	   with	   an	   expectation-­‐maximization	  
algorithm	   where	   each	   parameter	   is	   estimated	   in	   turn	   over	   the	   course	   of	   increasingly	   more	  
confident	   iterations.	   Thoroughly	   understanding	   this	   population	   prior	   would	   have	   the	   added	  
benefit	   of	   converting	   the	   IBD	   likelihood	   scores	   into	   full	   posterior	   probabilities,	   allowing	  
segments	   from	   different	   populations	   and	   studies	   to	   be	   properly	   compared	   and	   facilitating	  





Association	  with	  haplotype	  heterogeneity	  
One	   deficiency	   of	   the	   DASH	   methodology	   is	   that	   each	   IBD	   cluster	   is	   treated	   as	   a	   single	  
independent	   unit	   for	   association.	   With	   large	   populations,	   we	   would	   expect	   that	   multiple	  
haplotypes	  occur	  over	  each	  single	  physical	   locus,	  and	  a	  proper	   test-­‐statistic	  must	  account	   for	  
this	  kind	  of	  overlap	  in	  tests.	  One	  opportunity	  for	  improvement	  is	  to	  test	  the	  DASH	  clusters	  in	  an	  
omnibus	  way,	  that	  is,	  to	  look	  for	  association	  at	  all	  n	  haplotypes	  overlapping	  the	  locus	  with	  an	  n	  
degree-­‐of-­‐freedom	   association	   test.	   Though	  with	  many,	   such	   a	   test	  would	   incur	   a	   significant	  
degree-­‐of-­‐freedom	  penalty	  that	  may	  be	  prohibitive	  dense	  haplotype	  regions.	  Another	  option	  is	  
to	   make	   use	   of	   the	   growing	   field	   group-­‐wise	   association	   tests.	   These	   tests	   were	   primarily	  
developed	   for	   testing	   sequenced	   rare	   variants	   within	   a	   gene	   where	   each	   individual	   variant	  
cannot	  reach	  statistical	  significance.	  Because	  we	  expect	  the	  DASH	  clusters	  to	  be	  proxies	  for	  an	  
underlying	   unobserved	   variant,	  we	   can	   test	   the	   overlapping	   clusters	   directly	   in	   a	   group-­‐wise	  
association	  as	  if	  they	  were	  individual	  variants.	  Such	  a	  strategy	  would	  allow	  one	  to	  look	  for	  rare	  
locus-­‐wide	   effects	   without	   having	   full	   sequence	   data.	   Lastly,	   one	   could	   ignore	   the	   clusters	  
altogether	   and	   form	   all	   of	   the	   pairwise	   segments	   that	   overlap	   a	   locus	   (say,	   a	   gene)	   into	   a	  
relatedness	  matrix,	  whose	  {x,y}	  entries	  correspond	  to	  the	  segment	  length	  shared	  between	  the	  
respective	  x	  and	  y	  individuals.	  This	  matrix	  could	  then	  be	  tested	  directly	  for	  correlation	  between	  
pairwise	  phenotype	  covariance	  and	  pairwise	  segment	  sharing	  conditional	  on	  the	  genome-­‐wide	  
sharing.	   As	   with	   population-­‐based	   linkage	   tests,	   the	   assumption	   is	   that	   a	   causal	   variant	   will	  
encourage	   affected	   individuals	   to	   share	  more	   IBD	   segments.	   The	   correlation-­‐based	   approach	  
proposed	   here	   would	   extend	   such	   tests	   to	   incorporate	   qualitative	   traits	   and	   distinguish	  





The	  DASH	  algorithm	  generates	  IBD	  clusters	  as	  proxies	  for	  untyped	  variants	  without	  dependence	  
on	  a	  reference	  panel.	  However,	  where	  reference	  data	  is	  available	  it	  could	  be	  used	  together	  with	  
the	   reference-­‐free	   clusters	   to	   explicitly	   infer	   untyped	   variants.	  We’ve	   observed	   in	   Chapter	   5	  
that	   the	   presence	   of	   an	   IBD	   segment	   between	   two	   sequenced	   individuals	   indicates	   a	   >95%	  
chance	  that	  those	  individuals	  will	  share	  a	  rare	  homozygous	  variant.	  Another	  way	  to	  look	  at	  this	  
finding	  is	  that	  in	  a	  scenario	  where	  only	  one	  individual	  in	  the	  pair	  has	  been	  sequenced,	  we	  can	  
expect	  to	  infer	  the	  homozygous	  variants	  of	  all	  individuals	  IBD	  with	  similarly	  high	  accuracy.	  This	  
type	  of	  strategy	  has	  recently	  been	  shown	  to	  be	  successful	  in	  isolated	  populations	  with	  the	  SLRP	  
algorithm,	  which	  constructs	  a	  Bayesian	  graphical	  model	   to	  propagate	  variants	   from	  reference	  
individuals	  through	  IBD	  segments122.	  The	  SLRP	  method	  requires	  major	  computational	  resources	  
in	   large	  populations	  and	  performs	  a	  single	   IBD	  detection	  step.	  However,	   just	  as	  rare	  variation	  
has	   improved	   IBD	   detection	   accuracy	   in	   sequence	   data,	   we	   can	   take	   advantage	   of	   imputed	  
variants	  to	  similarly	  guide	  IBD	  detection	  in	  any	  study	  cohort.	  Specifically,	  we	  can	  infer	  untyped	  
variants	  using	  the	  DASH	  algorithm	  by	  clustering	  reference	  and	  study	  individuals	  together,	  with	  
the	   variants	   present	   in	   some	   reference	   individuals	   of	   a	   cluster	   propagated	   to	   all	   cluster	  
members.	   Then	   with	   these	   partially	   imputed	   sites	   we	   could	   re-­‐compute	   the	   IBD	   segments	  
based	  on	  the	  new	  information,	  and	  perform	  the	  imputation-­‐detection	  loop	  iteratively	  until	  both	  
values	   have	   converged	   to	  maximum	   likelihood.	   Since	   the	   latest	   extension	   to	   GERMLINE	   also	  
allows	   for	   partially-­‐phased	   haplotypes,	   we	   can	   simultaneously	   infer	   phase	   for	   some	   of	   the	  




Hidden	  relatedness	  in	  the	  whole-­‐genome	  era	  
The	  oncoming	   torrent	  of	  whole-­‐genome	  sequencing	  data	  begs	   the	  question	  of	  what	   role	   IBD	  
segments	  will	  play	  when	  sequenced	  genomes	  are	  as	  ubiquitous	  as	  current	  GWAS	  data.	  During	  
the	   transition	   period,	   IBD-­‐based	   algorithms	   for	   sample	   selection	   and	   variant	   imputation	   can	  
certainly	   increase	   the	   information	   gleaned	   from	   partially	   sequenced	   cohorts.	   But	   what	  
additional	  insights	  can	  IBD	  analysis	  offer	  for	  a	  cohort	  where	  the	  entire	  spectrum	  of	  variants	  has	  
been	  assayed?	  
Certainly	   any	   methods	   that	   require	   quantifying	   segment	   lengths,	   such	   as	   those	   estimating	  
family	   relatedness	   or	   population	   demography,	   would	   continue	   to	   benefit	   from	   increased	  
segment	   detection	   accuracy.	   These	   algorithms	   depend	   explicitly	   on	   obtaining	   an	   accurate	  
distribution	   of	   genome-­‐wide	   sharing	   to	   infer	   hidden	  parameters	   and	   their	   reach	   is	   increased	  
with	  accurate	  short	  segments.	  Similarly,	  IBD	  segment	  analysis	  in	  sequenced	  families	  has	  proven	  
successful	   in	   short-­‐listing	   putative	   causal	   variants	   for	   rare	   disease129,130.	   By	   tracking	   the	  
inheritance	  of	  genetic	  segments	  through	  the	  pedigree	  and	  focusing	  on	  only	  those	  regions	  that	  
fit	  the	  model	  of	  genetic	  inheritance,	  a	  study	  can	  significantly	  reduce	  the	  search	  space	  for	  causal	  
variation131.	   In	   population-­‐based	   studies,	   a	   similar	   strategy	   can	   take	   advantage	   of	   hidden	  
relatedness	   to	   short-­‐list	   genes	   for	   subsequent	   rare-­‐variant	   testing.	   Unlike	   short-­‐listing	  
strategies	   that	   prioritize	   variants	   by	   allele	   frequency	   or	   nominal	   association,	   this	   approach	  
selects	   entire	   regions	   and	   is	   less	   susceptible	   to	   variant	   ascertainment	   bias.	  Moreover,	   causal	  
variants	   that	   are	   complex	   –	   such	   as	   those	   undergoing	   local	   epistasis	   –	   are	   often	   difficult	   to	  




present	  on	  the	  background	  of	  a	  single	   inherited	  haplotype,	  however,	  such	   interactions	  would	  
still	  show	  strong	  association	  in	  a	  segment-­‐based	  analysis.	  Compound	  heterozygous	  mutations,	  
for	   example,	   wherein	   an	   affected	   individual	   has	   two	   different	   functional	   mutations	   on	   the	  
homologous	   copies	   of	   a	   gene	  would	   be	   short-­‐listed	   by	   analysis	   of	   shared	   segments.	   Though	  
such	  multi-­‐variant	  cases	  are	  expected	  to	  be	  very	  rare	  they	  have	  been	  observed	  numerously	  as	  
causal	   in	   complex	  disease132-­‐134.	   Examining	   segments	   (the	  units	  of	   inheritance)	   in	   conjunction	  
with	  the	   individual	  mutations	  (the	  units	  of	  variation),	  has	  the	  potential	   to	  significantly	  reduce	  
the	  statistical	  testing	  burden;	  one	  of	  the	  main	  hurdles	  to	  capturing	  causal	  variants	  of	  low	  effect.	  
A	   more	   general	   contribution	   of	   IBD	   segment	   analysis	   is	   the	   ability	   to	   integrate	   time	   and	  
demographics	   together	   with	   disease	   mapping.	   IBD	   segments	   are	   the	   genetic	   relics	   of	   deep-­‐
rooted	   relationships	   and	   their	   length	   -­‐	   reduced	   by	   recurring	   recombination	   events	   -­‐	   is	   an	  
indicator	  of	  the	  age	  of	  that	  relationship.	  Individual	  mutations,	  based	  on	  their	  allele	  frequency,	  
can	  also	  be	  used	  as	  indicators	  of	  time	  but	  they	  correspond	  to	  a	  much	  more	  ancient	  time-­‐frame.	  
On	   the	   other	   hand,	   IBD	   segment	   analysis	   provides	   insight	   into	   recent	   genetics	   (~100	  
generations)	   that	   cannot	  be	  otherwise	   reproduced.	  Understanding	   this	   indicator	   allows	  us	   to	  
effectively	   zoom-­‐in	   to	   the	   specific	   historical	   interval	   we	   are	   interested	   in.	   Given	   a	   historical	  
prior,	  we	  could	  look	  for	  functional	  variants	  by	  analyzing	  only	  the	  IBD	  segments	  of	  corresponding	  
length;	  optimizing	  our	  historical	  and	  functional	  priors	  simultaneously.	  
This	  kind	  of	  fusion	  of	  population	  and	  disease	  is	  essential	  to	  a	  broad	  understanding	  of	  genetics.	  
As	   GWAS	   matured,	   researchers	   became	   more	   aware	   that	   a	   thorough	   understanding	   of	   the	  




as	  population	  stratification	  or	  admixture	  can	  confound	  a	  study	  with	  false-­‐positives	  and	  reduce	  
overall	  power	  to	  detect	  true	  variants.	  If	  properly	  accounted	  for,	  however,	  these	  “artifacts”	  can	  
actually	   be	   leveraged	   to	   improve	   mapping,	   as	   has	   been	   well	   demonstrated	   by	   studies	   of	  
association	  by	  admixture	  analysis.	  Many	  successful	  strategies	  have	  been	  developed	  to	  account	  
for	  these	  artifacts,	  typically	  by	  treating	  genotypes	  as	  a	  matrix	  of	  independent	  data-­‐points.	  But	  
more	  subtle	  sub-­‐structure	  that	  occurs	  recently	  or	  does	  not	  depend	  on	  distinguishable	  reference	  
panels	   is	   still	   difficult	   to	   elucidate.	   With	   ubiquitous	   population-­‐wide	   sequence	   data,	   IBD	  
segment	  analysis	  can	  enrich	  our	  understanding	  of	  recent	  population	  demographics	  and	  disease	  
etiology,	  with	  insights	  from	  one	  domain	  benefiting	  the	  other.	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Supplementary	  Figure	  1:	  Bootstrapped	  imputation	  accuracy	  dependent	  on	  reference	  size	  and	  allele	  frequency	  
Mean	   imputation	  accuracy	   (allelic	   r2	   correlation	  between	   inferred	  and	   true	  variant)	  as	  a	   function	  of	   true	  variant	  
allele	   frequency	   is	   shown	   for	   reference	   samples	   selected	   randomly	   (colored	   points)	   and	   based	   on	   information	  
content	   (solid	   lines/points).	   Results	   are	   shown	   for	   six	   reference	   panel	   sizes	   from	   100	   to	   600	   individuals,	   with	  
colored	  concentration	  bands	  showing	  maximum	  and	  minimum	  accuracy	  from	  10	  trials	  of	  sampled	  individuals	  (with	  
replacement).	  In	  all	  cases,	  sample	  selection	  based	  on	  information	  content	  increases	  imputed	  marker	  accuracy.	  





Supplementary	  Figure	  2:	  Imputation	  capacity	  for	  genotype	  versus	  haplotype	  selection	  strategies	  
Detailed	  breakdown	  of	  Total	   Information	  Potential	  as	  a	   function	  of	  sequencing	  budget	   for	  genotype-­‐based	  (light	  
blue)	  and	  haplotype-­‐based	   (dark	  blue)	   inference;	  categorized	  according	   to	   random	  selection	  of	   samples	   (dashed	  
line)	  and	  greedy	  optimization	  of	  sample	  selection	  (solid	  line).	  







Supplementary	  Figure	  3:	  Detailed	  simulated	  power	  analysis	  
Power	  to	  detect	  a	  single	  rare	  variant	  at	  risk	  allele	   frequency	  range	  of	   (0%,5%)	  with	  proxy	  markers	  of	  MAF	  ≥	  5%.	  
Lower	   x-­‐axis	   details	   planted	   variant	   allele	   frequency	   and	  upper	   x-­‐axis	   details	   corresponding	   relative	   risk.	   Tested	  
separately	   were	   single	   markers	   (yellow	   triangle,	   SNP);	   imputation	   from	   HapMap	   reference	   and	   single	   markers	  
(green	  cross,	  IMP);	  DASH	  haplotypes	  (blue	  circle,	  DASH);	  DASH	  haplotypes	  and	  single	  markers	  (blue	  triangle,	  DASH	  
&	  SNP);	  DASH	  haplotypes	  and	  imputed	  markers	  (brown	  cross,	  DASH	  &	  IMP).	  Each	  point	  represents	  power	  to	  detect	  
genome-­‐wide	  significant	  association	  at	  500	  randomly	  planted	  markers.	  Panel	  A	  plots	  results	  in	  isolate	  cohort	  from	  
Kosrae,	   Micronesia	   (imputed	   from	   JPTCHB	   reference);	   Panel	   B	   plots	   results	   in	   European	   cohort	   from	   WTCCC	  
(imputed	  from	  CEU	  reference).	  





Supplementary	  Figure	  4:	  Regions	  showing	  strong	  evidence	  of	  association	  in	  European	  cohort	  
Haplotype	  boundaries	  represented	  as	  blue	  bars	  with	  height	  of	  bar	  corresponding	  to	  allelic	  P-­‐value;	  genome-­‐wide	  
significant	  haplotypes	  shown	  in	  red;	  single	  marker	  associations	  shown	  as	  black	  cross.	  Lower	  panel	  details	  physical	  
position	  along	  chromosome	  and	  fine-­‐scale	  recombination	  map	  from	  HapMap	  reference.	  















Supplementary	  Figure	  6:	  Sequencing	  coverage	  and	  detected	  copy	  loss	  at	  locus	  of	  haplotype	  association	  to	  
HBa1c	  
CNV	  calling	   in	   carriers	   (A)	  and	  non-­‐carriers	   (B)	  of	  haplotype	  association	  on	  chromosome	  16	   to	  Hemoglobin	  A1c.	  
Red	  blocks	  represent	  window-­‐normalized	  log2	  ratio	  of	  coverage;	  grey	  regions	  represent	  HMM-­‐based	  heterozygous	  
deletion	  calls	   (no	  other	  CNVs	  were	  present	   in	   the	   region);	  points	  along	   the	  X-­‐axis	  correspond	  to	  genotyped	  SNP	  









Supplementary	  Figure	  7:	  Detected	  CNV	  regions	  and	  carrier-­‐specific	  sites	  at	  locus	  of	  haplotype	  association	  to	  
HBa1c	  
Genome	  browser	  plot	  detailing	  structural	  variants	   in	   region	  of	  haplotype	  association	  to	  Hemoglobin	  A1c.	  Shown	  
are	  (A)	  CNVs	  present	  in	  carriers;	  (B,	  green)	  CNV	  regions	  exclusively	  in	  carriers;	  (C)	  CNVs	  present	  in	  non-­‐carriers;	  (D)	  
OMIM	  genes,	   (E)	  UCSC	  known	  genes;	  and	   (F)	   known	  CNVs	   from	  the	  Database	  of	  Genomic	  Variants.	  Table	   in	   (G)	  
details	  carrier	  exclusive	  regions,	  observed	  homozygosity	  in	  Affymetrix	  500k	  SNPs	  and	  overlapping	  exons.	  




Supplementary	  Table	  1:	  Data-­‐set	  summary	  
	  	   Kosrae	   WTCCC	  
Total	  samples	   2,906	   16,179	  
Total	  polymorphic	  variants	   398,876	   451,490	  
Hidden	  variants	   121,633	   93,896	  
in	  reference	  panel	   98,488	   75,845	  
Simulated	  causal	  variants	   12,500	   12,500	  
in	  reference	  panel	   10,380	   10,333	  
Total	  tested	  variants	   277,243	   357,594	  
Genome-­‐wide	  significance	  threshold	  (DASH)	   4.0x10-­‐8	   5.4x10
-­‐8	  
Genome-­‐wide	  significance	  threshold	  (GWAS)	   2.5x10-­‐7	   2.0x10
-­‐7	  
Genome-­‐wide	  significance	  threshold	  (imputation)	   2.1x10-­‐7	   9.3x10
-­‐8	  




Supplementary	  Table	  2:	  All	  genome-­‐wide	  significant	  regions	  identified	  in	  the	  WTCCC	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CAD	   6	   160,730,710	   160,927,528	   1.3%	   2.13	   8.2E-­‐11	   1.4E-­‐04	   5.9E-­‐05	   2.3E-­‐06	   2.3E-­‐10	   SLC22A3,LPAL2,LPA	   0.98	   0.9
7	  
CAD	   6	   160,927,528	   160,930,756	   1.2%	   2.05	   3.4E-­‐09	   1.4E-­‐04	   5.9E-­‐05	   1.4E-­‐06	   7.1E-­‐09	   SLC22A3,LPAL2,LPA	   0.64	   0.64	  
CAD	   9	   22,062,730	   22,227,321	   34.9%	   0.78	   1.4E-­‐11	   7.7E-­‐15	   2.9E-­‐17	   NS	   NS	   CDKN2A	   0.90	   0.90	  
CD	   1	   67,374,727	   67,523,062	   14.8%	   1.38	   5.1E-­‐12	   5.0E-­‐19	   1.2E-­‐24	   NS	   NS	   IL23R	   0.94	   0.88	  
CD	   5	   131,829,846	   131,844,802	   37.7%	   1.29	   4.2E-­‐12	   8.1E-­‐08	   8.2E-­‐12	   NS	   NS	   5q31	  region	   0.89	   0.88	  
CD	   16	   49,152,847	   49,164,501	   3.7%	   1.95	   9.9E-­‐19	   9.9E-­‐16	   7.5E-­‐19	   1.4E-­‐08	   1.4E-­‐08	   NKD1	   0.89	   0.2
8	  
CD	   16	   49,477,102	   49,477,284	   1.6%	   2.10	   5.3E-­‐12	   9.9E-­‐16	   7.5E-­‐19	   5.1E-­‐07	   5.1E-­‐07	   NOD2	   0.96	   0.95	  
RA	   6	   33,903,649	   33,907,610	   1.1%	   2.18	   1.4E-­‐09	   2.7E-­‐42	   9.4E-­‐64	   4.1E-­‐07	   1.2E-­‐05	   MHC	   0.64	   0.1
1	  
T1D	   6	   28,110,942	   28,119,631	   0.8%	   3.57	   1.5E-­‐23	   4.2E-­‐144	   4.9E-­‐175	   2.1E-­‐04	   1.5E-­‐04	   MHC	   0.99	   0.99	  
T1D	   6	   28,476,919	   28,478,225	   12.1%	   1.61	   4.1E-­‐25	   4.2E-­‐144	   4.9E-­‐175	   2.1E-­‐02	   1.4E-­‐02	   MHC	   0.77	  
0.7
7	  
T1D	   6	   33,787,785	   33,790,392	   0.6%	   3.94	   4.2E-­‐24	   4.2E-­‐144	   4.9E-­‐175	   2.7E-­‐13	   1.0E-­‐07	   MHC	   0.99	   0.99	  
Haplotypes	  also	  shown	  in	  Table	  1	  are	  marked	  in	  bold	  
1Strongest	  association	  in	  locus,	  conditionally	  independent	  of	  all	  genome-­‐wide	  significant	  and	  local	  haplotypes	  on	  chromosome	  
2Most	  significant	  nearby	  single	  marker	  association	  with	  NBS	  &	  58C	  controls	  only	  
3Most	  significant	  nearby	  single	  marker	  association	  with	  combined	  alternative	  cases	  and	  controls	  
4Least	  significant	  haplotype	  association	  after	  conditioning	  on	  any	  nearby	  single	  markers	  (combined	  cases	  and	  controls)	  
5Haplotype	  association	  after	  conditioning	  on	  all	  independently	  genome-­‐wide	  significant	  single	  markers	  (combined	  case	  and	  controls)	  
6Strongest	  correlation	  (r2)	  to	  a	  haplotype	  identified	  in	  a	  subset	  of	  markers	  with	  at	  least	  98%	  of	  samples	  having	  genotype	  call	  confidence	  of	  0.95	  
7Strongest	  correlation	  (r2)	  to	  a	  haplotype	  identified	  in	  a	  subset	  of	  markers	  with	  at	  least	  98%	  of	  samples	  having	  genotype	  call	  confidence	  of	  0.98	  




Supplementary	  Table	  3:	  All	  genome-­‐wide	  significant,	  localized	  regions	  identified	  in	  the	  WTCCC	  
Trai








only	  	  	  	  	  	  	  	  	  	  
P	  GWAS2	  	  
Pooled	  
controls	  	  P	  
GWAS3	  
conditioned	  	  	  	  	  	  
P	  DASH4	  
stepwise	  
conditioned	  	  	  	  	  	  
P	  DASH5	  











CAD	   6	   160,932,260	   161,017,268	   1.7%	   2.17	   4.1E-­‐14	   1.4E-­‐04	   5.9E-­‐05	   2.6E-­‐09	   4.1E-­‐14	   SLC22A3,LPAL2,LPA	   1.00	   1.0
0	  
CAD	   9	   22,021,005	   22,109,128	   35.8%	   1.30	   4.1E-­‐14	   7.7E-­‐15	   2.9E-­‐17	   NS	   NS	   CDKN2A	   1.00	   0.99	  
CD	   1	   67,283,445	   67,348,663	   4.5%	   0.39	   8.0E-­‐15	   5.0E-­‐19	   1.2E-­‐24	   5.7E-­‐04	   1.2E-­‐03	   IL23R	   0.99	   0.99	  
CD	   1	   67,424,321	   67,478,314	   25.3%	   1.43	   1.9E-­‐20	   5.0E-­‐19	   1.2E-­‐24	   NS	   NS	   IL23R	   0.99	   0.99	  
CD	   5	   131,703,880	   131,782,903	   42.2%	   1.29	   6.8E-­‐13	   8.1E-­‐08	   8.2E-­‐12	   4.6E-­‐02	   4.6E-­‐02	   5q31	  region	   0.97	  
0.9
3	  
CD	   16	   49,244,058	   49,244,516	   7.2%	   1.80	   1.7E-­‐24	   9.9E-­‐16	   7.5E-­‐19	   3.0E-­‐10	   3.0E-­‐10	   NKD1	   0.98	   0.9
8	  
RA	   6	   33,512,042	   33,684,663	   2.4%	   2.35	   1.0E-­‐23	   2.7E-­‐42	   9.4E-­‐64	   1.8E-­‐16	   3.3E-­‐13	   MHC	   1.00	   1.00	  
T1D	   6	   26,507,565	   26,509,417	   12.4%	   1.43	   4.0E-­‐14	   4.2E-­‐144	   4.9E-­‐175	   NS	   1.6E-­‐02	   MHC	   0.99	   0.9
9	  
T1D	   6	   26,622,750	   26,636,229	   0.6%	   3.78	   1.1E-­‐21	   4.2E-­‐144	   4.9E-­‐175	   1.6E-­‐03	   1.8E-­‐05	   MHC	   1.00	   1.00	  
T2D	   11	   22,429,718	   22,483,326	   0.3%	   3.79	   1.9E-­‐10	   2.8E-­‐03	   3.1E-­‐03	   4.3E-­‐08	   1.9E-­‐10	   -­‐	   0.99	  
0.9
9	  
Haplotypes	  also	  shown	  in	  Table	  1	  are	  marked	  in	  bold	  
1Strongest	  association	  in	  locus,	  conditionally	  independent	  of	  all	  genome-­‐wide	  significant	  and	  local	  haplotypes	  on	  chromosome	  
2Most	  significant	  nearby	  single	  marker	  association	  with	  NBS	  &	  58C	  controls	  only	  
3Most	  significant	  nearby	  single	  marker	  association	  with	  combined	  alternative	  cases	  and	  controls	  
4Least	  significant	  haplotype	  association	  after	  conditioning	  on	  any	  nearby	  single	  markers	  (combined	  cases	  and	  controls)	  
5Haplotype	  association	  after	  conditioning	  on	  all	  independently	  genome-­‐wide	  significant	  single	  markers	  (combined	  case	  and	  controls)	  
6Strongest	  correlation	  (r2)	  to	  a	  haplotype	  identified	  in	  a	  subset	  of	  markers	  with	  at	  least	  98%	  of	  samples	  having	  genotype	  call	  confidence	  of	  0.95	  
7Strongest	  correlation	  (r2)	  to	  a	  haplotype	  identified	  in	  a	  subset	  of	  markers	  with	  at	  least	  98%	  of	  samples	  having	  genotype	  call	  confidence	  of	  0.98	  




Supplementary	  Table	  4:	  All	  genome-­‐wide	  significant	  regions	  identified	  in	  Kosraen	  data	  




end	   f	  
Hom	  
ref1	   Het1	  
Hom	  






P	  DASH2	   P	  GWAS3	  





Folate	   19	   10,738,387	   10,755,240	   3.2%	   1,758	   118	   6	   1.68	   1	   6.4E-­‐08	   6.7E-­‐05	   5.1E-­‐05	   LDLR;	  TYK2	  
HBA1C	   16	   87,308,019	   87,339,751	   4.4%	   981	   98	   0	   0.52	   2	   2.0E-­‐09	   6.3E-­‐08	   4.3E-­‐05	   	  
HBA1C	   16	   88,656,265	   88,690,776	   2.9%	   1,032	   45	   2	   0.45	   1	   8.6E-­‐09	   9.4E-­‐04	   1.0E-­‐06	   	  
LDL	   12	   99,350,824	   99,608,800	   2.8%	   2,615	   160	   0	   0.59	   0	   1.0E-­‐08	   1.0E-­‐04	   2.5E-­‐06	  
	  
Total	  Cholesterol	   6	   161,091,801	   161,107,669	   13.4%	   2,065	   642	   46	   1.33	   1	   6.9E-­‐11	   2.5E-­‐06	   4.9E-­‐06	   LPA	  
Total	  Cholesterol	   12	   99,321,530	   99,350,824	   2.7%	   2,603	   150	   0	   0.54	   0	   9.1E-­‐11	   5.9E-­‐04	   1.6E-­‐08	  
	  
Triglycerides	   11	   116,105,036	   116,272,109	   32.1%	   1,245	   1,236	   273	   1.27	   4	   2.6E-­‐13	   3.0E-­‐12	   0.01	   APOA1,	  APOA5	  
TSH	   9	   97,467,378	   97,674,793	   14.0%	   1,371	   429	   58	   0.71	   1	   2.6E-­‐11	   2.4E-­‐14	   NS	  
	  
Uric	  Acid	   11	   64,653,308	   64,661,484	   1.8%	   1,796	   65	   0	   0.13	   2	   5.5E-­‐48	   3.7E-­‐17	   2.3E-­‐33	   SLC22A11-­‐12	  
Uric	  Acid	   19	   63,081,167	   63,093,854	   1.6%	   1,797	   64	   0	   0.46	   0	   9.3E-­‐08	   3.4E-­‐03	   9.5E-­‐06	   	  	  
1Number	  of	  phenotyped	  carriers	  
2Most	  significant	  association	  in	  locus,	  conditionally	  independent	  of	  all	  nearby	  haplotypes	  
3Most	  significant	  nearby	  single	  marker	  association	  
4Least	  significant	  haplotype	  association	  after	  conditioning	  on	  all	  nearby	  single	  markers	  




Supplementary	  Table	  5:	  All	  genome-­‐wide	  significant,	  localized	  regions	  identified	  in	  Kosraen	  data	  




end	   f	  
Hom	  
ref1	   Het1	  
Hom	  





P	  DASH2	   P	  GWAS3	  





C-­‐Reactive	  Protein	   1	   156,427,059	   156,492,709	   24.7%	   1,048	   713	   111	   1.28	   3	   8.2E-­‐09	   9.0E-­‐09	   NS	   SPTA1	  
C-­‐Reactive	  Protein	   19	   50,153,836	   50,169,221	   12.3%	   1,413	   434	   25	   0.73	   1	   3.6E-­‐09	   6.5E-­‐13	   NS	   APOE,	  APOC	  
HBA1C	   16	   87,261,769	   87,465,349	   9.9%	   872	   201	   6	   0.47	   3	   2.5E-­‐24	   6.3E-­‐08	   2.1E-­‐17	   	  
LDL	   19	   46,645,270	   46,787,809	   1.0%	   2,71
9	  
56	   0	   0.45	   0	   2.1E-­‐08	   1.7E-­‐06	   1.0E-­‐03	  
	  
LDL	   19	   50,114,427	   50,255,095	   12.4%	   2,120	   621	   34	   1.43	   1	   5.0E-­‐17	   1.1E-­‐23	   NS	   APOE,	  APOC	  




142	   1.21	   4	   8.5E-­‐08	   2.0E-­‐05	   9.1E-­‐04	   APOA1,	  APOA5	  
Total	  Cholesterol	   19	   50,065,116	   50,254,711	   12.4%	   2,103	   616	   34	   1.40	   1	   5.8E-­‐15	   8.7E-­‐18	   NS	   APOE,	  APOC	  




205	   1.31	   4	   2.2E-­‐15	   3.0E-­‐12	   6.8E-­‐05	   APOA1,	  APOA5	  
TSH	   9	   97,613,702	   97,676,546	   18.1%	   1,261	   507	   90	   0.72	   1	   1.6E-­‐12	   2.4E-­‐14	   NS	   PTCH1	  
Uric	  Acid	   11	   64,117,281	   64,341,535	   1.8%	   1,796	   65	   0	   0.13	   2	   6.6E-­‐49	   9.6E-­‐35	   2.9E-­‐17	   SLC22A11-­‐12	  
1Number	  of	  phenotyped	  carriers	  
2Most	  significant	  association	  in	  locus,	  conditionally	  independent	  of	  all	  nearby	  haplotypes	  
3Most	  significant	  nearby	  single	  marker	  association	  
4Least	  significant	  haplotype	  association	  after	  conditioning	  on	  all	  nearby	  single	  markers	  




Supplementary	  Table	  6:	  Phenotype	  summary	  for	  Kosraen	  data	  
Trait	   Abbreviation	   Total	  Samples	  
Body	  Mass	  Index	   BMI	   2,369	  
Cornell	  voltage	   CLVresstd	   1,576	  
C-­‐Reactive	  Protein	   logCRP	   1,872	  
Diastolic	  Blood	  Pressure	   DBP	   2,520	  
Fasting	  Blood	  Sugar	   FBS	   1,753	  
Folic	  Acid	   Folate	   1,882	  
Height	   HeightZ	   2,364	  
Hemoglobin	  A1c	   HBA1C	   1,079	  
High	  Density	  Lipoprotein	  Cholesterol	   HDL	   2,774	  
Homocysteine	   Homocysteine	   1,870	  
Insulin	  Sensitivity	   INSD	   1,166	  
Leptin	   LEP	   2,849	  
Low	  Density	  Lipoprotein	  Cholesterol	   LDL	   2,775	  
Percentage	  of	  Body	  Fat	   pctfat	   1,796	  
PR	  interval	   PRresstd	   1,595	  
QRS	  interval	   QRSdurresstd	   1,573	  
Resting	  rate	  interval	   RRresstd	   1,513	  
Sokolow-­‐Lyon	  voltage	   SLVresstd	   1,541	  
Systolic	  Blood	  Pressure	   SBP	   2,521	  
Thyroid	  Stimulating	  Hormone	   TSH	   1,858	  
Total	  Cholesterol	  Levels	   TC	   2,753	  
Triglyceride	   TG	   2,754	  
Uric	  Acid	   logUrate	   1,861	  
Waist	  Circumference	   waist	   2,814	  
Weight	   WT	   2,335	  




Supplementary	  Table	  7:	  Phenotype	  summary	  for	  WTCCC	  data	  
Trait	   	   Cases	  
Bipolar	  Disorder	   BD	   1,998	  
Coronary	  Artery	  Disease	   CAD	   1,988	  
Chron's	  Disease	   CD	   2,005	  
Hypertension	   HT	   2,001	  
Rheumatoid	  Arthritis	   RA	   1,999	  
Type	  1	  Diabetes	   T1D	   2,000	  
Type	  2	  Diabetes	   T2D	   1,999	  




Supplementary	  Table	  8:	  Initial	  and	  replicated	  haplotype	  association	  with	  HBa1c	  
Cohort	   Start	   End	   SNPs	   f1	   PVAL	  
corrected2	  
PVAL	   OR	  
Kosrae	   87,261,769	   87,465,349	   10	   9.95%	   2.5E-­‐24	   8.5E-­‐19	   0.47	  
DGI	  replication	   87,404,625	   87,560,132	   16	   0.63%	   3.9E-­‐05	   0.015	   0.19	  
1Frequency	  in	  entire	  cohort	  
2Bonferroni	  corrected	  for	  all	  haplotypes	  tested	  




Supplementary	  Table	  9:	  Functional	  variants	  present	  in	  carriers	  of	  two	  associated	  haplotypes	  













































2	   2	   0	   1	   0	   1	   1	   3	   0	   0	   16	   87,240,737	   CYBA	   rs4673:G	   TOLERATED	   0.003	  
2	   2	   0	   0	   1	   1	   4	   0	   0	   0	   16	   87,306,116	   C16orf84	   rs7205989:A	   DAMAGING	   0.051	  
1	   2	   0	   0	   1	   0	   4	   0	   0	   0	   16	   87,399,646	   CDT1	   rs507329:C	   TOLERATED	   -­‐	  
5	   0	   0	   2	   1	   1	   3	   1	   0	   0	   16	   87,821,231	   ZNF778	   novel	   DAMAGING	   0.001	  
2	   2	   0	   0	   1	   2	   3	   1	   0	   0	   16	   87,875,539	   ANKRD11	   novel	   TOLERATED	   0.122	  
12	   0	   2	   1	   0	   9	   0	   4	   0	   0	   16	   87,877,261	   ANKRD11	   novel	   TOLERATED	   -­‐	  
8	   0	   1	   2	   0	   7	   0	   4	   0	   0	   16	   87,878,113	   ANKRD11	   novel	   TOLERATED	   -­‐	  
	  
